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Abstract 
 
Histone modifications have been closely associated with changing levels of gene 
expression, but their role in determining, or possibly predicting, patterns of 
expression is uncertain. Here, the link between histone modifications and Hoxb gene 
expression in mouse embryonic stem (ES) cells was explored. 
 
Levels of the “active” modifications H3K9ac and H3K4me3 at Hoxb promoters varied 
widely from gene to gene, but were closely correlated in ES cells. Contrastingly, the 
repressive modification H3K27me3 was found at equivalent levels across the cluster. 
Treatment with the histone deacetylase inhibitor valproate induced a coordinate 
increase in the levels of H3K9ac and H3K4me3 at all Hoxb promoters, but not other 
genes, whilst H3K27me3 was unaffected. Such increases were not maintained upon 
removal of the inhibitor.  
 
All Hoxb genes were silent in undifferentiated ES cells, but expression was activated 
at defined times of differentiation in the expected 3’ to 5’ sequence. The valproate-
induced increase in active modifications did not induce Hoxb expression from the 
cluster in undifferentiated cells, nor was there any major shift in the timing of Hoxb 
expression in cells transiently exposed to valproate (ie. hyperacetylated) during the 
start of differentiation. Thus, active histone modifications at the Hox genes are 
uncoupled from transcription. 
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1 Introduction 
1.1 Regulation of Transcription Initiation 
1.1.1 Prokaryotic gene regulation 
The basic principles of transcriptional regulation were first elucidated by Francois 
Jacob and Jacques Monod at the Lac operon in E. coli (Jacob & Monod, 1961). In 
prokaryotes the promoter, in the absence of any regulatory sequences, is in a 
permissive ground state. Transcription initiation is limited only by the rate at which 
RNA polymerase can gain access to, and clear the promoter (Struhl, 1999). 
However, even simple prokaryotes must be able to respond to external cues, 
particularly in response to nutritional status, since induction of metabolic pathways is 
important to allow adaptation to environmental changes. To this end, multiple genes 
required in metabolic pathways are transcribed as long polycistronic RNAs and 
hence are regulated in concert. At the lac operon this is achieved by repressive and 
activating systems that are able to sense the relative levels of lactose and glucose in 
the environment respectively (Figure 1.1). The protein repressor constitutively binds 
the cis regulatory sequence, the operator (Figure1a). The lac repressor is a tetramer 
Upon its metabolism into allolactose, lactose is able to bind the repressor protein 
causing a conformational change and its dissociation from the regulatory DNA 
(Figure1.1b). This clears the promoter for RNA polymerase binding and transcription 
of the genes required for lactose metabolism. Significant transcription, however, 
requires that the CAP (catabolite activator protein) binds at a sequence upstream of 
the promoter as the promoter is weak. CAP is only able to bind if it itself is bound to 
cAMP, a metabolite that is only abundant in the absence of glucose (Figure1.1c). 
Thus the bacterium is fine-tuned such that it only transcribes the genes for lactose 
metabolism in the presence of lactose, and when there is no alternative substrate. 
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1.1.2 Eukaryotic Gene Regulation 
The simple prokaryotic model of gene regulation is elegant and effective, however 
does not meet the complex needs of higher eukaryotes. In higher eukaryotes, genes 
are arranged adjacent to individual promoters and co-ordinately regulated genes are 
not transcribed as one. The genome of such organisms is vast when compared with 
prokaryotes. This size is compounded by the complexity that arises because the bulk 
of eukaryotic genomes are non-protein-coding. In addition, gene number is not 
correlated with complexity, but the number of non-coding sequences is, thus the C. 
Elegans genome is 30 times smaller than the human genome, implicating these 
additional non-coding sequences in gene regulation (Taft et al, 2007). As in 
prokaryotes, transcription initiation requires the recruitment of the RNA polymerase, 
but also general transcription factor proteins are required. In fact, across eukaryotes, 
the basic mechanism of transcription initiation and the proteins required are very well 
conserved. First, activators must bind upstream of the core promoter leading to 
recruitment of multi-protein adaptor complexes such as SAGA or mediator that are 
then able to bring in the general transcription factors to the site of transcription 
initiation. These general transcription factors, TFIIA, TFIIB, TFIID, TFIIE, TFIIF and 
TFIIH are able to form the pre-initiation complex with RNA polymerase (Thomas & 
Chiang, 2006). TFIIH then “melts” the DNA at the transcription start site, opening up 
the two strands of DNA in order to poise the polymerase to commence transcription. 
The polymerase is then sequentially phosphorylated at its C terminal domain before it 
loses contact with the pre-initiation complex and moves on to the elongation stage. 
However, in contrast to the permissive ground state of a prokaryotic promoter, 
eukaryotic promoters are restricted, that is, trans-acting factors are a requirement for 
activation of these promoters (Struhl, 1999). This does however, present somewhat 
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of a challenge to the organism as these activating proteins must locate their cognate 
binding sites, as small as 6-8 base pairs long in the expanse of non-coding DNA. 
Furthermore, such binding must be strictly regulated as the small consensus binding 
sequences mean there is a high number of potential binding sites present in the 
genome (Thorne et al, 2009). This presents a challenge in our understanding of 
eukaryotic gene expression. Just what is it that produces the restrictive environment, 
and how are genes switched on, and indeed off? 
 
1.2 Chromatin and transcriptional regulation 
The increase in genome complexity through evolution is proposed to have been 
possible only through the coordinate introduction of a buffer to prevent inappropriate 
transcription (Bird & Tweedie, 1995). The central candidate for such a buffer is the 
structure of proteins and DNA termed chromatin into which DNA is packaged within 
the nucleus (Knezetic & Luse, 1986; Lorch et al, 1987). 
 
Chromatin is made up of different levels of regular structure (Figure 1.2). At the 
lowest level, the fundamental repeating unit is the nucleosome (Luger et al, 1997). 
The nucleosome comprises, two histone H2A-H2B protein dimers flanking an histone 
H3-H4 tetramer to form an octameric globular protein core. The histone proteins are 
basic and so provide a good platform to package negatively charged DNA. 146 base 
pairs of DNA are wound around this octamer in 1 ¾ superhelical turns. Variable linker 
lengths are present between each nucleosome, producing a “beads on a string” 
structure. This structure can be further wound into the “30nm fibre”. The precise 
nature of the structure of this fibre is not known, and is still the topic of heated  
5 
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debate, however it is known to involve a fifth “linker” histone protein, H1 (Satchwell & 
Travers, 1989). Further regular levels of structure exist that result in the compaction 
of DNA into the nucleus (Figure 1.2).  
 
The existence of two forms of chromatin identifiable by electron microscopy; 
euchromatin, a transcriptionally more permissive gene-rich form and 
heterochromatin, a transcriptionally inactive gene-poor compacted form supports the 
role of chromatin in gene regulation. However, some essential genes are located 
within constitutive heterochromatin and are transcribed (Dimitri et al, 2005). 
Nonetheless one might speculate that chromatin does play a role in the regulation of 
gene transcription and that this might simply be to “block” the recruitment of both 
general and specific transcription factors to the DNA. 
 
1.2.1 Regulating access to DNA 
The discovery that in mammalian cells, the mouse mammary tumour virus promoter 
contains consistently ordered nucleosomes when integrated into mammalian cells 
indicated a possible role for these nucleosomes in transcriptional regulation at this 
promoter (Fragoso et al, 1998; Richard-Foy & Hager, 1987). This is highlighted by 
the fact that the second of these nucleosomes is positioned over the binding site for 
the glucocorticoid receptor. This protein, along with nuclear factor 1 (NF1) is involved 
in the transactivation of the virus. For transcription to commence, the glucocorticoid 
receptor must recruit ATP-dependent remodellers to the promoter (BRG or SWI/SNF) 
(Fryer & Archer, 1998; Muller et al, 2001). These open up the chromatin and allow 
the recruitment of NF1 and the assembly of the transcriptional initiation complex 
(Archer et al, 1992). Thus, here, the ordered positioning of nucleosomes before 
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activation, and their remodelling upon activation argues for a simple “blocking” role of 
chromatin. 
 
The ATP-dependent remodelers were initially discovered in yeast. The SWI/SNF 
family were known to be transcriptional activators for a long time, though their 
mechanism of action remained elusive until it was discovered they could remodel 
chromatin upon hydrolysis of ATP (Clapier & Cairns, 2009). Thus, as is now evident, 
these proteins open local chromatin to allow, amongst others, transcriptional 
activators and the core components of the transcription complex to the DNA. 
However, there still remains the question of how these activators are targeted to 
specific genes. In addition, such transcriptional “blocking” seems a rather blunt tool 
with which to finely tune transcription. For this, we must look to the unstructured 
histone tails. 
 
1.3 Histone tail modifications  
The histone N-terminal tails that protrude from the nucleosome core particle are 
subject to an array of post-translational modifications. They include; phosphorylation 
at serine and threonine residues, acetylation at lysine residues and ubiquitination and 
methylation at lysine and arginine residues. These modifications are performed by 
specific enzymes and occur at specific amino acid residues.  
 
1.3.1 The Dynamics of histone tail modifications 
The enzymes regulating histone acetylation and deacetylation are well characterised. 
They consist of histone acetyl transferases (HATs) that catalyse the addition of acetyl 
groups onto the ε-amino group of lysine residues, and histone deactylases (HDACs)  
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that catalyse their removal from the lysine group (Carmen et al, 1996; Johnson & 
Turner, 1999; Sterner & Berger, 2000) (Figure 1.3). The HATs are grouped into three 
main families; GNAT, MYST and CBP/p300. Generally histone acetyl transferases 
show specificity for more than one lysine. The histone deactylases are also classified 
into three groups; class I, class II and the class III NAD dependent family. In general, 
these enzymes are of broad specificity. Interestingly, the class I enzymes may be 
inhibited by naturally occurring short-chain fatty acids and class III by nicotinamide 
(Johnson & Turner, 1999).  
 
The histone lysine methyl mark is deposited by the lysine methyltransferase 
enzymes. These transfer the methyl group of s-adenosyl methionine to the specific 
lysine group of the histone tail. They are highly specific when compared with the 
acetyl transferases (Zhang & Reinberg, 2001). The histone lysine demethylases, also 
show residue specific activity (Bannister & Kouzarides, 2005). In addition, 
methylation shows further complexity in that lysine molecules may be mono, di or tri 
methylated with the enzymes themselves showing specificity not only for the residue, 
but also for the level of methylation. Thus far, only the enzymes that methylate, not 
demethylate the arginines of histones have been elucidated. However, although no 
demethylating activity has been found, a deimination enzyme has and this activity is 
found to antagonise that of histone arginine methylation (Cuthbert et al, 2004). There 
are many more enzymes that have been characterised that may modify histone tails, 
further relatively-well characterised groups are the kinases and phopshatases 
involved in depositing and removing the phosphate mark (Nowak & Corces, 2004) 
and the enzymes involved in ubiquitination and deubiquitination (Shilatifard, 2006).  
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From this equilibrium of histone modifying enzymes, two important points have been 
made. Firstly, histone tail modifications are dynamic and are therefore a reflection of 
the action of the enzymes that deposit and remove them (Figure 1.3). They are thus 
likely to localise to different parts of the genome at different developmental stages, or 
in response to different external signals to maintain or alter histone modifications at 
different loci. Secondly, the dependence of many of the histone tail modifying 
enzymes upon both intracellular and extracellular cofactors means that the 
nucleosome must, at least to some extent, reflect the metabolic state of the cell and 
the environment in which the cell finds itself (Figure 1.3). Thus, the nucleosome could 
potentially be a signalling molecule at the end of a signal transduction cascade, 
regulating gene expression in response to external cues (Johnson & Turner, 1999; 
Thorne et al, 2009). 
 
1.3.2 Charge-specific effects of histone modifications 
At their initial discovery, it was proposed that histone modifications could induce their 
transcription-related outcomes via the modulation of the overall charge of the 
nucleosome. Thus, histone acetylation would result in a decrease in the positive 
charge of the nucleosome, decreasing the attraction between the negatively charged 
DNA and the nucleosome. Thus, transcriptional activation at a locally acetylated 
region of chromatin would merely be a result of an “opening” of chromatin due to 
neutralisation of the basic tails. Evidence for such charge-specific effects has been 
displayed in artificially reconstituted nucleosome arrays(Tse et al, 1998). The 
incorporation of acetylated histones prevented the formation of the 30-nanometre like 
fibres. This is consistent with a more “open” form of chromatin. However, charge 
effects alone could not explain the H4K16ac-specific effects seen in a different study. 
In this study, a series of yeast mutants were generated mutating each histone lysine 
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acetylation site at histone H4 to an arginine, both individually and combinatorially 
(Dion et al, 2005). This builds on previous work, that showed that mutation at these 
sites was not lethal but did confer phenotypes consistent with a role for these acetyl 
residues in gene expression, nuclear division and DNA replication (Megee et al, 
1990). Another earlier study mutating the H4 tail also showed the H4 acetylation sites 
to be important in gene regulation (Durrin et al, 1991). The mutation of lysine to 
arginine mimics the charge effects of this residue in its unacetylated state and does 
not allow acetylation. Transcriptional effects on mutation at the sites were cumulative 
except for at histone H4K16. Thus, mutation at all other sites was consistent with 
charge effects alone (Dion et al, 2005). Such a result is not surprising if one 
considers that not all histone tail modifications result in the alteration of charge at the 
tail, for example methylation. Thus some other mechanism must exist by which 
histone tails may act to activate or repress transcription. The observation that 
differently acetylated H4 isoforms localise to specific regions in Drosophila polytene 
chromosomes led to the hypothesis that the nucleosome tails may act as specific 
docking modules for non-histone proteins by means of their post-translational 
modifications (Turner et al, 1992). Such non-histone proteins could then modulate 
chromatin structure and function themselves by bringing in further histone modifying 
activities or transcription factors to name but a couple of potential examples. 
 
1.3.3 Chromatin readers 
For such a model of protein recruitment to be feasible, there must be some means 
for the post-translational modifications to be interpreted; therefore proteins must exist 
that can firstly bind to the specifically modified histone, and secondly recruit gene 
repression or activation activities. Furthermore, it would be expected that some 
12 
combinations of modifications actively deter the binding of some transcriptional 
modulators.  
 
The acetylated lysine motif is “translated” by the bromodomain. This domain was first 
described in Drosophila in the brahma transcriptional activator (Tamkun et al, 1992). 
In this study, it was noted that this motif was common to many transcriptional 
activators across eukaryotes. Since then, bromodomains have been found in many 
chromatin associated proteins, notably chromatin remodellers and most histone 
acetyl transferases (Horn & Peterson, 2001). A study in yeast went on to confirm the 
role of bromodomains in remodeller recruitment (Hassan et al, 2002). The study 
displayed the absolute dependence of the binding of the chromatin-remodelling factor 
SWI/SNF upon both its bromodomain and previous acetylation at the promoter by the 
yeast HAT complexes SAGA or Nu4; thus building up a sequential picture of gene 
activation. Since then human homologues have been elucidated that are also 
dependent upon their bromodomains (Chiba et al, 1994). A direct role for this domain 
in activating transcription is displayed in the TFIID constitutive transcription factor 
subunit TAF1. TAFIID is required for the recruitment of pol II to the TATA box. The 
structure of a fragment of the TAF1 protein containing the double bromodomain from 
humans revealed tandem domains suitable for binding to diacetylated histone H3K9 
and K14 (Jacobson et al, 2000). Such a tandem arrangement of domains confers 
specificity of protein binding. Indeed, bromodomains, whilst conserved across 
proteins and species are variant, this variance no doubt influences binding specificity. 
A role for protein context in specificity has also been inferred (Hassan et al, 2002). In 
accordance with its recruitment role, the bromodomain is found widely distributed 
across histone modifying enzymes and chromatin remodellers (de la Cruz et al, 
2005). Furthermore, its presence at histone acetyl transferases immediately suggests 
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a model of self-potentiation of the mark through binding, modifying and further 
recruitment.  
 
The first discovered histone methyl mark translator was the chromodomain. It was 
first identified in the heterochromatin protein HP1 and Drosophila polycomb protein 
(Paro & Hogness, 1991). Both polycomb and HP1 are involved in stable gene 
silencing which will be further discussed later. HP1 binds specifically at H3K9me3 
(Bannister et al, 2001). Gene repression may be induced by artificially targeting the 
H3K9 methylation enzyme activity to genes in human cells indicating that this 
modification is sufficient to initiate gene silencing (Snowden et al, 2002). In addition 
to its interaction with H3K9me3, HP1 interaction with the suv39 methyl transferase is 
also a requirement for the recruitment of this protein to heterochromatin in mammals 
(Stewart et al, 2005). The interaction between the two proteins, also suggests a self-
propagating mechanism of heterochromatin whereby HP1 can recruit further 
methylase activity which, in turn, recruits further HP1. Thus, it can be envisaged that 
methylation spreads along the chromosome in concert with these two proteins.  
 
Conversely, histone lysine methyl marks at H3K4me3 are known to be associated 
with active genes. This mark is catalysed by the Set 7/9 and MLL family of histone 
methyl transferases in humans (Milne et al, 2002; Nishioka et al, 2002; Wang et al, 
2001) and in yeast by Set1 (Briggs et al, 2001). A translator of this mark is the 
binding protein Chd1. Chd1 has been demonstrated to function in chromatin 
remodelling, gene expression and transcriptional elongation in yeast (Simic et al, 
2003; Tran et al, 2000). The CHD family of proteins have two chromodomains and an 
ATP dependent chromatin remodelling activity (Woodage et al, 1997). Chd1 was 
found to be a part of the yeast SAGA and SLK complexes; large histone acetyl 
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transferase containing gene-activating complexes (Pray-Grant et al, 2005). One of 
the chromodomains was shown to bind specifically to H3 trimethylated at lysine 4, 
thus coupling its role of transcriptional activation with binding to chromatin. Thus, 
reading the histone post-translational modifications gives a defined transcriptional 
activity. This role may be, however, organism specific since it was found in a different 
study that unlike human chd1, yeast Chd1 was unable to bind to H3K4me3 (Sims et 
al, 2005). Chromodomains are part of the tudor domain “royal family” that includes 
the tudor and MBT domains (Kim et al, 2006a). Tudor and MBT domains have also 
been shown on arrays to posses the ability to bind to methylated histone H3 and H4 
tails (Kim et al, 2006a). There is also another domain, the PHD finger domain that 
has been shown to link H3K4me3 with active transcription (Wysocka et al, 2006). 
This domain is found in the nuclear remodelling complex NURF, an ISWI containing 
nuclear remodelling complex. Depletion of H3K4me3 causes a decrease in binding of 
the subunit containing this domain and the bromodomain preventing the recruitment 
of the ATPase subunit to chromatin. This causes the repression of a subset of genes 
including Hoxc8.  
 
There still remain many modifications for which the details of the protein ‘translators’ 
are not known. An interesting mark, H3K36me3, currently has no clear ‘readers’. In 
yeast, the H3K36me3 depositing enzyme set2 is known to associate with the 
elongating polymerase, providing a direct link for this modification in transcription, 
though the exact mechanism is not known (Kizer et al, 2005). It is known however, 
that acetylation at H4 is required for set2 binding, and hence the enzyme itself 
contains an H4 acetylation chromatin reader (Du et al, 2008). Furthermore, a 
common acute myeloid leukaemia (AML) gene nuclear receptor-binding SET domain 
protein 1 (NSD1) that is translocated in AML is able to methylate at H3K36me3. The 
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fused enzyme is able to induce the HoxA7 and HoxA9 proto-oncogenes by 
maintaining histone H3K36methylation by binding through its PHD domain(Wang et 
al, 2007). The direct mechanisms by which this modification is able to active these 
HoxA genes in mice is still unknown. Thus the translation of histone modifications is 
still very much an active part of research.. 
 
Interestingly, domains also exist that may only bind to unmodified tails. The de novo 
DNA methyltransferases DNMT3A is dependent upon the stimulation by DNMT3L, an 
associated protein. The N terminal domain of this protein is only able to bind H3 tails 
that are unmethylated H3K4, and hence those genes that are already marked for 
transcription by this modification are unable to be silenced by the methylation of their 
DNA(Ooi et al, 2007). Thus unmodified tails may ‘mark’ genes to be silenced and 
hence require their own translators. 
 
1.3.4 Combinatorial possibilities and the histone code hypothesis 
Whilst the exact significance of the chromodomain within the yeast SAGA and SLK 
complex remains controversial, it does introduce the concept that histone 
modifications may act in concert. Here, a methylated residue brings acetylation to 
adjacent residues. Since bromodomains are present in histone methylating enzymes, 
these may act to produce a defined combination of marks whereby a histone 
methytransferase binds chromatin via its bromodomain and then methylates, in cis, 
adjacent residues (Loyola & Almouzni, 2004). Thus, one specific modification may 
not result in a functional outcome alone, but when placed in the context of other 
modifications, it may result in active or inactive transcription by recruiting multiple 
non-histone proteins, or proteins with more than one domain that recognises 
modified histones. Indeed, it may be that the deposition of one mark predisposes that 
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histone tail for further enzyme modification establishing a mechanism for producing 
combinations of marks. Such a mechanism has been shown to exist in the cross-talk 
between histone H3K4 methylation and histone acetylation. The action of the H3K4-
specific methyl transferase MLL is stimulated by histone substrates that are pre-
acetylated (Nightingale et al, 2007). Given such combinatorial possibilities at the 
histone tails, a histone code hypothesis was proposed (Jenuwein & Allis, 2001; Strahl 
& Allis, 2000; Turner, 1993; Turner, 2000; Turner, 2002). This suggested that the 
combination of histone modifications result in a specific function being conveyed at a 
chromatin locality. Much of this can be explained by simple biochemistry. The 
modifications provide docking sites for (i) chromatin remodellers that may open or 
close the chromatin, (ii) transcription factors that may induce transcription, (iii) 
histone modifying enzymes that may add further modules to the code (iv) other 
proteins that convey distinct functional outcomes upon chromatin. Such recruitment 
or in other cases exclusion is the result of steric interactions between the proteins. To 
really take the code further the combination of modifications must be predictive of a 
certain functional outcome, i.e. they must be causative, not just permissive or 
consequential of such an outcome. 
 
A good example of combinatorial outcomes is provided by the TFIID transcription 
factor. As discussed above, the TAF1 subunit contains tandem bromodomains able 
to bind at tandemly acetylated lysines. However, in addition to this, the TAF3 subunit 
of TFIID is able to bind to the actively associated H3K4me3 modification via its PHD 
domain and this interaction of TFIID with H3K4me3 is potentiated by the acetylation 
of H3K9Ac and H3K14Ac, presumably due to their interaction with TAF1 (Fig 1.4). 
Furthermore, the interaction of TAF3 with H3K4me3 is inhibited by the asymmetric 
methylation of H3R2 (Jacobson et al, 2000). Thus, here there is a combination of  
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 modifications that may lead to the recruitment or ‘blocking’ of a constitutive 
transcription factor leading to transcription, or not, as appropriate. 
 
Following on from this ‘negative’ outcome produced by H3R2me2 another ‘negative’ 
outcome is exemplified by HP1’s interactions with chromatin. The HP1 protein, as 
previously discussed, is able to recognise the H3K9me3 mark, localising this protein 
to heterochromatin. Initial in vitro experiments showed that the binding of HP1 to 
H3K9me3 modified peptides was ablated by the adjacent modification 
phosphorylation of H3S10 resulting in the hypothesis of a “methyl-phosphoryl” switch 
(Fischle et al, 2003a) (Figure 1. 4). In vivo, however, the two modifications H3K9me3 
and H3S10 phosphorylation were shown to coexist at the beginning of mitosis and 
HP1 ejection was a result of coordinated H3K14 acetylation and H3S10 
phosphorylation (Mateescu et al, 2004). This is however, consistent with previous 
findings that the Aurora B kinase, the kinase responsible for depositing the H3S10 
phosphorylation mark is required for the ejection of HP1 from heterochromatin during 
mitosis (Hirota et al, 2005).  
 
The H3S10P mark is not only involved in the ejection of HP1 in mitosis. It has been 
shown to be a final phosphorylation mark in immediate early gene signal transduction 
upon exposure to mitogens or stress (Mahadevan et al, 1991). This is induced on the 
MAP kinase pathway by the Rsk-2 or Msk-1 kinases, or on the p38 stress activated 
by Msk-1 (Thomson et al, 1999). Again, as in mitotic heterochromatin, there is strong 
evidence for a coupling of this mark with histone acetylation upon mitogenic 
stimulation using antibodies to the doubly modified mark H3K9acH3S10P (Clayton et 
al, 2000). In addition, histone phosphorylation was shown to precede acetylation in 
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vivo and in vitro. H3 acetylation was stimulated by an H3S10 phosphorylated peptide 
(Cheung et al, 2000).  
 
The presence of more than one histone modifying enzyme in a complex together 
further argues for a combinatorial code. For example, the histone acetyl transferase, 
MOF associates with the methyl transferase MLL1 (Figure 1.4). Both are responsible 
for the implementation of so-called “active” marks H4K16ac and H3K4me3 
respectively. They were shown to coordinate methylation and acetylation both in vitro  
and in vivo, and to both be required for the activation of known MLL target genes and 
in an in vitro transcription assay (Dou et al, 2005). Furthermore, the mechanism of 
this complex recruitment is known to be reliant upon the WDR5 component of the 
MLL complex that is able to bind to histones di and tri-methylated at histone H3K4 
using its WD40 repeat domain. Note that the specificity of WDR5 for di and tri-methyl 
H3K4 means that it is not involved in the initial recruitment of MLL to unmethylated 
H3K4, however, it is involved in a self-potentiation mechanism of this mark. A study 
in yeast further elucidated a mechanistic link between the active H3K4me3 and 
acetylation marks, though this time at H3K14ac. In this example, the histone “reader” 
is a PHD finger at the Yng1 protein in the NuA3 histone acetyl transferase complex. 
Disrupting the binding of the acetyltransferase complex at H3K4me3 resulted in a 
decrease in H3K14ac levels and altered transcription in a subset of NuA3 target 
genes (Taverna et al, 2006). This example thus further supports the hypothesis of a 
combinatorial code.  
 
A final fascinating example of histone modifications talking to one another code is 
provided by the link of H2B ubiquitination in trans with subsequent H3K4 and H3K79 
methylation, again in yeast (Dover et al, 2002; Ng et al, 2002; Sun & Allis, 2002). The 
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link between these reactions is mediated by the transcription elongation complex 
Paf1 which is proposed to recruited to the ubiquitination mark and remodel chromatin 
in order allow the recruitment of histone methyl transferases (Ezhkova & Tansey, 
2004). The monoubiquitination H2B mark, this time at K120, has also shown to be 
important in transcriptional regulation of the Hoxa and c genes in humans. 
Importantly it appears that this mechanism of cross-talk between H2B ubiquitination 
and H3K4me3 and H3K79me3 is conserved between yeast and humans (Zhu et al, 
2005). 
 
The protein domains that translate combinations of marks must also occur in tandem 
if they are to read a combinatorial code. The tandem bromodomains of the TFIID 
transcription factor subunit TAF1 have already been discussed above, but equally 
proteins have been discovered that contain two different chromatin-binding domains 
that cooperate. For example, the PHD finger domain is often found adjacent to 
chromodomains and bromodomains as exemplified by TFIID and was shown to be 
important in conferring the specificity of binding of p300, a transcriptional activator 
(Ragvin et al, 2004). 
 
1.3.5 Histone codes induced by cell signalling 
A comprehensive study of the induction of the interferon promoter upon viral 
stimulation led to the elucidation of a specific combination of histone lysine 
modifications read by bromodomain containing proteins at this promoter. This study 
exemplified much of the major elements required for a histone code; modifications 
occurred sequentially and were accompanied by sequential recruitment of 
transcriptional activators followed by transcriptional activation (Agalioti et al, 2002). 
Through the use of recombinant mutant histone proteins, the relative importance of 
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sites of histone acetylation for protein recruitment was established. Acetylation of 
histone H4 at lysine 8 by GCN5 (a HAT) was required for the binding of the BRG1 
bromodomain containing subunit of the SWI/SNF complex, and acetylation at lysines 
9 and 14 by the same protein required for the recruitment of the transcription factor 
TFIID (TAF1 is the bromodomain containing subunit of this transcription factor as 
discussed above)(Jacobson et al, 2000). Surprisingly, despite its recruitment to the 
promoter, p300 was not required for these acetylation events. The conformational 
change induced at the promoter by the binding of TFIID causes the SWI/SNF protein 
to act by sliding the previously modified nucleosome downstream and allowing 
transcription to commence (Lomvardas & Thanos, 2001). Thus recruitment of the 
SWI/SNF by its bromodomain at specifically modified lysines results in chromatin 
remodelling and a specific transcriptional outcome. 
 
Another example of cell signalling to the nucleus resulting in histone modifications 
changes is that of the immediate early signalling pathway as discussed above. Here, 
mitogenic stimulation of cells in G0 results in the phosphorylation of a select group of 
immediately genes such as myc and fos at H3 serine10. This results in the 
recruitment of 14-3-3 proteins specifically to these regions of chromatin (Macdonald 
et al, 2005). Such an interaction is not adversely affected by the acetylation of 
H3K9Ac or H3K14Ac, and may even form a part of a combinatorial code. Such 14-3-
3 proteins are linked to control of a wide range of biological processes such as cell 
cycle timing, signal transduction, cell death, and functions related to transcription and 
histone modification. Thus, this link of H3S10 with these proteins provides an insight 
into the function of the modification. 
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Finally, a more complex picture of sequential events was determined at the 
oestrogen receptor alpha’s target promoter, pS2 (Metivier et al, 2004). Since this is a 
hormonally induced promoter, conclusions are most likely only relevant to such 
promoters but nevertheless show significant interest. The studies characterised the 
sequential recruitment of around thirty different proteins and four histone 
modifications to the promoters at the oestrogen receptor alpha target promoter pS2 
in a cell culture system. Synchronicity in induction was achieved by treating the cells 
with a transcriptional inhibitor before introducing the oestrogen receptor ligand. The 
proteins studied included; histone modifying enzymes, transcription factors, central 
components of the transcriptional machinery and nucleosome remodelling enzymes. 
Changes in histone modifications and nucleosome remodelling directed transient 
recruitment of different protein complexes through three different cycles and were 
thus postulated as being the “clock” mediator. Interestingly, the first cycle does not 
result in transcription, but poising the promoter ready for transcription (Metivier et al, 
2004). Also, protein complexes often associated with transcriptional repression were 
important for clearing active states between cycles. From this study, and that at the 
interferon promoter it is clear that a histone code is unique at each promoter. In 
addition, the code may be different dependent upon the stimulus since histone 
modifications induced at the Hsp70 promoter were shown to be unique dependent 
upon whether induction was caused by heat shock or by sodium arsenite, and 
therefore not simply a measure of transcriptional induction in general (Thomson et al, 
2004). 
 
1.3.6 Multiple roles for histone marks 
Despite the link of the two marks H3K4me3, and H2B mono-ubiquitination discussed 
above by a transcriptional elongation complex, the readout of these marks does not 
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always result in gene activation. At some loci these two marks are involved in gene 
silencing, thus the manner in which the code is read is of utmost importance and 
most probably relies upon some other mark or mechanism to provide context for the 
mark reading (Fingerman et al, 2005). Similarly, in mammals, association of the ING 
family of PHD domain proteins at H3K4me3 confers a repressive read-out of the 
H3K4 trimethyl mark, contrary to active readout by Chd1 and Wdr5 95 (Santos-Rosa 
et al, 2003; Shi et al, 2006). This ING protein mediates its repressive role further by 
recruiting HDAC complexes to its target promoters. Thus this protein was speculated 
to have a particularly important role in rapid shut down of gene transcription during 
acute stress, for example during the DNA damage response. Furthermore, H3K9me3 
and HP1 proteins are not always associated with gene silencing (Vakoc et al, 2005). 
H3K9me3 was shown to be enriched at induced erythroid specific genes in an 
erythroid cell line. This enrichment was shown to be coordinated with the binding of a 
form of the HP1 protein, HP1 gamma. Thus it appears that the result of a histone 
modification very much depends upon its protein translator and, as yet unidentified 
context.  
 
Building on this context-dependence of histone modifications. The H3K36me3 mark, 
a mark often associated with transcriptional elongation, was recently shown to be 
preferentially associated with exons in C. elegans. (Kolasinska-Zwierz et al, 2009). 
This marking was present only in highly expressed genes and was not so at 
alternatively included exons, suggesting the modification marks the exon for 
inclusion. This pattern was shown to be conserved through to humans and mouse. A 
further study showed that, in fact the exons are enriched for nucleosomes, and other 
modifications including the H3K36me3 modification (Schwartz et al, 2009). In fact, 
the levels of these modifications varied in the exons from the 5’ to the 3’ end of the 
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gene, thus suggesting that the marking of exons by nucleosomes may have a role in 
defining the exon-intron structure of a gene. Thus, the histone ‘code’ need not apply 
only to transcription. 
  
1.4 The location of histone marks within genes 
If histone marks are truly involved in the coordination of transcription, be it initiation or 
elongation, then one would expect their distribution across active or inactive genes to 
follow a non-random distribution i.e. those that are involved in the initiation of 
transcription would be found at the promoter, and those involved in elongation in the 
body of the gene. Indeed, initial studies in yeast showed the exclusive association of 
H3K4me3 with transcriptionally active genes and H3K4me2 within euchromatic sites 
(Noma et al, 2001; Santos-Rosa et al, 2002). Further to this, the enzyme Set1, 
responsible for depositing the H3K4me3 mark was found to associate with a form of 
the polymerase that immediately precedes the elongation phase of transcription 
leaving H3K4me3 at the coding regions of genes (Ng et al, 2003). Thus H3K4me3 
was postulated as having a direct role in initiation of transcription consistent with its 
interaction with Chd1 as discussed above. H3K36me2 has also been postulated as 
having a direct role in transcription from evidence in yeast. It is found in actively 
transcribed regions within yeast and its deposition enzyme, Set2, is found associated 
with the elongation-termination form of the polymerase (Krogan et al, 2003; Xiao et 
al, 2003).  
 
1.4.1 Genome-wide technology and histone modifications 
The advent of microarray and high-throughput sequencing technologies has meant 
that chromatin immunoprecipitation studies are no longer limited to the study of one 
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or a group of genes. These have allowed the further characterisation of histone 
modifications both within genes, from their promoters to their site of transcription 
termination, and across large expanses of chromosome. When examining these 
data, it is wise to keep in mind the limitations of such genome-wide experiments. 
Firstly, as with conventional ChIP, antibody specificity is of utmost importance. For 
example, antibodies against H3K9me3 and H3K27me3 must be tested thoroughly as 
their adjacent peptide sequences are identical. Second, again as with conventional 
ChIP, different methods for preparing chromatin may yield different results; the most 
fundamental difference being whether nucleosomes are generated by cross-linking 
and sonication, or by nuclease digestion (O'Neill & Turner, 1996). Finally, such 
experiments are performed on asynchronous populations of cells and provide a 
snapshot of this population at that given point in time. Thus, modification states are 
likely to be highly heterogenous. Also, when dealing with microarray data, the 
additional amplification step required to generate enough DNA label a slide may 
generate a bias toward specific sequences. 
 
In yeast, the initial ChIP-chip studies confirmed the location of H3K4me3 at the 
promoters of active genes, with dimethylation and monomethylation of the same 
residue being sequentially more enriched toward the end of genes (Pokholok et al, 
2005). Consistent with its role in elongation, H3K36me3 was found to localise to the 
body of active genes and acetylation of both H3 and H4 was found to localise to the 
promoters of genes (Krogan et al, 2003; Pokholok et al, 2005). 
 
In mammals, ChIP-chip data exists for a variety of different cell types at different 
developmental stages including human and mouse embryonic stem cells, neural 
progenitor cells, fibroblasts, hepatocytes and T cells (Barski et al, 2007; Li et al, 
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2007; Mikkelsen et al, 2007; Roh et al, 2006). The localisation of marks within genes 
is shown to be highly consistent across the studies and so called “typical” patterns 
are highly predictive of transcriptional start sites (Birney et al, 2007). Active genes 
are enriched for H3K4me3 and H3 and H4 acetylation in their promoters (Pan et al, 
2007) (Figure 1.5). They also show high levels of monomethylation at H3K27, H3K9, 
H4K20 and H3K79 (Figure 1.5). Inactive genes show high levels of trimethylation at 
H3K27 and H3K9. Thus, the consistent association of specific marks with active or 
inactive genes further supports a direct role for these marks in transcription by 
dictating a histone code. For the purpose of this thesis the marks that are found 
associated with active genes shall be termed active modifications and those 
associate with silent genes repressive marks. It must be remembered, however, that 
such studies are only correlative. 
 
Intriguingly, many of these genome-wide studies show that there is a difference in the 
patterns at CpG-poor and CpG-rich promoters. At CpG poor promoters, there is a 
correlation between active transcription and H3K4 methylation (Schubeler et al, 
2004). However, at CpG rich promoters, H3K4methylated forms are often found at 
the promoters independent of transcription (Barrera et al, 2008; Mohn et al, 2008; 
Weber et al, 2007). Interestingly, this is reliant upon the lack of methylation at the 
islands indicating a transcriptionally more “permissive” environment. Furthermore, the 
presence of methylated H3K4 prevents the binding of the de novo methylase 
Dnmt3a, and so methylation at H3K4 could also function to prevent de novo 
methylation at important regulatory elements. 
 
A final point to note when considering the relationship of histone modifications and 
transcription is; what do we actually mean by “active” transcription? The tightly 
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 regulated induction of gene expression has been called into question by the 
observed stochastic initiation of transcription. Indeed, such stochastic initiation has 
been shown to be of biological relevance. In erythroid cells, for example, stochastic 
gene expression is important in gene activation as initial stochastic gene expression 
patterns from alpha versus beta globin are clonally inherited (de Krom et al, 2002). 
More recently, transcription was shown to occur in bursts from a fluorescent reporter 
(Raj et al, 2006). Thus a gene that is considered active may only be periodically so. 
This “noise” can contribute significantly to the non-genetic heterogeneity of a cell 
population. Insertion of tandem copies of the transgene verses genome-wide 
insertion of multiple copies indicates that genes are under control of local, not global 
mechanisms. This is however, consistent with local chromatin structure playing a role 
in these transgene’s activation, keeping chromatin as a central candidate in gene 
control. In addition, measurements of stochastic wrapping and unwrapping of 
nucleosomal DNA could account for the access of proteins to the protein DNA-
binding sequences on a biological timescale (Li et al, 2005).  
1.5 Embryonic stem cells, pluripotency and chromatin 
1.5.1 Embryonic stem cell properties 
Embryonic stem cells (ES cells) are a population of pluripotent cells derived from 
epiblast cells of the inner cell mass of a pre-implantation stage embryo (Smith, 2001) 
and are a very interesting model in which to study transcriptional control (Figure 1.6). 
Their pluripotency confers the ability to divide to produce both a similarly pluripotent 
ES daughter cell and a more differentiated daughter cell (Figure 1.6). In culture, 
mouse ES cells and, to some extent, human ES cells, can be encouraged to 
differentiate down specific cell lineages providing a valuable tool in which to study 
differentiation and its associated changes in gene expression (Murry & Keller, 2008). 
Indeed, it is hoped that in the future such differentiation systems may be able to 
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provide a source of adult cells appropriate for regenerative medicine in the treatment 
of degenerative diseases such as Parkinson’s. 
 
The potential of ES cells to differentiate into all cell lineages requires that in the 
undifferentiated state, many genes are poised, ready for induction and therefore puts 
these cells in a “primed” state, whereby an external “push” in the right direction may 
result in commitment of the cells (Spivakov & Fisher, 2007). This has been proposed 
to result in ES cells existing in heterogenous populations, that puts them at an 
advantage as it continually presents opportunities for lineage specification (Silva & 
Smith, 2008). The pluripotency of stem cells is maintained by a transcription factor 
network, which includes Oct4, Nanog and Sox2 (Chambers et al, 2003; Ivanova et al, 
2006; Mitsui et al, 2003; Niwa et al, 2000). They act to repress genes whose 
expression would result in terminal differentiation and to maintain their own 
expression in a self-regulatory network. As a result, expression of these factors is  
decreased upon differentiation. Proof of the absolute requirement for some of these 
pluripotent transcription factors can be found in the rapidly expanding field of induced 
pluripotent cells (Welstead et al, 2008). These induced poluripotent stem cells (iPS) 
were first created in 2006 by transfecting both mouse embryonic or adult fibroblasts 
with Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi & Yamanaka, 2006). Such cells 
display nearly all of the characteristics of pluripotency and are the subject of high 
hopes for the generation of patient specific tissue and disease models. Since their 
original discovery, there has been a drive to decrease the number of factors required 
to induce pluripotency, and for a method that does not require the permanent 
modification of the host genome (Kaji et al, 2009; Okita et al, 2008; Stadtfeld et al, 
2008; Woltjen et al, 2009). 
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1.5.2 Embryonic stem cell chromatin 
Embryonic stem cells are known to possess many unique chromatin features that are 
presumed to be a result of their being poised ready for differentiation (Spivakov & 
Fisher, 2007). The chromatin structure of embryonic stem cells is highly dynamic, 
with a high rate of exchange of the H1 histone protein and high levels of histone 
acetylation (Mikkelsen et al, 2007). In addition, early replication of non-expressed 
developmentally regulated transcription factors is a signature of ES cell chromatin 
(Azuara et al, 2006) such early replication timing was initially believed to correspond 
to actively transcribing loci but also corresponds well with histone acetylation 
(Vogelauer et al, 2002). There is also a marked difference in the higher order 
genome architecture in ES cell nuclei, inactive and active genes reside in the same 
compartment whereas in differentiated lymphocytes, inactive genes are located close 
to centromeric heterochromatin suggesting gene silencing must be maintained by 
different mechanisms in ES cell (Smale, 2003). However, detailed study of the 
neural-commitment gene Mash1 showed that it located at the nuclear periphery in 
undifferentiated ES cells, and at the nuclear interior upon commitment into the neural 
lineage and concomitant initiation of expression. This suggests that location at the 
nuclear periphery is a potentially important mechanism of gene silencing in ES cells. 
The predominantly active chromatin features of ES cells have resulted in the 
proposal that the function of ES cell chromatin is to buffer against transcriptional 
“noise” rather than a more direct role in gene activation or repression (Chi & 
Bernstein, 2009). However, the increased efficiency of iPS cell generation by addition 
of valproic acid, (an HDAC inhibitor) or 5’-azacytidine (a DNA methyltransferase 
inhibitor) argues that chromatin alteration is required for the generation of pluripotent 
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cells and most likely plays an active role in the concomitant gene expression 
changes required for dedifferentiation (Huangfu et al, 2008). 
 
In a landmark ChIP-chip study, Bernstein and colleagues confirmed a chromatin 
“signature” termed the bivalent domain at the promoters of a raft of genes in mouse 
ES cells (Bernstein et al, 2006). The study validated the signature already found at 
the promoters of early replicating genes in ES cells (Azuara et al, 2006). In the study, 
the histone modifications at the most highly conserved noncoding elements of 
mammalian cells were examined using antibodies to H3K4me3, H3K27me3 and 
H3K9ac. These highly conserved elements are located adjacent to transcription 
factors that are important in developmental regulation. The unique chromatin 
signature elucidated contained long stretches of H3K27me3, within which were 
contained peaks of H3K4me3, thus marks traditionally associated with active and 
repressive genes were found to be colocalised. This was confirmed by sequential 
ChIP. It was proposed that such domains serve to keep developmental genes silent 
in embryonic stem cells whilst keeping them poised for activation since the bivalent 
mark was associated with a low level of transcription in ES cells. Consistent with this 
is the observation that when the authors looked in differentiated cell types, many of 
these bivalent domains were resolved into either H3K4me3 or H3K27me3-only 
domains in a manner consistent with their subsequent transcription. That is, those 
genes that were actively transcribed resolved into a H3K4me3 containing domain, 
and those repressed resolved into a H3K27me3 containing domain. This signature 
has subsequently been confirmed in Human ES cells as well as mice, its presence 
has also been observed in differentiated cells at genes that require rapid activation in 
T cells (Roh et al, 2006).  
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Recently it has been argued that bivalent chromatin domains are merely a 
consequence of the CpG status of the promoters of developmental regulators. The 
many genome-wide studies have shown that CpG rich promoters in ES cells harbour 
the H3K4me3 mark constitutively and regardless of transcriptional status in the 
absence of DNA methylation, something that may actually protect such regulatory 
elements against DNA methylation (Guenther et al, 2007; Mikkelsen et al, 2007; Pan 
et al, 2007; Weber et al, 2007; Zhao et al, 2007). However, the repressive mark 
H3K27me3, is also shown to be preferentially targeted to CpG rich promoters, thus 
providing a sequence-based targeting approach of these two modifications that is not 
based upon biological function (Mohn & Schubeler, 2009). 
 
The presence of H3K4me3 at non-transcribed genes is paradoxical regarding the 
evidence that points to a role of this modification in active transcription. However, 
such inactive bivalent genes were also shown to be enriched for another 
modification, ubiquitination at H2A, which was shown to be required for the binding of 
the “poised” ser 5 phosphorylated form of RNAPII. Furthermore, this poised form is 
surprisingly able to transcribe at low levels from these genes (Stock et al, 2007). 
Thus the H3K4me3 mark is again shown to localise with active genes. In a study in 
human ES cells transcription initiation was also shown to occur from the majority of 
“actively marked” genes, but that the polymerase does not proceed to elongation 
(Guenther et al, 2007). This would still be consistent with the role of the H3K4me3 
mark in transcription initiation. This may represent another level at which 
transcriptional control can be achieved, with transcriptional processivity requiring 
additional factors. Note that many of these initiating transcripts were associated with 
genes that did not contain the elongation-associated mark H3K36me3 in the body of 
the gene. This abortive transcript production may represent a mechanism of poising 
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at these genes with transition into elongation being all that is required for active 
transcription. However, abortive transcription is not a phenomenon restricted to ES 
cells as a similar trait was observed in differentiated cells in the same study. 
Contrary, to this, in a different study in mouse ES cells, full transcripts were observed 
at a low level from the majority of ES cell genes (Efroni et al, 2008). Again, such a 
mechanism was proposed as being important to transcriptional “poising”. Therefore, 
hyper-transcription may play a role in maintenance of pluripotency. 
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1.6 The Homeotic genes 
1.6.1 Hox genes as a model for transcriptional initiation 
A group of genes proposed as being transcriptionally “poised” in embryonic stem 
cells are the Hox genes. The Hox genes are a group of much-studied genes required 
during development for defining the distinct morphological identities along the 
anterior-posterior axis in vertebrates. These genes were originally identified in 
Drosophila mutants that displayed segmental transformation known as homeotic 
transformations (Frischer et al, 1986). In these transformations, a correct structure 
was formed, but in the wrong place; for example, a leg may be formed in place of a 
wing. These mutations were shown to arise as a result of mutation of the homeotic, 
or Hox genes. The genes were first shown in Drosophila to be clustered on the 
genome in an orientation collinear to both their anterior to posterior segmental 
expression and their timing of expression (Lewis, 1978). Such a co-linear expression 
mechanism is present in all metameric animals (McGinnis & Krumlauf, 1992). In 
addition, these genes are known to contain a conserved motif; the homeobox 
domain, important for binding to DNA. In mammals, there are four Hox gene clusters 
located on four different chromosomes which, in mouse are termed A to D (Figure 
1.7, (McGinnis & Krumlauf, 1992)). Between the cluster, paralogous genes have 
similar structures and equivalent expression patterns. That is, the gene termed “2” on 
all four clusters will have the same restricted expression as the gene termed “2” on 
the other clusters. However, between Drosophila and mammals, there must have 
been several rounds of duplication and deletion as equivalent genes are not always 
present (Figure 1.7). In mouse, Hox gene expression commences from the 3’ end of 
the cluster at an early stage in development. The earliest expressed Hox genes are 
expressed in the mesoderm and more weakly in the epiblast of the posterior primitive 
streak in late streak stage embryos (E7.5)(Deschamps et al, 1999). Such an 
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 induction occurs concomitant with gastrulation and hence as the cells ingress, it 
results in widened field of induction of the Hox genes brought about by fibroblast 
growth factor and retinoic acid signalling, with the more 5’ genes being expressed 
later and in the more posterior domain of the embryo. Through the use of the 
teratogen and homeotic mutation inducer retinoic acid in mice, it was argued that it is 
the combination of Hox genes within a segment that determines its identity resulting 
in the Hox code hypothesis (Kessel & Gruss, 1991). The need for tight transcriptional 
regulation of Hox genes is highly apparent. The Hox genes were thus proposed to 
undergo three phases of transcription; initiation, establishment and maintenance 
(Deschamps et al, 1999). Initially, it was proposed that the timing of Hox gene 
expression determined the ultimate pattern of gene expression in the “Hox clock” 
hypothesis since vertebrate development itself occurs in a rostral to caudal temporal 
progression (Kmita & Duboule, 2003).  
 
1.6.2 A chromatin dependent mechanism of activation 
Early genetic studies of Hox genes are consistent with a mechanism of activation that 
arises from progressive chromatin opening. Insertion of “anterior” transgenes Hoxd11 
and d9 into a more posterior position in the Hoxd cluster resulted in the position-
dependent timing of induction of these genes consistent with a repressive 
mechanism acting at the posterior end of the cluster (van der Hoeven et al, 1996). 
However, whilst early activation did result in the posteriorization of expression of the 
transgenes; the genes still maintained some of the spatial restriction of their 
endogenous copies. Thus, localisation of Hox gene expression does not correlate 
entirely with timing, though co-linearity does play some role in the initiation of gene 
expression patterns in early mice embryos. In addition to a higher (chromatin 
dependent) level of co-linear control, these experiments also displayed the 
38 
importance of Hox specific cis-acting elements since the transgene was able to 
induce spatially-dependent expression of the adjacent Hox gene (van der Hoeven et 
al, 1996). A further experiment, generating a fusion of the Hox d12 second exon and 
Hoxd13 first exon resulted in a surprising Hoxd11-like expression of the fusion, 
further supporting a role for a progressive chromatin opening. This was proposed to 
be mediated by repressive protein binding (Kondo et al, 1998). Later experiments 
used a twofold approach to examine Hox gene regulation (Kondo & Duboule, 1999). 
First, sequential insertion of a Hoxd9/lacZ transgene upstream of the cluster, 
revealed the location at which the repressive element no longer functions and 
second, deletion at this location confirmed its presence. Interestingly, deletion of the 
element resulted in aberrant gene expression only at the initiation phase of gene 
expression from the locus. Thus the higher-order control possibly mediated by 
chromatin only acts at this phase. Insertion of a Hoxb1 transgene, (i.e. the most 
anterior gene) at Hoxd13 the most posterior position of the Hoxd cluster did not result 
in complete “anteriorisation” of hoxb1 (Kmita et al, 2000). It resulted in the surprise 
interplay between regulatory elements of the endogenous complex and integrated 
gene. The Hoxb1 gene was activated in a manner consistent with both that of the 
endogenous gene and its newly inserted position and led to the activation of the 
adjacent Hoxd13. Thus the anterior transgene can recruit factors necessary for its 
own activation, resulting in a chromatin opening and active transcription of the 
adjacent gene. Therefore cluster control might be transcription-dependent, with co-
linear activation relying upon an anterior entry point for activating factors that triggers 
the processing from a closed to open configuration across the cluster (Kmita et al, 
2000).  
 
39 
Retinoic acid responsive elements (RAREs) are a control feature of many Hox genes. 
Notably, Hoxb1 contains both 5’ and 3’ RAREs and a distal RARE (Marshall et al, 
1994). Hoxb1 and Hoxb2, unlike genes more 5’ in the HoxB cluster are able to 
respond to exogenous retinoic acid addition by precocious activation at a stage 
termed pre-initiation (Roelen et al, 2002). This pre-initiation mimics Hoxb1 patterns of 
gene expression in the developing embryo only 24 hours earlier. The 5’-most genes, 
do respond after their initial endogenous expression, indicating a different degree of 
accessibility of the genes at the 3’ end. The RARE, therefore, may be able to open 
this 3’ chromatin more easily through the recruitment of associated HATs 
(Bhattacharyya et al, 1997). However, a randomly integrated transgene containing all 
these RARE elements, was not able to respond to exogenous retinoic acid addition 
at the initiation phase, but only after the expression of the endogenous gene. This 
indicates a necessity for Hoxb1 to be in its cluster for its complete regulation. Thus, 
the local chromatin opening at the 3’ end of the cluster is a mechanism of gene 
control hierarchically higher than that conferred by the RAREs.  
 
Finally, long-range enhancers have also been shown to have a role in Hox gene 
activation. These are distal sequences that occur outside of the cluster. For example, 
at Hoxd, a 5’ “digit enhancer” has been shown to be important for a second round of 
co-linear expression of the 5’ Hoxd genes in digits (Spitz et al, 2003). Such 
enhancers, by being positioned outside of the cluster bring an intrinsic asymmetry to 
control mechanisms. A strategy involving serial deletion and duplication analyses 
confirmed a two-wave expression mechanism from this cluster in forelimb and digit 
development. The first round relies on an early limb enhancer that is telomeric to the 
cluster and an element 5’ to the cluster which spatially restricts the 5’ genes. This 
enhancer acts against the repressive mechanisms seen at the 3’ end of the cluster. 
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Direct evidence for a progressive chromatin opening mechanism came from studies 
at the Hoxb cluster (Chambeyron & Bickmore, 2004). In a landmark paper, the 
gradual induction of Hox genes upon addition of retinoic acid in culture systems was 
exploited (Simeone et al, 1990). Upon addition of retinoic acid, there was an increase 
in the activating modifications, H3K9ac and H3K4me2 at the promoters of Hoxb1 and 
Hoxb9, despite the lack of induction of Hoxb9 at this early stage. In addition, the 
authors observed a decondensation of the locus. This decondensation was not solely 
due to histone acetylation as induced increases in this mark by trichostain A, a 
histone deacetylase inhibitor, did not result in cluster opening. Further to this 
opening, Hoxb1 was excluded from the local chromosome territory in a process 
parallel to the kinetics of its expression. Hoxb9 also loops away at day 10, but never 
to the same extent as that of Hoxb1. Subsequently, it was confirmed that such a 
mechanism occurs in vivo in developing mice embryos (Chambeyron et al, 2005). 
Detailed analysis of Hoxb gene expression in distinct areas of the embryo suggested 
in vivo decondensation of the cluster and movement from out of the chromosome 
territory is differentially regulated at different developmental stages and no “priming” 
mechanism is visible. 
 
Analysis of this mechanism at the Hoxd cluster, which makes complex use of 
different enhancers in its control was a key test of the role of chromatin opening in 
Hox gene activation. Here, it was displayed, however, that decondensation and 
relocation outside of the chromosome territory were not necessarily linked 
mechanisms of gene activation both in vivo and in vitro in ES cells (Morey et al, 
2007). It was postulated that the difference in chromatin structure response to 
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activation might arise due to the different enhancers required for activation within 
different embryonic regions. 
 
The link between induction of expression and chromatin decondensation was further 
dissected by the use of a transgene (Morey et al, 2008). As in earlier experiments, 
the Hoxb1 transgene was placed 3’ of the Hoxd13 gene with this gene able to 
recapitulate some of the expression patterns of the endogenous gene (Kmita et al, 
2000). It was able to ectopically reorganise the Hoxd cluster resulting in a large 
decondensation of the Hoxd locus in the primitive streak (Morey et al, 2008). 
Furthermore, in rhombomere 4 where the Hoxd inserted transgene is silent, there 
was some movement of the transgene to the edge of the chromsome territory (CT) 
indicating a dominant effect of the transgene on the Hoxd cluster. Significantly, this 
provides evidence for movement to the edge of the CT being an event that occurs in 
advance of transcriptional activation. 
 
Such cluster-wide mechanisms of co-linearity must not be ignored when considering 
the activation of individual Hox genes, however, these systems are good models in 
which to study the interplay of specific cis elements with domain-wide mechanisms. A 
detailed study of Hoxd4 activation in neurally differentiating cells studied chromatin 
changes at this gene and at the 3’ neural enhancer required for central nervous 
system (CNS) expression (Rastegar et al, 2004; Zhang et al, 1997). Other cis 
elements at this gene include a RARE and an autoregulatory element, both of which 
function in the model system used (Popperl & Featherstone, 1992; Popperl & 
Featherstone, 1993). Upon retinoic acid treatment, Hoxd4 expression peaked 
between days 3 and 4 of treatment. This treatment induced changes in histone 
modifications; active H3 phospho-acetylation increases at the 3’ enhancer preceded 
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those at the promoter and arose coordinate with the induction of hoxd4. However, 
active modifications at the enhancer persisted longer than at the promoter. In 
addition, retinoic acid induced the presence of H3 diacetylated at lysines 9 and 14 at 
the enhancer and a general increase of H4 acetylation across the locus concomitant 
with expression. Again, to further dissect the sequence of chromatin structure 
rearrangement and transcription, the histone modification changes were studied in 
vivo. Analysis of histone modifications in an embryonic tissue that precedes the 
activation of Hoxd4 by a few hours showed active histone modifications had already 
been deposited at the neural enhancer, along with the activator CBP. Thus, here an 
important discovery has been made, that of the “priming” of the Hox locus before its 
transcription in the relevant tissue (Rastegar et al, 2004). 
 
1.7 Heritability of gene expression patterns 
1.7.1 Epigenetics 
Thus far, in considering histone modifications, only those mechanisms directly 
involved in the initiation of Hox gene transcription have been considered. However, 
as an embryo divides and differentiates, the different lineages of the embryo must 
“remember” the gene expression changes that arise. Thus, the development of an 
organism and the execution of its genetic programme are intrinsically linked. For 
such a concept, the term epigenetics was coined by Conrad Waddington from the 
greek “epigenesis”, a theory of development that proposed the embryo to be 
undifferentiated (Waddington, 1939). This idea was later revisited by Robin Holliday 
in his article “The inheritance of epigenetic defects” that discussed how some genetic 
defects and developmental changes could not be explained by Mendelian 
inheritance, but could be explained by DNA methylation (Holliday, 1987). This was a 
culmination of the idea gaining ground in the mid-1980s that not all inheritance was 
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based on DNA sequence. This resulted in Holliday’s proposal of definitions for 
epigenetics in 1994 (Holliday, 1994). For the purpose of this thesis epigenetics will be 
defined as the nuclear inheritance of gene expression patterns that is not based on 
changes in DNA sequence. There is now little doubt that DNA methylation plays a 
strong part in epigenetics and epigenetic inheritance. Histone modifications too have 
been proposed to play a role in this epigenetic inheritance, however, their heritability 
has not been definitely proven, though their potential to maintain gene expression 
programmes in memory is highly attractive. Thus, the epigenetic code hypothesis 
was proposed (Turner, 2000; Turner, 2007).  This hypothesis draws on the predictive 
role that histone modifications must play to any transcriptional outcome within a 
defined developmental stage. Thus the modifications are proposed to dictate not the 
actual gene expression programme, but the potential for that programme, such that a 
locus is predisposed to activation, or, indeed repression. In fact, the final example at 
Hoxd discussed in the previous section exemplifies this. 
 
1.7.2 Epigenetic Maintenance of Hox gene expression, Polycomb 
and Trithorax proteins 
The maintenance of Hox gene expression patterns in flies and mice has largely been 
attributed to the polycomb and trithorax proteins. Polycomb genes were originally 
identified in Drosophila as genetic repressors of homeobox proteins (Lewis, 1978). 
Trithorax genes were identified in the same study as mutations that suppressed 
those at the polycomb complexes. In mammals, a double knock-out confirmed the 
two complexes are antagonistic regulators of Hox gene expression (Hanson et al, 
1999). Polycomb group proteins are known to exist in at least three separate 
complexes of which PRC1 and PRC2 are the best characterised, with a third 
complex, the Pho complex also being relatively well understood. The polycomb  
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repressive complex (PRC2) complex in Dropsophila is made of a core of E(z) 
(Enhancer of Zeste), Esc (Extra sex combs), Su(z)12 (Suppressor of zeste 12) and 
Nurf (nucleosomal remodelling factor). The PRC1 complex has at its core Pc 
(Polycomb), Ph (polyhomeotic), Posterior Sex combs (Psc) and dRING. Mammalian 
homologues have been found for all of these proteins (Table 1.1). However, in 
mammals copies are often multiplied as a result of genome duplication events (Table 
1.1). In flies, the PRC1 complex is found to associate with core components of the  
transcriptional machinery, though this is not the case in mammals (Saurin et al, 
2001). It is believed that this may play a direct or indirect part in the silencing role of 
these proteins through recruitment of the PRC1 complex. Genetic studies in mice 
revealed components of the PRC1 complex to be important in anterior-posterior 
patterning and determining correct spatial expression patterns of different subsets of 
Hox genes (Akasaka et al, 1996; Akasaka et al, 2001; Core et al, 1997; del Mar 
Lorente et al, 2000; van der Lugt et al, 1996). Furthermore mouse knockouts of 
polycomb proteins eed, suz12 and Rnf2 show defects in anterior-posterior patterning 
during gastrulation, suggesting a role in Hox gene control (Faust et al, 1998; Pasini et 
al, 2004; Voncken et al, 2003). Interestingly, a double knock-out of the PRC1 
components, bmi-1 and Rnf110 (both PSC equivalents) showed a window post 8.5 
days where these proteins are required for maintenance of the spatial programme of 
Hox gene expression. That is the Hox gene expression patterns are established 
correctly in this double knock out, but deteriorate after day 8.5. This implicates a role 
for these proteins in the memory of gene expression (Akasaka et al, 2001). 
Furthermore, a conditional Rnf2 knock-out indicates a role for this protein in the 
maintenance of Hox gene repression (Fujimura et al, 2006). Trithorax proteins are 
involved in the converse role of maintenance of active Hox gene expression 
programmes is shown by mouse mll knock-out studies (Yu et al, 1998).  
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1.7.3 The mechanism of polycomb silencing 
Initial hypotheses in Drosphila suggested that polycomb proteins bind to Polycomb 
repressive elements (PREs) elements and then spread along the chromosome in a 
manner analogous to the repressor protein HP1 in heterochromatin, causing 
silencing by blanketing the chromosome (Paro, 1990). However, it has become 
apparent that such a smothering mechanism is unlikely given that transcription 
factors may bind to silenced promoters in Drosophila cells (Breiling et al, 2001). Also, 
genome-wide studies of the localisation of polycomb proteins at Hox promoters are 
inconsistent with the blanketing of repressed genes (Schwartz et al, 2006).  
 
The elucidation that components of the PRC2 complex are able to methylate H3 at 
lysine 27 in a manner that is conserved across mammals and flies suggested a 
simplex “indexing” mechanism by which polycomb might achieve its silencing role 
(Cao et al, 2002; Czermin et al, 2002; Kuzmichev et al, 2002). Suz12 depleted HeLa 
cells show derepression of a subset of Hox genes concomitant with the loss of 
H3K27me3 at these genes (Cao & Zhang, 2004). Furthermore, genome-wide studies 
consistently show across all species that the binding of polycomb group proteins 
correlates with H3K27me3 (Boyer et al, 2006; Bracken et al, 2006; Lee et al, 2006; 
Negre et al, 2006; Squazzo et al, 2006). Such studies indicate that despite the large 
conservation seen between mouse, human and Drosophila proteins, and the 
significant conservation of polycomb group targets, the binding pattern of these 
proteins varies significantly between mammals and Drosophila. Mouse and human 
proteins bind throughout the large domains of H3K27me3 at Hox genes and 
specifically at promoters of other genes, whereas Drosophila proteins bind at 
punctate sites (presumably the PREs). This seems to suggest a difference in the 
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mechanism by which polycomb-repressed genes are regulated in flies and mammals, 
and care must be taken when comparing between species.  
 
A definitive mechanism for H3K27me3-maintained gene-silencing has not been 
elucidated, however, the PC subunit of the PRC1 complex is able to bind to 
H3K27me3 and to some extent H3K9me3 using its chromodomain, thus a sequential 
order of recruitment whereby PRC2 generates a mark promoting the binding of PRC1 
has been proposed (Fischle et al, 2003b; Min et al, 2003). A further role for histone 
modifications in polycomb mediated silencing has been inferred from the capacity of 
the RING2/Ring1B subunit of PRC1 to monubiquitinate at H2A at lysine 119 both in 
Drosophila and mammals (Wang et al, 2004; Zhu et al, 2005). Ubiquitination at this 
residue was shown to be downstream of H3K27 methylation in a mouse Bmi (PRC1 
RING subunit) knock-out (Cao et al, 2005). The loss of H2A ubiquitination correlated 
with an increase in expression of Hoxc13 although the level of H3K27me3 at this 
gene did not change. Similarly, a Suz12 knock-down, resulted in no H3K27me3 at 
the Hoxc13 promoter preventing the binding of bmi1 or ring1 and resulting in the 
absence of H2A ubiquitination. This is consistent with PRC2 generating a binding site 
for PRC1 in the H3K27me3 mark (Figure 1.8). Recently, a direct role for H2A 
ubiquitination in arresting transcriptional elongation has been proposed (Reinberg & 
Sims, 2006). This study did not examine polycomb-related H2A ubiquitination, but 
H2A mono-ubiquitination catalysed by the N-Cor recruited ligase 2A-HUB/hRUL138 
at a subset of genes in macrophages. This modification prevented the recruitment of 
FACT (facilitates chromatin transcription), a core transcription factor that would 
normally act to facilitate transcription by binding and displacing the H2A/H2B dimer 
from core nucleosomes (Reinberg & Sims, 2006) . 
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To further delineate the relationship between polycomb-mediated Hox gene 
repression and histone modifications, a detailed study in the maintenance of Hox 
gene transcriptional programmes has been carried out at the Hoxb8 locus (Fujimura 
et al, 2006). The PRC1 complex was previously shown to play a role in Hoxb8 
posterior restriction. The association of the full PRC1 complex with Hoxb8 was 
confirmed in non-expressing tissues in the E12.5 embryo, however, a partial complex 
lacking the Rnf2 (Ring1B) component was also present in expressing regions. The  
role of this partial complex is not clear. H3K9ac and H3K4me3 levels were also 
correlated with active expression in the embryonic tissue whereas H3K27me3 was 
more abundant at the Hoxb8 locus in the transcriptionally repressed tissue. Thus, 
active and repressive marks appear to play a role in the maintenance of expression 
of this gene. The role of polycomb group proteins in transcriptional repression has 
been challenged by evidence for PRC1 complexes playing a role in gene activation. 
A study in which a Hox reporter transgene was randomly inserted into the genome in 
the mouse polycomb null mutants, Mel18 (PSC equivalent) and Rae28 (PH 
equivalent), resulted in the lack of normal activation of this transgene (d Graaff et al, 
2003). Intriguingly, in this study, the inactivated transgene displayed a high degree of 
DNA methylation at its promoter, therefore the role of polycomb proteins may be to 
protect from DNA methylation. Further to this, a drop in expression in Hoxb8 occurs 
at around 9.5 dpc in Bmi/Rnf110 and phc1/phc2 double mutants (Akasaka et al, 
2001; d Graaff et al, 2003; Isono et al, 2005). This coordinated with a drop in the 
level of H3K9 acetylation in those regions, whereas in wild type cells, Hoxb8 
expression and H3K9acetylation is maintained (Fujimura et al, 2006).  
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1.7.4 The mechanism of Trithorax regulated gene expression 
Trithorax proteins maintain boundaries of active Hox gene expression in a manner 
that is also reliant upon the alteration of chromatin state. Several trithorax complexes 
have histone H3K4 methylation activity (Byrd & Shearn, 2003; Dou et al, 2005; 
Nakamura et al, 2002; Wysocka et al, 2005). The close link of this mark with 
transcription initiation has been discussed elsewhere. The Hox gene spatial 
maintenance defect of mll knock-out mice suggests a special relationship of Hox 
genes with trithorax related proteins (Yu et al, 1995). Further to this, the knock-down 
of components of the mll complex, rather than the enzyme itself also results in the 
lack of maintenance of expression of Hoxc8 and Hoxa9, coordinate with a loss in 
H3K4 methylation (Wysocka et al, 2005). ChIP-chip arrays across MEFs in 
differentiated cells i.e. cells that would display maintenance patterns, has revealed a 
peculiar pattern of H3K4me3. This mark appears to blanket across these domains 
(Bernstein et al, 2005). Consistent with this, the large scale mapping of MLL binding 
sites in a human lymphoma cell line reveals that whilst binding specifically at the 
promoters of most of its targets, at the Hoxa cluster, it displays a more global pattern 
of binding; binding both up and downstream of the transcriptional start site (Guenther 
et al, 2005). Consistent with observations in mouse knock-out studies showing MLL’s 
preference for regulating 5’ Hox genes, this unique binding pattern occurs at Hox 
genes A7 through to 10, though does also encompass Hoxa1.  
 
Studies at individual genes have confirmed trithorax proteins are important in 
maintaining Hox gene active expression. For example, at Hoxc8 MLL binds 
specifically at the promoter of this gene, not at 5’ or 3’ regulatory enhancer 
sequences (Milne et al, 2002). mll knock-out in MEFs resulted in a decrease of 
Hoxc8 expression, but not interestingly, hoxa1 since MLL primarily regulates 5’ Hox 
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genes (Hanson et al, 1999). Activation of Hoxc8 by mll knock-in in these knock-out 
cells was accompanied by histone acetylation at the 5’ and 3’ enhancer and H3K4 
methylation at the promoter reliant upon the MLL set domain. Interestingly, Hoxc8 
experienced DNA hypermethylation at the promoter in mll-/- lines which could not be 
overcome in Mll knock-in lines, again showing the H3K4me3 may protect against 
DNA methylation. Another mammalian homologue of the trithorax proteins, ASH1L 
was shown to methylate H3K4me3 in vitro and was impaired by methylated H3K9, 
thus providing a conserved mechanism for trithorax-mediated Hox gene expression 
maintenance (Gregory et al, 2007).  
 
It is interesting to note that in the above mouse genetic studies that in polycomb and 
trithorax protein knock-outs, it is only a subset of genes that are affected, revealing 
that different complexes are used at specific subsets of Hox genes, no doubt 
conferring tissue-specific regulation. In mammals, for example, the PRC2 complex is 
not always made of the same components and is believed to confer tissue-specific 
maintenance of Hox gene expression programs in such a manner. For example, the 
mammalian PRC2 complex may contain hPHF1, a homologue of Drosophila PHF 
(Cao et al, 2008). The knockdown of the mouse protein in cell culture resulted in Hox 
gene specific alterations in gene expression 
 
1.7.5 A dynamic mechanism of gene regulation; the lysine 
demethylases and pluripotency 
Contrary to what this gene expression maintenance role of polycomb and trithorax 
proteins suggests, the two modifications H3K4me3 and H3K27me3 are dynamic and 
may be removed by demethylases (Shi & Whetstine, 2007). H3K27me3/me2 may be 
demethylated by the mammalian proteins UTX and JMJD3, two demethylases that 
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associate with the promoters of Hox genes in a cell-type specific manner correlating 
with transcriptional activity (Agger et al, 2007; Lan et al, 2007). A functional role for 
these demethylases in the activation of Hox genes was demonstrated in the retinoic 
acid-induced transcription of Hox genes in embryonic carcinoma (EC) cells. Upon 
addition of retinoic acid, Hoxb1 expression increased accompanied by an increased 
presence of UTX, and a decrease in H3K27me3 (Agger et al, 2007). This 
demethylase associated with the MLL2 complex and the further use of the retinoic 
acid differentiation system revealed an ordered recruitment in Hox gene activation 
whereby the MLL2 complex is first recruited to promoters followed by the UTX 
demethylase (Lee et al, 2007b). Also, knock-down studies displayed a role for UTX in 
regulating PRC1 binding and H2A ubiquitination at its regulated promoters. Note that 
the authors found this mechanism operating at a specific subset of Hox genes. 
 
The expanding family of demethylases also includes those that demethlyate 
H3K4me3 (Shi et al, 2004). Specific to Hox gene regulation, RBP2 is a histone lysine 
demethylase that in retinoic acid-induced differentiating ES cells, was shown to 
dissociate from a subset of Hoxa genes, coordinate with their upregulation and 
increase in H3K4me3. (Christensen et al, 2007). In fact, the PRC2 complex is able to 
recruit this demethylase to polycomb targets, indicating a potentially rapid means of 
gene repression (Pasini et al, 2008). 
 
Such rapid induction of gene expression may have a role in differentiation. Genome-
wide profiling of a variety of different cell types has indicated that, in vertebrates 
significant proportion of polycomb group targets are transcription factors important in 
regulating developmental pathway. Their regulation must, by functional inference, be 
dynamic. Indeed, polycomb group proteins have been shown to play a role in 
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maintaining pluripotency, which has been proposed to be a direct result of the 
repression of transcription factors that determine differentiated cell states (Boyer et 
al, 2006; Lee et al, 2006). Thus, at least at these earlier stages in mammalian 
development, polycomb gene repression must be dynamic. Interestingly, a study that 
followed the association of polycomb proteins across genes in the differentiation of 
neuronal precursors showed that that genes that were activated in differentiation 
showed a loss of PcG binding, but those that were active in precursors still were 
associated with PcG proteins, and upon their repression, association only increased 
slightly (Bracken et al, 2006).  
 
1.7.6 The role of active transcription in memory 
Despite the majority of the genome being non-coding, much of it is transcribed 
(Carninci et al, 2005). In Drosophila, active transcription through PREs has been 
proposed as a mechanism whereby the expression of the related gene is maintained. 
In this model, silencing at PRE controlled genes occurs by default, and transcription 
from the element prevents silencing and maintains the gene in the “on” state (Schmitt 
et al, 2005). The molecular basis of this activation was elucidated with the discovery 
that the recruitment of the trithorax protein ASH1 to the UBX PRE/TRE relies on its 
interaction with non-coding transcripts from these PREs which directly recruit this 
protein by remaining associated with the PRE (Sanchez-Elsner et al, 2006). Memory 
of transcription was then proposed to persist through the cell cycle by the retention of 
these transcripts at the PRE in an epigenetic “bookmark” that is then able to re-
recruit ASH1 and its deposition of H3K4me3. Alternatively, the H3K4me3 mark may 
persist though the cell cycle and result in the re-establishment of transcription of 
these non-coding RNAs, full recruitment of ASH1 and establishment of transcription 
patterns (Schmitt & Paro, 2006).  
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Mammals, too display significant transcription from non-coding domains. 
Transcription occurs, in fact, right across the Hox clusters in mouse and human 
(Sessa et al, 2007). This study focused on opposite strand synthesis of such 
noncoding RNAs. Interestingly, this transcription correlates with the co-linearity of 
transcription from the HoxA cluster upon retinoic acid induction in teratocarcinoma 
cells and appeared to be related to the activation of transcription from the genes 
themselves, particularly as such non-coding transcription persists. However, the role 
of these intergenic transcripts is unclear as they are not conserved and when 
transfected into teratocarcinmoa cells are unable to activate Hoxa genes in trans.  
An impressive study in humans profiled the transcription from Hox clusters in 
fibroblasts derived from multiple differentiated tissues (Rinn et al, 2007). This study 
identified a long noncoding RNA transcribed antisense to the Hoxc locus termed 
HOTAIR, which interacts with, and is required for PRC2 occupancy and histone H3 
lysine 27 trimethylation at Hoxd. Strikingly, its depletion resulted in the activation of 
the Hoxd cluster. Similarly, another noncoding RNA, the spliced long nc RNA, 
Hoxb5/6 is expressed from a 15kb region in the Hoxb cluster that encompasses the 
Hoxb5 and b6 genes (Dinger et al, 2008). Its expression profile correlates with that of 
these genes, both in EB differentiation systems, and in developing mice embryos. It 
can also associate with MLL, leading to the speculation that it may help to recruit or 
maintain this protein at these genes. Thus, recruitment of protein complexes by 
RNAs appear to be important in regulating Hox gene expression.  
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1.8 Aims 
In surveying histone modifications, it is clear that they are interlinked with 
transcription, be it as a consequence or as a cause. It is also clear that defined 
combinations of modifications are associated with defined outcomes of transcription 
at specific loci. Therefore this study aims to further delineate the relationship between 
histone modifications and gene expression at a defined set of inducible genes, the 
Hoxb cluster. Using this model, it is possible to ask the following questions. 
• Are histone modifications combinatorial? 
• Are relative levels of histone modifications predictive of transcriptional 
outcomes? 
• Can a change in histone modification alone induce gene transcription? Or, 
are histone modification changes transcriptionally dependent. 
 
Histone modifications have also been postulated as playing a role in the “memory” of 
gene activity therefore maintaining gene transcription programmes throughout 
development. The maintenance of expression at the Hox gene cluster is imposed by 
the trithorax and polycomb group proteins. Therefore, this model system is ideal for 
the study of memory associated histone marks as the histone modifications that are 
associated with this memory process within the cluster are clearly defined. Therefore, 
the following questions may be asked. 
• Are externally induced histone modification changes “remembered” by the 
genes of the Hoxb cluster in a maintenance of elevated levels 
• Are externally induced histone modification changes remembered by the 
genes of the Hoxb cluster by an alteration in gene expression programmes. 
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2 Materials and Methods 
2.1 Cultured Cells 
2.1.1 Mouse ES cells 
Male CCE/R mouse embryonic stem cells were provided by G. Anderson. The cells 
were grown at 37oC in Dulbecco’s modified Eagle’s medium (DMEM)(Gibco) 
supplemented with 15 % Foetal calf serum (Gibco), 1% penicillin/streptomycin 
(Gibco), 1% L-glutamine (Gibco), non-essential amino acids (Gibco), 0.25% 2-
mercaptoentanol (Gibco) supplemented with 1U/µl leukaemia inhibitory factor 
(LIF/ESGRO, Millipore). Cells were cultured in T25/T75 (Sarstedt) tissue culture 
flasks coated with 0.1% gelatin. Cells were harvested by trypsinisation (1 x Trypsin 
EDTA, Gibco) at 37oC and washed three times in ice-cold PBS containing 5mM 
sodium butyrate and centrifuged at 280g (MSE chilspin) for 5 minutes. For sodium 
valproate treatment, exponentially growing cells were treated with 1M sodium 
valproate (Sigma) resupended in water to a final concentration of 1 mM in tissue 
culture medium. For wash-out, the cells were trysinised, washed out of the culture 
medium, washed twice by centrifugation in valproate-free medium and replated as 
normal. 
 
2.1.2 Differentiation of CCE/R cells 
CCE/R cells were induced to differentiate by following the method developed by 
(Chambeyron & Bickmore, 2004). Briefly, cells were replated onto non-adherant 
plastic in the absence of LIF. Two days after removal of LIF, cells were differentiated 
along the neuroectoderm lineage by addition of 0.1µM retinoic acid. After 7 days of 
differentiation in this manner, cells were replated onto adherent plastic allowing the 
embryoid bodies to settle and continue differentiation. 
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2.1.3 Mouse embryonic fibroblasts 
Primary mouse embryonic fibroblasts were used for ChIP experiments and as 
feeders for 3G4 cells. Mouse embryonic fibroblasts were derived from E12 BALB/c 
mice. Heads were first removed, along with any internal organs. A single cell 
suspension was created by first cutting the tissue with a scalpel and trypinising for 10 
minutes. Any remaining large lumps of tissue were allowed to settle before removing 
the supernatant and plating the remaining single cells in a T25 tissue culture flask. 
Primary MEFs were then cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10 % Foetal calf serum (Gibco), 1 % penicillin/streptomycin 
(Gibco), 1% L-glutamine (Gibco). 
 
MEFs for use as feeders were irradiated in order to arrest growth. Cells were first 
trysinised and resuspended at a concentration of 1 x 107 cells/ml in culture medium 
and then irradiated using a Caesium 137 source for 10 minutes. Irradiated MEFs 
were then plated at 1 x 106 / T25 or 3 x 106 / T75. 
2.1.4 3G4 Cells 
Wild type and knock-out 3G4 GCN5 -/- cells were a gift from Sharon Dent (Lin et al, 
2007) grown at 37oC in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 15 % Foetal calf serum (Gibco), 1% penicillin/streptomycin (Gibco), 1% L-
glutamine (Gibco), non-essential amino acids, 0.25% (Gibco) 2-mercaptoentanol 
supplemented (Gibco) with 1U/µl leukaemia inhibitory factor (LIF/ESGRO, Millipore). 
Cells were cultured in T25/T75 tissue culture flaks (Sarstedt) coated with 0.1% 
gelatin. Wild type cells were grown on irradiated MEFs as described above whereas 
knock-out cells were grown without feeders. Wild type cells were harvested by 
trysinisation and titrated from the MEF feeder layer by allowing the MEFs to settle 
first on tissue culture flasks for 20 minutes. Suspended ES cells were pipetted-off 
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and the process repeated three times. Cells were then washed 3 times in ice-cold 
PBS 5mM sodium butyrate. 3G4 GCN5 -/- cells were harvested as described for 
CCERs. 
2.1.5 Drosophila SL2 cells 
Drosophila SL2 cells were grown anaerobically at 26oC in Schneider’s medium 
(Gibco) supplemented with 8% foetal calf serum (Gibco) and antibiotics 
(Penicillin/Streptomycin). 
 
2.1.6 Alkaline Phosphatase activity assay 
ES cells were rinsed once in ice cold PBS and fixed in ice cold NFB (3.7% 
paraformaldehyde, 112mM NaH2PO4, 30mM NaH2PO4H2O) for 15 minutes. Cells 
were then incubated for 45 minutes using 1mg/ml Napthol-AS-MX-phosphate 
(Sigma) dissolved in 0.1M Tris HCl pH 8.3, 4% DMF as a substrate with 0.6mg/ml 
Fast Red Violet LB salt (Sigma) as a coupler. Pluripotent positive colonies appear 
red. 
 
2.2 Flow cytometric analysis  
MEFs were harvested by trypsinisation and resuspended in DMEM/10%FCS at a 
concentration of 107cells/ml. Cells were permeabilised in 0.1% NP40 DMEM and 
stained using 10mg/ml propidium iodide followed by immediate analysis. Flow 
cytometry analysis was carried out using a Beckman Coulter Epics XL bench-top 
flow cytometer (Beckman Coulter), data was analysed using the Windows Multiple 
Document Interface Flow Cytometry Application program (WinMDI Version 2.8). 
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2.2.1 Cell cycle fractionation by flow cytometry. 
Vybrant Dyecycle stained MEFs were harvested by trypsinisation, and resuspended 
at a concentration of 106 cells/ ml in DMEM/10%FCS/Vybrant DyeCycle green in a 
volume of 1ml and labelled at 370C for 30 minutes. Cells were then passed through a 
nylon filter and transferred into polypropylene FACS tubes (Becton Dickinson) in the 
labelling medium. High speed sorting was carried out on a MoFlo high speed sorter 
(Dako cytomations, Gloustrop, Denmark). Cells were sorted into DMEM 10% FCS in 
polypropylene FACS tubes. 
 
2.2.2 Chromatin Isolation from ES cells 
CCE/R cells were grown to their exponential phase and labelled overnight with 3H-
thymidine at 0.5µCi/ml (Amersham). After harvesting, cells were resuspended to a 
concentration of 2 x 107cells/ml in TBS (15mM NaCl, 0.15M NaCl , 10mM Tris-HCl 
(pH 7.5), 3mM CaCl2, 2mM MgCl2, 5mM Na butyrate) and an equal volume of 
1%Tween40/TBS added. Cells were stirred on ice for 1 hour and homogenised using 
a Dounce all-glass homegnizer with a tight pestle in order to release nuclei (1 stroke/ 
107 cells). This process was monitored by microscopy and stopped when 70-80% 
nuclei had been attained. Cell lysates were centrifuged at 800 x g for 20minutes at 
4oC (MSE Chilspin) and the pellet resupended in TBS/5% sucrose and spun at 800 x 
g for 20 minutes. The nuclei were resuspended in 5ml digestion buffer (0.32M 
Sucrose, 50mM Tris/HCl (pH 7.5), 4mM MgCl2, 1mM CaCl2, 0.1mM PMSF, 5mM Na 
butyrate) and the A260/280 determined to get an estimate of the concentration. The 
concentration of the sample was readjusted to 0.5mg/ml. 1ml aliquots of the nuclei 
suspension were digested with 35-50U micrococcal nuclease (Pharmacia/Sigma) at 
37oC for 5 minutes. The reaction was stopped by adding 0.5mM EDTA to a final 
concentration of 15mM and chilled on ice for 5 minutes. After micrococcal nuclease 
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digestion, aliquots were centrifuged at 1,800g for 10 minutes (MSE microcentaur) 
and the first supernatant (S1) removed and kept at 4oC. The pellet was resuspended 
in 1ml lysis buffer (1mM Tris/HCl (pH7.4), 0.2mM Na2EDTA, 0.2mMPMSF, 5mM Na 
butyrate) and dialysed overnight at 4oC against 2 litres of equivalent buffer. 
Solubilised chromatin (S2) was recovered by spinning dialysed S1 samples at 1,800g 
for 10 minutes (MSE Chilspin) and the remaining insoluble pellet (P) resuspended in 
250µl of lysis buffer. 
 
All three chromatin fractions, S1, S2 and P were analysed by agarose gel 
electrophoresis (Figure 2.1). S1 and S2 fractions were pooled and used for chromatin 
immunoprecipitation (Figure 2.1). 
2.2.3 Chromatin Isolation from mixed SL2 / ES cells 
For the carrier chromatin immunoprecipitation (CChIP) procedure, Drosophila SL2 
cells were pelleted and washed 3 x in ice cold PBS, 5 mM sodium butyrate. Cells 
were resuspended to 5 x 107 cells / ml and 1 ml aliquots were mixed with a small 
number (104) of FACS cell cycle sorted populations of MEFs. Cell mixtures were 
washed twice in NB buffer (15 mM Tris-HCL pH 7.4, 60 mM KCl, 15 mM NaCl, 5 mM 
MgCl2, 0.1 mM EGTA, 0.5 mM 2-mercaptoethanol, 0.1 mM PMSF) supplemented 
with 5 mM sodium butyrate. The final pellet was resuspended in 2 ml NB buffer, and 
mixed with an equal volume 1% Tween 40 in NB buffer and stirred for one hour on 
ice. Nuclei were released by homogenisation in a Dounce all glass homogeniser with  
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a “tight” pestle using four cycles of 10 strokes with pauses of 10-15 min (on ice) 
between each cycle to prevent excessive foaming. This results in a 75-80% yield of  
intact nuclei as observed by counting under the microscope. Nuclei were pelleted 
(800 x g, MSE 3000, 15 min. 4oC), resuspended in 20 ml NB buffer, 5% (v/v) sucrose 
and pelleted (800 x g, MSE 3000, 25 min, 4oC). Nuclei were resuspended in 5 ml 
digestion buffer (50 mM Tris-HCl pH 7.4, 0.32 M sucrose, 4 mM MgCl2, 1 mM CaCl2, 
0.1 mM PMSF). A260 was measured to give a rough estimate of DNA concentration 
and the sample adjusted to 250 µg/ml. 1 ml aliquots were mixed with 50 U 
micrococcal nuclease (Pharmacia) and incubated for 5 min at 28oC. The digested 
samples were spun at 217g, 5 min and the supernatant removed (fraction S1). The 
pellet was resuspended in 1 ml lysis buffer (2 mM Tris-HCl pH 7.4, 0.2 mM EDTA, 5 
mM Na butyrate, 0.2 mM PMSF, 0.4 mM glycine) to give fraction S2. Both fractions 
were dialysed overnight at 4oC against lysis buffer, centrifuged (217g, 10 min MSE 
3000) and the supernatants (fractions S1 and S2) analysed by agarose gel 
electrophoresis. If the chromatin was satisfactory (ie. predominantly but not 
exclusively mononucleosomes with minimal sub-nucleosomal fragments), S1 and S2 
were combined and used for chromatin immunoprecipitation (ChIP). 
 
2.2.4 N-ChIP 
In order for maximum recovery of chromatin, siliconised pipettes, eppendorfs and 
15ml Falcon tubes were used throughout. Affinity-purified antibody (50-125 μl, 50-
100 mg/μl) was added to 50 µg unfixed chromatin and the final volume made up to 1 
ml with incubation buffer (50 mM NaCl, 20 mM Tris-HCI, pH 7.5, 20 mM sodium 
butyrate, 5 mM Na2EDTA, 0.1 mM PMSF). After overnight incubation (on a rotating 
platform) at 4°C, 200µl 50% w/v protein A-Sepharose (Pharmacia) was added and 
the incubation continued for a further 3hrs at room temperature. After centrifugation 
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(7500 x g, 10 min) the supernatant was removed and the protein A-Sepharose pellet 
resuspended in 1 ml wash buffer (50mM Tris-HCL (pH 7.5), 10mM EDTA, 5mM Na 
butyrate, 150mM NaCl) and layered onto 9ml of the same buffer. Following 
centrifugation (600 x g, 4°C, 10 min) the supernatant was removed by aspiration and 
the pellet washed twice more in 10ml wash buffer. Bound material was eluted from 
the protein A-Sepharose by addition of 125µl 1% SDS in incubation buffer and 
incubating for 15 min at room temperature on a rotating platform. After centrifugation 
(11 600 g, 10 min) the supernatant was removed and stored on ice. The protein A-
Sepharose pellet was extracted as above with a further 125µl 1% SDS in incubation 
buffer. The two extracts were combined with an equal volume of incubation buffer to 
reduce the concentration of SDS to 0.5%. DNA was obtained from the input and 
bound fractions by two phenol/chloroform extractions and one chloroform extraction. 
DNA was ethanol precipitated using glycogen as a carrier and redissolved in 250µl 
water. All DNA samples were analysed initially by electrophoresis on a 1.2% agarose 
gels and stained with ethidium bromide. [3H] Thymidine in each sample was 
determined by scintillation counting.  
 
2.2.5 Preparation of cross-linked chromatin 
Formaldehyde cross-linked chromatin was prepared essentially by the method 
outlined by (Orlando & Paro, 1993) Essentially, ES cells were harvested, washed 3 
times in PBS / 5mM butyrate and resuspended at a concentration of 1 x 106 cells/ ml. 
Cells were cross-linked in 1% paraformaldehyde for 8 minutes at room temperature. 
The reaction was stopped by addition of glycine to a final concentration of 150mM. 
Cross-linked cells were washed twice with PBS 5mM butyrate and resuspended in 
130 µl lysis buffer (50mM Tris-HCl, 10mM EDTA, 1%SDS, 5mM butyrate). Cells were 
sonicated using the Diagnode Biorupter for 10 minutes on medium at 4oC. An aliquot  
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of cross-linked chromatin was taken for reversal of the cross links by proteinase K 
digestion at a concentration of 50 µg/ml at 68oC, 300rpm for 2 hours in an Eppendorf 
Thermomixer. DNA was extracted by two phenol/chloroform extractions and one 
phenol extraction. DNA was precipitated by centrifuging at 13,000rpm (MSE 
microcentaur) and resuspended in water. DNA was ran out on a 1% agarose gel to 
check the size of the fragments (Figure 2.2). Fragments were typically between 300 
and 1000bp. 
2.2.6 Precipitation of cross-linked chromatin 
Antibody-bead complexes were formed by first washing Dynabeads protein A 
(Invitrogen) 4 times in RIPA buffer (10mM Tris-HCl pH 7.5, 1mM EDTA, 0.5mM 
EGTA, 1% Triton, 0.1% SDS, 0.1% Na deoxycholate, 150mM NaCl) and then 
incubating with 2.5µg antibody overnight at 4oC. 25µg cross-linked chromatin was 
added per antibody-bead complex and rotated at room temperature for 2 hours on a 
fast turntable. Beads were then washed with 200µl RIPA buffer five times before 
washing once with TE (1mM EDTA, 10mM Tris). Antibody-Bound DNA was eluted by 
addition of Elution buffer (20mM Tris-Hcl pH 7.5., 5mM EDTA, 5mM Na butyrate, 
50mM NaCl) 1% SDS. Cross links were reversed by proteinase K digestion at a 
concentration of 50µg/ml at 68oC, 300 rpm for 2 hours in an Eppendorf Thermomixer. 
DNA was ethanol precipitated following 2 phenol/chloroform extractions and one 
phenol extraction. DNA was recovered by centrifuging at 13,000rpm (MSE 
microcentaur) and resuspended in 20 µl water. 
2.3 Extraction of RNA and cDNA synthesis 
RNA was extracted using the RNeasy mini kit (Qiagen) according to the 
manufacturers instructions. Concentration of RNA was analysed by nanodrop and 1 
µg loaded on a 1% agarose gel to check RNA integrity (Figure 2.3). For cDNA  
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synthesis, 3µg RNA was first denatured by incubation at 65oC in 2.5µM oligo dT20  
(Invitrogen) and 250 µM dNTP (Invitrogen). cDNA synthesis was performed by the  
addition of First Strand Buffer (final concentration 50mM tris-HCl, 75mNaCl, 
3mMgCl2), 0.05U/µl SuperScript Reverse transcriptase (Invitrogen), 5µM DTT at 
55oC and RNAase inhibitor and inactivated at 70oC. RNA was removed by addition of 
0.1U/µl RNAaseH (NE Biolabs) and incubating at 37oC. The integrity of the cDNA 
was first checked by standard PCR using actin primers (Table 2.2) and running on an 
agarose to gel to ensure the production of a single amplicon. 
2.4 Real-time SYBR green PCR 
2.4.1 Native ChIP analysis 
For native ChIP analysis input chromatin DNA was diluted to equal the concentration 
of the equivalent bound sample based upon the tritiated thymidine counts. All 
samples were then diluted x2 to achieve a concentration optimal for PCR. Real-time 
SYBR green PCR reactions were performed in a total volume of 10µl using SYBR 
green REDDY mix (Qiagen). Forward and reverse primers were added to a final 
concentration of 0.5µM each with 2µl DNA. Reactions were performed in an ABI 
7900HT machine using the following conditions. 
96oC 15mins 
94 oC 15s 
Tm 30s 40 cycles 
72 oC 30s 
95 oC 15s 
60 oC 15s Dissociation curve 
95 oC 15s 
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2.4.2 PCR primers for native ChIP analysis 
All primers, (Table 2.1) except those to Hoxb1, Hoxb9, Gapdh, Pou5f1 and Nanog 
were designed using sequences downloaded from the UCSC mouse genome 
assembly from February 2007. Primers were designed in the promoter region within 
100bp of the first exon. Primers were designed using the web based programme 
primer 3 http://frodo.wi.mit.edu/ and ordered from Invitrogen. Hoxb1, Hoxb9, Hoxb13 
primers are detailed in Chamberyon et al, (2004). Gapdh, Pou5fl and Nanog primers 
were taken from O’neill et al, (2006). Sequences are in table 2.1. All primers were 
optimised such that only a single peak was produced on a dissociation curve. 
2.4.3 Formaldehyde cross-linked ChIP analysis 
For cross-linked ChIP analysis, input chromatin was serially diluted to generate a 
standard curve. Bound chromatin was added to the reaction without dilution. Real-
time SYBR green PCR reactions were performed in a total volume of 10µl using 
SYBR green REDDY mix (Qiagen). Forward and reverse primers were added to a 
final concentration of 0.5µM each with 2µl DNA. Reactions were performed in an ABI 
7900HT machine using the following programme. 
96oC 15mins 
94 oC 15s 
Tm 30s 40 cycles 
72 oC 30s 
95 oC 15s 
60 oC 15s Dissociation curve 
95 oC 15s 
 
Primers were the same as for native ChIP. 
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Table 2.1 Primers used for ChIP analysis in real-time SYBR Green PCR.  
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2.4.4 cDNA Analysis 
For cDNA analysis, cDNA from reverse transcriptase reactions were first diluted 10 x 
to a concentration of 100ng/µl according to Nanodrop analysis. Real-time SYBR 
green PCR reactions were performed in a total volume of 10µl using SYBR green 
REDDY mix (Qiagen). Forward and reverse primers were added to a final 
concentration of 0.8µM each with 2µl cDNA. Reactions were performed in an ABI 
7900HT machine using the following programme. 
 
96oC 15mins 
94 oC 15s 
Tm 30s 40 cycles 
72 oC 30s 
95 oC 15s 
60 oC 15s Dissociation curve 
95 oC 15s 
 
2.4.5 PCR primers for cDNA expression analysis 
PCR primers were designed using primer3 such that they spanned an intron 
http://frodo.wi.mit.edu/. The sequences are in Table 2.2. Primers were optimised 
using serial dilutions of cDNA know to contain the target gene using different 
annealing temperatures until the standard curve was equal to -3.3 +/- 0.3 and the r2 
was no less than 0.95. An example is shown in Figure 2.4 
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2.4.6 CChIP PCR analysis 
PCR reactions were performed in duplicate with mouse and Drosophila DNA controls 
run in parallel to monitor cross-hybridization. 45 µl of Reddy Mix PCR Master Mix (AB 
Gene, UK) was added to 3 µl input DNA (about 25 ng) and 2 µl primer mix. 0.1 µCi of 
dCTP radiolabelled with α-32P (Amersham, UK) was added to each PCR reaction 
before cycling (41 cycles of 60 sec at 95°C, 60 sec at 60oC, and 90 sec at 72°C). In 
all reactions, unbound samples were diluted to equal the concentration of the 
equivalent bound sample using the [3H] Thymidine counts. 
 
In the standard protocol, aliquots were removed after 38 and 41 cycles and loaded 
onto 5% polyacrylamide gels and electrophoresed at 400Volts and 30mA for 15 
minutes. Gels were dried onto filter paper (SpeedGel System, Thermo Savant, UK) 
for a minimum of 2 hours. Filters were exposed to a phosphor screen overnight and 
scanned with a PhosphorImager (Typhoon 9200, Amersham, UK). Intensity values 
for each PCR product were analysed with ‘Image Quant 5.2’ software (Molecular 
Dynamics).  
 
2.5 Antibodies 
Rabbit polyclonal antisera to H3K9K9Ac (R607) and H3K4me3 (R612), H4K5ac 
(R401) H4K8ac (R403), H3K4me2 (R149) were raised by immunization with 
synthetic peptides conjugated to ovalbumin as previously described (Turner & 
Fellows, 1989; Turner et al, 1989; White et al, 1999). Specificity was assayed by 
inhibition ELISA for all in-house antisera used and checked by western blotting. For 
all antisera, cross-reaction with epitopes other than that against which the antiserum 
was raised was insignificant. Antibodies against H3K27me3 were from Millipore and 
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were re-tested in house to ensure specificity. Cross-reaction with H3K9me3, which 
shares the motif ARKS was minimal. 
2.6 Histone Acid Extraction 
Cells were harvested as detailed. Cells were suspended in Triton extraction buffer (1 
xPBS, 5mM Na Butyrate, 0.5% Triton X-100, 2µM PMSF, 0.02%Na azide) at a 
concentration of 107 cells/ml. Cells were incubated on ice for 10 minutes and pelleted 
at 217 x g for 10 minutes (MSE chilspin). Cells were then resuspended in half the 
previous volume of TEB and centrifuged again. Histones were extracted in 0.2N HCl 
(50µl / 2 x 106 cells) at 4oC overnight. Histones were then isolated by centrifugation 
(217g for 10 minutes) and the histone containing supernatant removed. 
 
The protein concentration of histone samples was calculated using the Pierce assay. 
Samples were diluted 50 x in Pierce reagent and left on ice for the colour change to 
develop. The concentration was analysed by absorption at 595nm against an equally 
treated sample of 0.2N HCl. The concentration of histones was determined using a 
BSA standard curve. 
 
2.6.1 Sodium doecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Proteins were separated according to size using the method developed by (Laemmli, 
1970). For histone separation, a resolving gel of 15% acrylamide, 0.4% 
NN’bisacrylamide, 375mM Tris-HCl pH 8.8%, 0.1% SDS polymerised with 300 µl 
10% w/v ammonium persulphate and 30µl TEMED per 30ml gel solution. The gel 
was overlaid with iso-butanol during polymerisation to prevent evaporation which was 
then washed off before addition of the stacking gel. The stacking gel consisted of 3% 
75 
acrylamide, 0.16% N,N’bisacrylamide, 125mM Tris-HCl pH6.9 0.1% SDS, 
polymerised with 100 µl 10% w/v ammonium persulphate and 10µl TEMED per 10ml 
of gel solution.  
 
Protein samples were prepared for SDS PAGE as follows: 
x µl protein (5-10µg) + yµl H20 (x + y = 60µl), 10µl standard dissociating buffer (1M 
Tris-HCl pH 7.2, 10mM Na2EDTA, 10%SDS, 1.432M 2-mercaptoethanol) 25µl 50% 
glycerol, 5µl 0.02% bromophenol blue. Samples were incubated at 100oC for 10 
minutes and cooled on ice for 5 minutes and loaded onto the gel though SDS 
reservoir buffer (50mM Tris, 0.384M glycine, 0.1% SDS). Gels were electrophoresed 
at 400V, 30mA, 20W until the bromophenol blue band had just ran off the end of the 
gel. 
 
2.6.2 Acid-urea-Triton (AUT) polyacrylamide electrophoresis 
Proteins were separated according to charge on AUT-PAGE essentially as described 
(Bonner et al, 1980). The resolving gel consisted of 12% acrylamide, 0.32% NN’ 
bisacrylamide, 8M urea, 1M glacial acetic acid and 0.05M ammonia. Gel solutions 
were degassed before addition of 500 µl Triton X100, 150µl TEMED and 2ml 
0.0004% riboflavin per 30ml gel solution and photopolymerised in front of a 2 x 15W 
light source. The resolving gel was overlaid with a few drops of water saturated 
isobutanol to prevent evaporation during polymerisation. Isobutanol was washed off 
the resolving gel with several changes of double distilled water before addition of the 
stacking gel. The stacking gel consited of 4% acrylamide, 0.21% bisacrylamide, 8M 
urea, 1m glacial acetic acid and 0.15M ammonia. It was degassed before addition of 
100µl TEMED and 700µl 0.004% riboflavin per 10ml gel solution. 
Photopolymerisation was carried out as for the resolving gel. 
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Protein samples were prepared for AUT-PAGE as follows: 
1 volume of protein sample (20-50µg) was mixed with 2 volumes of AUT-loading 
buffer (8M urea, 5% 2 – mercaptoethanol, 1M glacial acetic acid, plus a few drops of 
tracking dye pyroninY), vortexed and spun at 13,000rpm for 15minutes (MSE 
microcentaur) before loading through AUT reservoir buffer (1M glycine, 0.1M glacial 
acetic acid). The gels were electrophoresed for 15hours at 150V, 30mA, 10W at 10oC 
using reversed polarity. 
 
2.6.3 Transfer of proteins onto nitrocellulose 
Proteins separated by SDS-PAGE were transferred onto Hybond C nitrocellulose 
filters (Amersham) essentially as described (Towbin et al, 1979). Briefly, a piece of 
Hybond C was cut to the same size as the gel, pre-soaked in transfer buffer (25M 
Tris, 192mM Glycine, 20% Methanol) and overlaid on top of the gel. Gels were 
sandwiched between Whatman No1 filter paper and Scotch brite sponge pads. All air 
bubbles were removed and the gel plus pads placed in a cassette and slotted into a 
Biorad Transfer apparatus, ensuring the membrane was situated between the gel 
and the anode. Protein transfer was carried out at 300mA for 3 hours for SDS-PAGE.  
 
2.6.4 Western Blotting 
A non-radioactive method for detection of proteins on nitrocellulose was used, 
Enhanced Chemiluminescence (ECL) (Amesham). After transfer, filters were blocked 
in 5% powdered milk/TBST (TBS (20mM Tris pH7.5, 150mM NaCl), 0.1% Tween 20), 
for 1 hr at room temperature and rinsed in TBST before addition of the first antibody. 
After incubation at room temperature for 1hr, the filters were washed vigorously with 
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3 changes of TBST. The secondary antibody, goat anti-rabbit horse radish 
peroxidase was applied to each filter diluted at x20,000 in TBST and the incubation 
continued for a further 1 hour. All filters were washed vigorously with 3 changes of 
TBST before addition of substrate (Amersham). Filters were wrapped in Saran wrap 
and exposed to film several times in order to optimise signal to noise ratio. 
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3 Results 
3.1 Histone modifications at the Hoxb cluster 
3.1.1 What is the pattern of histone modifications at the promoters 
of the Hoxb cluster? 
Specific histone modifications are associated with distinct transcriptional outcomes. 
H3K4me3 and histone acetylation, for example, are generally associated with 
transcriptionally active loci whereas H3K9me3 is generally associated with 
heterochromatin and transcriptionally repressed silent domains. These modifications 
are therefore often referred to as “active” and “repressive” respectively. However, 
these terms are broad generalisations and counter examples of active modifications 
being associated with inactive genes, and vice versa, do exist (Vakoc et al, 2005). 
 
Genome wide studies in pluripotent cells have shown the Hox genes are located 
within chromatin domains that contain both active and repressive modifications, 
termed “bivalent domains” (Bernstein et al, 2006). It has been suggested that they 
may maintain gene repression in an undifferentiated state but also allow genes to be 
activated upon differentiation. The two modifications H3K4me3 and H3K27me3 are 
associated with these bivalent domains and are put in place by the trithorax and 
polycomb proteins respectively (Ringrose & Paro, 2004). These gene products are 
responsible for maintaining the spatial expression of Hox genes in the early embryo 
(Hanson et al, 1999). The patterns of H3K4me3 and H3K27me3 over the Hoxb 
genes as elucidated by ChIP-seq is shown in figure 3.1. Progressing from these 
genome-wide ChIP-seq studies here is described, a detailed study of the role of 
individual modifications at the HoxB gene promoters, performed using native ChIP 
coupled with qPCR. Such a study will a allow a high resolution picture to be 
generated at these Hox gene promoters. 
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As appropriate for a study investigating bivalent domains, chromatin was extracted 
from the undifferentiated mouse embryonic stem cell line CCE/R and 
immunoprecipated using antibodies raised against the modifications H3K4me3, 
H3K27me3, and the activating modification H3K9ac. PCR primers were designed 
against the promoters of the genes Hoxb1, b3, b4, b5, b6, b7, b8, b9 and b13 within 
100bp of the first exon and these primers were used to analyse the amount of these 
gene promoters in the input and bound chromatin by quantitative real time PCR 
(Figure 3.2). Primers designed against Hoxb2 repeatedaly failed to amplify for 
unknown reasons. A ratio of bound DNA to input DNA greater than one indicates an 
enrichment for the modification at the location of that primer set, and a ratio of less 
than one indicates a depletion. 
 
Analysis of the distribution of H3K9 acetylation shows a non-uniform distribution of 
this modification across Hoxb gene promoters (Figure 3.2a). Hoxb9 shows much the 
highest enrichment for this modification with a bound:input ratio of 5; this gene 
therefore contains more than four times the levels of H3K9ac in its promoter than 
Hoxb1, and more than twice the level of enrichment seen across the rest of the 
cluster. Hoxb3 is also conspicuous, but in its lack of H3K9ac compared with the other 
genes in the cluster. The majority of the genes display relatively low levels of the 
modification with bound:input ratios of between one and two. 
 
Subsequent analysis of the distribution of H3K4me3, another activating mark, shows 
its levels are clearly linked with those of H3K9ac (Figure3.2b). Again, there is a 
striking enrichment for this active modification at the promoter of Hoxb9. In addition, 
Hoxb3 displays the lowest level of enrichment for this modification as it did for 
H3K9ac. There are two other gene promoters that also contain elevated levels of 
H3K4me3; Hoxb4 and Hoxb5. These two gene promoters did not stand out so 
prominently as having high levels of H3K9ac relative to the other gene promoters. It  
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is also important to note that despite the pattern of relative levels of H3K9ac and 
H3K4me3 being similar, H3K4me3 is present at higher absolute levels at Hoxb 
promoters than H3K9ac.  
 
Finally, the abundance of the repressive mark H3K27me3 is generally more similar, 
in value, to that of H3K4me3 than H3K9ac (Figure 3.2 b and c). However, much less 
gene by gene variation is displayed compared with both previously discussed active 
modifications. This serves to emphasise the variation seen in the active 
modifications. For example, Hoxb9 that displayed the highest levels of active 
modifications at its promoter does not show an equivalent high level of H3K27me3 
and so has a high ratio of active to repressive modifications. Other genes showing a 
similar pattern are Hoxb4, Hoxb5 and Hoxb13. 
 
3.1.2 Are levels of histone modifications found in the Hoxb cluster 
promoters predictive of gene expression? 
Histone modifications are known to play a role in transcriptional regulation, but this 
could reflect either ongoing transcription, or future activity. That is, in a gene not yet 
expressed, a high level of a specific combination of active modifications could 
indicate its imminent transcription, making these “predictive” marks. Since there is no 
gene transcription from Hox gene promoters in undifferentiated mouse embryonic 
stem cells, the active histone modifications seen at the HoxB promoters were 
postulated to predict future patterns of gene expression (Bernstein et al, 2006). 
Therefore, in an attempt to convey meaning to the varying level of activating 
modifications seen at the Hoxb gene cluster, gene expression patterns in 
differentiating CCE/R cells were determined to establish any correlation with histone  
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modification levels at Hoxb gene promoters. In early embryos, the timing and spatial 
restriction of Hox gene expression is co-linear with their physical location within the  
cluster; the more 3’ the gene, the earlier it is switched on, and the more anterior its 
expression (Kmita & Duboule, 2003). The sequential timing of induction of homeotic 
genes in response to retinoic acid in mouse embryonic carcinoma cells has been 
shown to reflect that of embryos (Papalopulu et al, 1991; Simeone et al, 1990). 
 
In order to confirm that this sequential induction of Hox gene expression is conserved 
in CCE/R mouse embryonic stem cells, the cells were differentiated into embryoid 
bodies in the presence of retinoic acid (Figure 3.3a). RNA was extracted at each day 
of differentiation, cDNA synthesised, and the levels of Hox gene mRNA compared to 
that in undifferentiated cells and normalised to actin using real-time PCR. In addition, 
the level of the pluripotency marker Nanog was assayed. Nanog is a marker of 
pluripotency expressed by undifferentiated embryonic stem cells (Niwa, 2007). Upon 
differentiation, its expression is diminished. In this system as expected, its 
expression was found to decrease after day 2 of differentiation (Figure 3.3b).  
 
The induction of genes from the Hoxb cluster occurred at defined times of 
differentiation with transcription generally commencing in a temporal sequential 
manner from the 3’ to the 5’ end of the cluster (Figure 3.4). In addition, all the genes 
seem to display a similar low level of transcription before the gene is fully induced. 
This may be a result of transcription from a minor lineage in the embryoid body 
before the major tissues that express the gene are fully formed. Alternatively, it may 
be due to the one drawback of this system. That is, when differentiated in this 
manner, embryonic stem cells differentiate asynchronously generating broad peaks 
of Hox gene expression. 
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Hoxb1, the most 3’ gene; and the first to be induced in differentiating embryos was 
also the first gene to be transcribed in this system (Figure 3.4a). There was a 
dramatic peak in the quantity of Hoxb1 mRNA at day 3, which was maintained until 
day 5.  Hoxb2, the adjacent gene reached maximal expression three days later 
(Figure 3.4b). An initial bout of expression from this locus was evident at day 4, and 
maximal expression was reached at day 6. At days 7 and 8 of differentiation, 
expression of the gene diminished. Hoxb3 is switched on co-ordinately with hoxb2 
(Figure 3.4b and c) but reached its maximal expression previous to that of Hoxb2, at 
day 5. Hoxb4 displays a very sharp peak in transcriptional activity at day 4 (Figure 
3.4d) with expression again beginning to increase at day 8. Hoxb5 is induced at a 
low level at day 3 (Figure 3.4e) and this low level is maintained until day 6 where 
maximal expression is reached. Hoxb7 displays 3 phases of gene expression (Figure 
3.4g); a minimal expression at days 2 to day 5, half maximal gene activity at days 6 
and 7, and a final maximal period at day 8. Hoxb8 also takes on a similar three-tiered 
pattern of gene expression; a very low level between day 3 and day 5, an 
intermediate level at day 6 and a final maximal level at days 7 and 8 (Figure 3.4h). Its 
expression does then, however enter a fourth phase until day 10. Hoxb9 reaches a 
sharp peak of expression at day 8 which has disappeared by day 10. As would be 
expected, Hoxb13 is the final gene to be fully induced, peaking in expression at day 
12. However, there is significant leaky expression of this gene between days 5 and 8. 
 
As regards histone modifications, levels of active marks are not a marker for early or 
late gene expression during differentiation. This is particularly evident at Hoxb9 
which displays the highest level of active modifications but is not induced until day 8. 
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3.2 Can a change in histone modifications induce 
transcription from the Hoxb cluster? 
In order to further distinguish the direct relationship between histone modifications 
and control of gene expression at this locus, it was decided to directly alter the level 
of one of the active modifications and ascertain whether this induced any effects 
upon gene expression. Specifically, could an increase in an active mark override the 
presence of a repressive mark?  
 
To alter the histone modifications, it was decided to treat with an HDAC inhibitor of 
the histone deacetylases. HDAC inhibitors fall into six structurally distinct classes; the 
small molecular weight carboxylates, the hydroxamic acids, benzmides, 
epoxyketones and the cyclic peptides. Several HDAC inhibitors have made it to the 
clinic as anti-cancer dugs owing to their anti-proliferative effects. Previous studies 
altering levels of histone acetylation at Hox genes have used the inhibitor TSA 
(Chambeyron & Bickmore, 2004). This inhibitor is a hydroxamic acid and is known to 
mediate its inhibitory effect by chelating the active zinc molecule of HDAC active 
sites, in combination with blocking the entrance to the active site and spanning the 
hydrophobic pocket of the active site (Drummond et al, 2005). In this study, however, 
valproate, a carboxylic acid was chosen. It too is able to chelate zinc ions, but is less 
effective than the hydroxamic acids at inhibiting HDACs and so has a much weaker 
HDAC inhibition constant. Valproate is a class II HDAC inhibitor, and also a 
teratogen, causing developmental defects in early embryos. It has been used widely 
in the clinic as an anti-epileptic drug but has been shown to cause birth defects if 
taken during pregnancy (Duncan, 2007). Studies in mice show it causes homeotic 
transformation and aberrant Hox gene expression in embryos exposed to the drug 
(Faiella et al, 2000). This may, or may not be a direct result of its histone deacetylase 
inhibitor activity. Valproate was, therefore was chosen above other available HDAC 
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inhibitors as a tool used to induce histone hyperacetylation across the Hox cluster. 
However, it must be noted that valproate is able to cause several potentially relevant 
effects within cells. Firstly it has been reported to be able to sequester acetyl CoA as 
it may be oxidised into its derivative valproylCoA, upsetting the metabolic balance in 
the cell (Becker & Harris, 1983). Secondly, as mentioned above, it chelates zinc ions, 
and finally it is a known inhibitor of the Wnt pathway, a pathway involved in control of 
stem cell differentiation, something particularly relevant to this study treating 
undiffentiated embryonic stem cells (Bug et al, 2005). 
 
3.2.1 What are the global effects of valproate on CCE/R cells? 
Initial experiments were performed in order to confirm that valproate is able to induce 
hyperacetylation in CCE/R cells through its HDAC inhibitor activity. Valproate was 
added to the culture medium of undifferentiated CCE/R mouse embryonic stem cells 
in the presence of LIF to a concentration of 1mM for a duration of 2 and 8 hours. 
Previous experiments had confirmed that this concentration was not toxic to these 
ES cells. 
 
Upon treatment of CCE/R cells with valproate there was an alteration of the 
morphology of the cells (Figure 3.4a). Undifferentiated CCE/R cells grow in colonies 
and upon addition of valproate to the culture medium, after 2 hours, there is no 
visible change in the cells (Figure 3.5a). After 8 hours of treatment however, the 
colonies flatten out, the individual cells within these colonies become more distinct 
and those at the edge of the colony develop protruding spines (Figure 3.5a). It is 
possible that valproate causes the cells to differentiate. However, the flattening-out 
and development of spines on the cells could also be the result of hyperacetylation of 
structural proteins within the cell, causing an alteration in the cell cytoskeleton. 
Previous experiments with another HDAC inhibitor, trichostatin A (TSA) in HeLa cells 
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 have shown this type of hyperacetylation after a 24 hour treatment (Kim et al, 
2006b). 
 
To further investigate whether the morphological changes induced by valproate are 
due to differentiation of the embryonic stem cells, alkaline phosphatase assays were 
performed on the cells (Figure 3.5b) as this enzyme is seen as a marker for 
pluripotency in embryonic stem cells (Berstine et al, 1973). The assay results in the 
enzyme substrate being converted into a pink product and hence undifferentiated 
cells stain pink. The colonies of untreated CCE/R embryonic stem cells stain bright 
pink in the alkaline phosphatase assay. Similarly, colonies of the treated embryonic 
stem cells still stain pink after 2 and 8 hours (Figure 3.5b). However, after 8 hours, 
the staining is paler and closer inspection of the treated colonies reveals that there is, 
indeed, less staining for alkaline phosphatase at the edge of the flattened colonies 
where cells have spikey protrusions (Figure 3.5b). 
 
Due to this decrease in alkaline phosphatase staining, the investigation into any 
possible differentiation upon valproate treatment was continued. Pou5f1 and Nanog 
are markers of pluripotency expressed by undifferentiated embryonic stem cells 
(Niwa, 2007). Upon differentiation, their expression is diminished. RNA was extracted 
from valproate treated cells and the levels of Pou5f1and Nanog mRNA compared 
with that before treatment and normalised to actin (Figure 3.5c). If valproate is 
inducing differentiation then the levels of these markers will decrease with respect to 
actin upon treatment. The data clearly shows a marked reduction in the levels of 
Nanog RNA after 2 hours of treatment with valproate (Figure3.5c). Transcription from 
the Pou5f1 locus is also decreased but not until 8 hours of treatment with valproate 
(Figure 3.5c). Thus, transcription from the Nanog locus is diminished before that from 
Pou5f1. 
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3.2.2 What are the effects of valproate upon global histone 
modifications? 
To assess the global affect of valproate upon histone tail modifications, histones 
were extracted by acid extraction and western blots were performed using the 
extracted histones. Antibodies used to probe the blots were those raised against the 
modifications; H3K9ac, H4K5ac, H4K8ac, H3K4me3 and H3K27me3. Several 
antibodies raised against histone acetyl lysines were used in order to fully ascertain 
the affect of valproate on global histone acetylation (Figure 3.5). Anti-H3K4me3 and 
anti-H3K27me3 antibodies were used due to the presence of these marks on the 
Hoxb cluster and their possible importance in control of gene expression. As 
expected, there is an increase in the global level of all the histone acetyl marks in 
CCE/R cells upon treatment with 1mM valproate (Figure 3.5). H3K9ac and H4K8ac 
show a steady increase, whereas H4K5ac levels plateau after 2 hours. These acetyl 
marks are associated with active transcription, and there is also a concomitant rise in 
the active H3K4me3 mark. This is not unexpected since it has been shown 
previously in other cell lines, that histone acetylation and H3K4me3 are linked 
possibly due to MLL stimulation by the acetyl mark (Nightingale et al, 2007). The 
level of H3K27me3 stays constant throughout treatment. This is despite the increase 
in its partnering bivalent mark H3K4me3, thus these two marks do not behave 
globally in a concomitant manner. 
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3.2.3 Can valproate induce hyperacetylation at individual genes? 
The changes induced by valproate were next assessed at the level of histone 
modifications over Hoxb promoters. In order to assess the effect of valproate, 
undifferentiated CCE/R cells were cultured in 1mM valproate for 2 and 8 hours in the 
presence of LIF. After both these timepoints, chromatin was extracted and 
immunoprecipitated using antibodies directed against H3K9ac, H3K4me3 and 
H3K27me3. As before, a bound to input ratio was then calculated. As a control for 
the potentially unique nature in which Hox gene expression is controlled, primers 
were also designed against the Gapdh promoter, Pou5f1 and Nanog. 
 
In CCE/R cells, the promoter of Gapdh is refractory to the effects of valproate (Figure 
3.6a). Given its status as a housekeeping gene, Gapdh is expressed in CCE/R cells, 
and hence is likely to be enriched for active modifications. The active modification 
H3K9ac is, indeed present at the Gapdh promoter, albeit at low levels (Figure 3.6a) 
and its levels are not increased after treatment with valproate. Thus the H3K9ac 
modification at Gapdh responds to valproate in a manner that is contrary to the 
global response of the histone tails where a significant global hyperacetylation is 
seen upon valproate treatment (Figure 3.5). The active modification H3K4me3 is also 
found at the Gapdh promoter at similar levels to H3K9ac and once again, its levels, 
too are unaltered by treatment with valproate. This is again contradictory to the 
global response of this modification (Figure 3.5). H3K27me3 has a bound:input ratio  
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of less than one at this promoter which indicates hypomethylation. This is 
unsurprising since it is a repressive modification and Gapdh is actively transcribed. 
Its level is not altered by treatment with valproate, coordinate with global levels 
(Figure 3.6, 3.7b). 
 
In contrast to Gapdh, the Pou5f1 promoter displays highly significant levels of both 
H3K9ac and H3K4me3 activating modifications (Figure 3.7b). The levels of H3K9ac 
do not change significantly upon treatment of valproate. Like Gapdh, this is contrary 
to the global increase seen in levels of this modification (Figure 3.6). The levels of 
H3K4me3 do change in response to valproate, however in a manner contrary to the 
global trend of increase, this modification decreases at the promoter upon treatment 
(Figure 3.7). The decrease is to around half the original untreated levels and is 
apparent after 2 hours of treatment with valproate. There is no enrichment for 
H3K27me3 at this promoter. Furthermore, the levels of this inactive modification do 
not change in response to valproate. 
 
Like the Pou5f1 promoter, the Nanog promoter contains highly significant levels of 
both H3K9ac and H3K4me3, the activating modifications (Figure 3.7c). The level of 
H3K9ac is refractory to valproate treatment. However, the level of H3K4me3, like that 
seen at the Pou5f1 promoter plummets significantly after 2 hours of treatment (Figure 
3.7c). In contrast, there is very little inactive H3K27me3 modification at this promoter, 
and it does not change upon valproate treatment. 
 
In contrast to the observations seen at Gapdh and Pou5f1, valproate induces 
substantial changes to the histone modifications on the Hoxb cluster (Figure 3.8). 
This is most clear for H3K9 acetylation (Figure 3.8a). After the prolonged 8 hours 
treatment, there is a consistent increase in the level of H3K9ac of about 2-fold at all 
Hoxb gene promoters. This is preceded by a small increase in H3K9ac after 2 hours  
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of treatment, resulting in an overall steady increase in H3K9 acetylation at the 
promoters. Since this experiment was performed twice at each gene, it is not valid to 
perfom a statistical test of significance on these values, however the patterns of 
increase at each HoxB gene was highly repeatable, and error bars representing the 
standard error of the mean have been included to represent this. Separate 
experiments performed in chapter 4 also support this pattern of increase in histone 
acetylation after valproate treatment. Interestingly, since all the Hoxb genes respond 
to valproate in a similar manner with respect to this modification, the overall pattern 
of H3K9ac along the cluster is maintained. Therefore, upon treatment with valproate, 
Hoxb9 remains the gene that is most enriched for H3K9ac at its promoter and Hoxb3 
the gene with the lowest levels. 
 
The level of H3K4 trimethylation at the promoters of the Hoxb genes also increases 
in response to valproate and thus the two activating modifications H3K9ac and 
H3K4me3 are linked at the HoxB promoters (Figure 3.8b). The H3K4me3 
hypermethylation seen upon treatment is less pronounced than the H3K9 
hyperacetylation. In Figure 3.8b it is also apparent that valproate treatment leaves 
the relative pattern of H3K4me3 levels unaltered, with Hoxb9 still displaying the 
highest level of H3K4me3 and Hoxb3 much the lowest. 
 
The repressive modification H3K27me3 displays a pattern of modifications quite 
different to the activating modifications in response to valproate as the levels of this 
modification do not change upon valproate treatment (Figure 3.8c). This is despite 
the increases in the active modifications H3K4me3 and H3K9ac. Thus, enrichments 
for active modifications in response to valproate are highlighted by this repressive 
modification’s refractory behaviour. 
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3.2.4 Are changes in histone modifications at the promoters of 
Hoxb genes linked to changes in gene expression in 
embryonic stem cells? 
The role that histone modifications play in direct control of the expression of Hoxb 
genes is unknown. Using the histone deacetylase inhibitor valproate, a system has 
been established in which the promoters of Hoxb genes may be enriched for the 
active modifications H3K9ac and H3K4me3 in the presence of the repressive 
H3K27me3 modification. Gene expression from the promoters of active modification 
enriched genes was examined in this system. This was an attempt to see if the active 
marks could override the repressive marks in relation to gene expression control. 
  
In order to assess the direct relationship between histone modifications and 
transcription at the Hoxb gene cluster, RNA was extracted from the same 
populations of cells that were treated with 1mM valproate for 2 and 8 hours in the 
presence of LIF for the ChIP experiments. cDNA was generated from this RNA and 
the levels of the genes in the cDNA assessed by quantitative real time PCR, 
normalised to actin and compared with levels in untreated cells. 
 
As above, it was difficult to amplify PCR products from the cDNA for these genes in 
these undifferentiated cells as they are not expressed. Products were often only 
being amplified at a cycle number greater than 35, if at all and triplicates occurred 
with little repeatability. This was taken as a marker that no significant expression 
from these loci occurred when compared with the consistent amplification and 
repeatability of actin amplification from the same samples. In fact, even after 8 hours 
of treatment with valproate, no significant gene expression was induced (data not 
shown) from any of the Hoxb gene promoters examined. 
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3.3 What is the role of GCN5, a histone acetyl transferase, in 
the response to valproate at Hox genes? 
At the Hoxc cluster, evidence for a possible direct role for histone acetylation in the 
control of Hox gene transcription has been found. Mouse embryos homozygous for 
the histone acetyl transferase GCN5 flox (neo) mutation, display anterior homeotic 
mutations that coincide with a shift in the anterior expression boundary of Hoxc8 and 
hoxc9 (Lin et al, 2008). This may be the direct result of an alteration of histone 
acetylation levels at these gene promoters. The role that GCN5 related histone 
acetylation has at these gene promoters was therefore investigated in a GCN5 -/- 
mouse ES cell line, a gift from Sharon Dent (Lin et al, 2007). GCN5 knock-out cells 
were grown off feeders and grew faster than the equivalent wild type line. These 
wild-type cells were kept on feeders due to their tendency to spontaneously 
differentiate. This discrepancy is between cells growing on feeders is not ideal as it 
makes the ‘control’ different from the genetically alterered lines and may be the basis 
of any difference in response to valproate. However, due to the amount of cells 
necessary for the experiments, this compromise was made. Before any experiments 
were performed on these cells, an alkaline phosphatase assay was carried out in 
order to check for pluripotency. Both sets of cells stained positively for alkaline 
phosphatase (Figure 3.9). 
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3.3.1 Are there global differences in histone acetylation in GCN5 -
/- cells? 
Before focusing on the Hoxc genes, global differences in histone modifications in wild 
type and GCN5 -/- ES cells were examined. These differences would only be 
apparent if histone acetyl transferases were unable to compensate for one another. 
In order to assess whether there are any global differences in histone acetylation, 
histones were extracted from these cells by acid extraction and the histones were ran 
on AUT gels which distinguish histones based upon their size and charge, allowing 
histones with different levels of acetylation to be distinguished. Since valproate is an 
HDAC inhibitor, treating with this drug will further highlight whether GCN5 is 
important for maintaining global levels of histone acetylation. If there is no enzyme 
that may compensate for GCN5 then the GCN5-/- cells will not display elevated 
levels of histone acetylation in response to treatment with valproate.  
 
The morphological effect that valproate has on both the wild type and the knock-out 
lines is shown in Figure 3.10. It can be seen that as for the CCE/R cells, there is an 
induction of a spiny morphology in the knock out 3G4 line after 8 and 16 hours 
treatment (Figure 3.10b). However, such a change is not seen in the wild-type line 
(Figure 3.10a). This is probably because the wild type line is grown on feeders and 
so subtle changes in wild type colonies cannot be easily discerned. 
 
The AUT gels show that there is no difference in histone acetylation between resting 
wild type and GCN5 -/- cells (Figure 3.11). Upon treatment with valproate for 8 hours, 
there is an increase in global hyperacetylation at both Histone H3 and H4 in wild type 
and GCN5-/- cells. Clearly, mono, di, tri and tetra acetylation of H4 is seen to 
increase upon treatment with valproate in both wild type and knock out cells. This 
increase is maintained in both cell types after 16 hours of treatment with 1mM 
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valproate. Thus GCN5-/- may be compensated for in order to maintain global levels 
of histone acetylation in GCN5 -/- cells, and this compensatory mechanism is still 
active in cells treated with 1mM valproate. 
3.3.2 What is the role of GCN5 in histone hyperacetylation at the 
Hoxc cluster? 
In order to discern the cause of Hoxc mis-expression in GCN5 -/- early embryos, 
ChIP assays were performed on GCN5 null and wild-type 3G4 ES cells. In addition 
ChIP assays were performed on valproate treated wild-type and knock-out cells. If 
GCN5 does, indeed play a significant role at these gene promoters, then there will be 
a less pronounced hyperacetylation in response to valproate. These experiments 
were performed once only as the cells were a technically difficult line to grow in large 
numbers. 
 
To confirm that 3G4 cells are able to respond to valproate treatment, its effects upon 
the histone modifications at the Hoxc8 andHoxc9 promoters were first examined in 
the wild-type line (Figure 3.12a). At these promoters, an increase in H3K9 acetylation 
was evident (Figure 3.12 a(i)). At both Hoxc8 and Hoxc9 the fold increase reached its 
maximum after 8 hours with an enrichment of roughly twice that seen in untreated 
cells. Immunoprecipitations with anti-H3K4me3 reveals that there was a rise in the 
level of this active modification at the Hoxc9 but not the Hoxc8 promoter (Figure 3.12 
a(ii)). This increase is lower than that seen with H3K9ac at the Hoxc9 promoter. Such  
 an increase is, however, consistent with those at the Hoxb in CCE/R cells in 
response to valproate. In contrast with the Hoxb cluster in CCE/R cells, this increase 
is accompanied by an increase in H3K27me3 levels at Hoxc9 (Figure 3.12 a (iii)). At 
Hoxc9 after 16 hours of treatment with valproate the levels of H3K27me3 are twice 
that seen in untreated cells, though at Hoxc8 the levels of this modification remain 
unchanged. Thus, at Hoxc9, the modifications H3K9ac, H3K4me3, and H3K27me3  
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are all linked and are enriched in valproate treated cells compared with resting cells. 
At Hoxc8, however, only the H3K9ac modification responds to valproate. The 
response to valproate is very different in knock-out cells compared with wild- type 
3G4 (Figure 3.12b). After treatment with valproate, the Hoxc9 promoter shows a very 
slight decrease in the H3K9ac modification, contrasting with the increase seen in 
wild-type 3G4 (Figure 3.12 b(i)). The Hoxc8 promoter displays an unexpected pattern 
of modifications; after 8 hours treatment, it shows an increase in its levels of H3K9ac. 
Subsequently, after 16hours of treatment, this increase is not maintained (Figure 
3.12b(i)). The H3K4me3 mark at this gene does not follow a similar pattern, and, 
instead maintains similar levels of modifications in untreated cells, and cells treated 
for eight hours, followed by a decrease at 16 hours (Figure 3.12b(ii)). Hoxc9 shows 
an earlier decrease in this modification at 8 hours, which is maintained at 16 hours. 
The repressive modification, H3K27me3 also shows a decrease at the Hoxc8 and 
Hoxc9 promoters upon treatment with valproate (Figure 3.12 b(iii). The Hoxc8 
decrease is most significant with a decrease of five times that of the initial resting 
level after 16 hours of treatment. The Hoxc9 decrease is not as large but is still 
significant.  
 
To ascertain any direct role that GCN5 plays in the acetylation differences seen in 
the wild-type and GCN5 knock-out 3G4 cells, X-ChIP was performed using an anti-
GCN5 antibody and an anti-pol II antibody as a control. It was hypothesised that the 
GCN5 enzyme would be located at the promoters of both Hoxc8 and Hoxc9 in wild 
type cells but not in the GCN5 -/- cells. However, despite the use of anti-GCN5 
antibodies from both Abcam and Santa Cruz, precipitated DNA could not be obtained 
using the anti-GCN5 antibody (data not shown).  
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3.3.3 Does GCN5 play an important role at the Hoxb cluster? 
At the promoters of the two genes of the Hoxc cluster studied above, increases in 
histone acetylation in response to valproate were impaired in GCN5 null cells. The 
GCN5 -/- 3G4 cells were subsequently used to assess the importance of this enzyme 
at the Hoxb locus in order to determine whether GCN5 also plays a role in valproate 
response at this locus. 
 
To assess the role that GCN5 plays at the promoters of the Hoxb cluster, quantitative 
real time PCR analysis with primers to the Hoxb gene promoters was performed on 
ChIP experiments using valproate treated wild-type and GCN5 -/- cells. It has been 
shown that treatment of the CCE/R mouse cell line with 1mM valproate resulted in 
H3K9 hyperacetylation at the Hoxb locus. If GCN5 is, indeed, important in depositing 
the histone H3K9acetyl mark at the promoters of the Hoxb gene cluster then in the 
GCN5 null cell line there will be a lack of histone hyperacetylation in response to 
valproate.  
 
The levels of the H3K9ac modification do not appear to have been severely affected 
by the knock-out of the GCN5 enzyme (Figure 3.12). At the promoters of the Hoxb 
genes, alteration of the levels of H3K9ac in response to valproate follow a similar 
pattern in untreated wild type and GCN5 null 3G4 cells (Figure 3.12 a(i), b(i)). In 
addition, the numerical values of resting levels are not significantly altered by knock-
out. The one exception is Hoxb5, which has five times the level of H3K9ac in its 
promoter in wild type cells compared with GCN5 null. The patterns of response to 
valproate at the promoters of Hoxb3, b4, b6, b7, b8 and b9 are near identical, and 
thus at these promoters, it is evident that the loss of GCN5 has not altered the 
acetylation/deacetylation equilibrium. At the Hoxb1 promoter, the level of H3K9 
acetylation is increased after 8 hours and further increased after 16 hours. In the 
knock-out cells, there is again an increase after eight hours, however, after a further 
108 
eight hours of treatment, this level has decreased back to that found at the resting 
level. It may be therefore that at Hoxb1, GCN5 is needed to maintain the level of 
hyperacetylation during longer treatment. At the promoter of Hoxb5, 
surprisingly,there is more H3K9 hyperacetylation in the GCN5 null cells in response 
to valproate than in the wild type cells. It is possible that this is because the histone 
acetylase that compensates for the loss of GCN5 at this gene has a higher turnover, 
and so when the deacetyalse is inhibited in the knock-out cells, there is a higher level 
of hyper-acetylation in these cells. Finally, at Hoxb13 the GCN5 -/- cells are unable to 
respond as well to valproate as the wild type cells. Overall, at the hoxb cluster 
though, there is little change in acetylation and hyperacetylation levels in response to 
valproate. 
 
As for the levels of H3K9 acetylation, the levels of H3K4me3 methylation are not 
altered significantly in resting GCN5 null ES cells in comparison to wild type cells 
(Figure 3.12 a(ii), b(ii)). This is with the exception of the Hoxb6 promoter that shows 
an approximately 2 fold increase in the levels of H3K4me3 in the wild type than in the 
GCN5 null cells. The responses of the gene promoters to treatment with valproate 
also display a similar pattern in the wild type and null cells. Surprisingly, there is no 
increase in H3K4me3 at the promoters in either of these cells, unlike in CCE/R cells 
where treatment with valproate results in an enrichment for H3K4me3 at Hoxb gene 
promoters. However, it is does appear that there is a link in the levels of H3K9ac and 
H3K4me3 marks, at least in the wild type cells as there was in the CCE/R cells. 
Contrary to the expected increase, there is, however, a decrease in H3K4me3 at 
several gene promoters. The two notable exceptions are Hoxb1 where the level of 
this modification increases in null cells upon 16 hours treatment with valproate but 
not in wild type cells, and Hoxb3 where H3K4me3 levels are increased in wild type 
cells but not in knock out cells. Overall, any differences in H3K4me3 at the promoters  
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of the Hoxb genes in the two cell types are slight, thus the mechanisms for 
deposition and maintenance of H3K4 tri-methylation are maintained in GCN5 null 
cells. 
 
The levels of H3K27me3 at the promoters of the Hoxb genes are very similar 
between wild type and knock-out cells (Figure 3.12 a(iii), b(iii)). There is also a very 
similar pattern of change in levels in response to valproate with any differences being 
subtle between to the two types of cells. 
 
Thus, it can be concluded that the presence or absence of the enzyme GCN5 makes 
little difference to the levels of H3K4me3, H3K27me3 and H3K9ac at the promoters 
of the genes of the HoxB cluster. 
3.3.4 Do histone modification changes result in gene expression 
changes in 3G4 cells? 
Although there were subtle differences in the changes in the histone modifications 
H3K4me3 and H3K9ac in 3G4 wild type and GCN5 -/- ES cells upon treatment with 
valproate, it was decided to extract RNA and see if there is any change in induction 
of these genes. cDNA was synthesised from the RNA extracted and changes in 
mRNA levels quantified as for CCE/R cells using quantitative real time PCR. As for 
the treatment of CCE/R cells, there was no induction of transcription in the 3G4 cells 
after valproate treatment for Hoxb and Hoxc genes studied (data not shown) 
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4 Memory of histone modifications at the Hoxb 
cluster 
4.1 Are changes in histone modifications remembered at the 
Hoxb cluster? 
In order to assess whether histone modifications at the promoters of the Hoxb locus 
are of a wider importance in memory at these promoters, cells were treated with 
valproate to induce the histone modification changes previously demonstrated (See 
Figure 3.8). However, in the following experiments, not only were the immediate 
effects of valproate upon Hoxb genes assessed, but also the potential persistence of 
induced histone modification changes was investigated by performing ChIP 48 hours 
after the initial valproate treatment (Figure 4.1a). This system was intended to 
investigate the epigenetic memory of histone modifications at the locus. 
 
4.1.1  Are histone modifications inherited at the Hoxb cluster? 
In order to investigate any possible epigenetic significance of histone modifications at 
the Hoxb cluster, CCE/R cells were treated for 8 hours with valproate. After this 
timepoint, the cells were harvested, chromatin extracted and immunoprecipitated 
using antibodies against H3K9ac, H3K4me3 and H3K27me3 (Figure 4.1a). In 
addition, another population of cells was valproate treated for 8 hours, the valproate 
washed-out of the tissue culture medium and the cells cultured for a further 48 hours 
whereupon ChIP was performed (Figure 4.1a). Untreated populations of cells were 
harvested concomitantly at 8 hours of valproate treatment and at washout. Their 
culture was exactly the same as the treated cells and so were considered a ‘control’ 
population. This allows a direct comparison of the levels of histone modifications in 
the treated cells with an equivalently cultured cell population. 
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Thus any effects of cell culture on histone modification were controlled, and, in the 
analyses of this experiment, bound:input ratios were normalised to those of the co-
ordinately harvested control cell population.  
 
It is strikingly clear from the fold enrichments obtained for the ChIP experiments 
using the H3K9ac antibody that there is no memory of the induced increase in H3K9 
acetylation at Hoxb promoters 48 hours after valproate treatment (Figure 4.2a). As 
displayed in previous experiments, there is a consistent increase in acetylation at all 
the promoters examined after treatment with valproate. This hyperacetylation then, 
for every gene, returns to levels equivalent to those in the respective untreated cells. 
Thus, no epigenetic memory is displayed at any of the Hoxb promoters, with all the 
genes behaving in the same manner.  
 
The H3K4me3 modification shows a similar story to that seen for the H3K9ac 
modification; thus the two activating modifications echo one another in their 
epigenetic behaviour (Figure 4.2b). Upon treatment with valproate, the promoters of 
the genes of the Hoxb cluster are hypermethylated; this is exactly as that seen at 
these promoters previously. Then, after 48 hours in culture without valproate, the 
Hoxb promoters do not retain previous H3K4-hypermethylation. This pattern is 
displayed at every gene promoter of the Hoxb cluster studied and thus the treated 
cells show ratios of enrichment in H3K4me3 of one when compared with equivalent 
untreated cells 48 hours after treatment. 
 
The H3K27me3 modification displays a different pattern of enrichment to the two 
active modifications (Figure 4.2c). Again, its levels at the Hoxb gene promoters are 
largely refractory to the effects of valproate. This is shown in the fold enrichment 
values for this modification, which do not stray far from one for all the genes at all 
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 timepoints studied. Interestingly, after treatment and wash-out, levels of this 
modification in the treated cells at Hoxb6 and Hoxb8 are less than those in control 
cells. 
 
4.1.2 Does valproate treatment result in delayed transcription 
induction from the Hoxb cluster? 
In order to assess whether the previous induction in histone modifications caused 
expression changes from the Hoxb cluster after further cellular growth, RNA was 
extracted at timepoints equivalent to those in the ChIP experiments. No significant 
gene expression changes were seen from the HoxB cluster throughout the duration 
of the experiment as, again there was sporadic amplification from the cDNA, and a 
typical example is given on page 3. Similar plots were obtained for Hoxb1,b5 and b9 
(data not shown) thus it can be concluded that valproate treatment does not induce 
later gene expression changes from Hoxb genes. 
 
4.1.3 Does increasing valproate treatment to one complete cell 
cycle result in result in fixed histone modification changes? 
After 8 hours of valproate treatment increases in H3K9ac or H3K4me3 levels at Hoxb 
promoters are not retained. However, it is possible that for a memory of a histone 
modification to be fixed, the cell must go through either S phase or mitosis where 
mechanisms exist that are important for maintaining histone modification patterns 
throughout the cell cycle. Once the cell has passed through these phases, the 
histone mark may be consolidated and further remembered by the cell. To assess if 
this is indeed the case, CCE/R cells were treated with valproate for an extended 
period of 16 hours so that a full cell cycle was completed during the time of treatment 
(Figure 4.3b) The valproate was then washed out as for the 8 hours treatment and  
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the levels of histone modifications at Hoxb gene promoters assessed. Despite the 
prolonged valproate treatment, the H3K9ac mark shows a similar pattern of 
hyperacetylation to that seen upon 8 hours treatment with valproate (Figure 4.3 a). 
That is, after 16 hours of exposure to valproate, there is a significant increase in 
H3K9 acetylation consistent across the two experiments performed, however, no 
cellular memory of this hyperacetylation remains after 48 hours culture without 
valproate. In one replicate, Hoxb5 and Hoxb6 did, however, show a maintenance of 
the increase in H3K9 acetylation. However, this was not repeatable and is reflected 
in the large error bar seen in the wash-out data. It could therefore be that something 
different occurred in this one experiment that resulted in the cementing of a memory. 
Generally, however, no memory of hyperacetylation was seen, despite completion of 
a full cell cycle with this hyperacetylation present.  
 
The active modification H3K4me3 echoes the changes seen with H3K9ac (Figure 
4.3b). However, it does not show as large an increase in its levels at the Hoxb 
promoters after 16 hours of treatment as does H3K9ac and does not appear to have 
maintained the levels seen after 8 hours treatment (Figure 4.2). There is, however, 
an increase in the levels of H3K4me3 at all gene promoters studied, except for 
Hoxb3 whose levels of H3K4me3 have been consistently less responsive to 
valproate than other genes. After the increase at 16 hours, the levels of H3K4me3 at 
the promoters of the HoxB genes then return to levels equivalent to those in the 
respective control cells. Therefore, for this activating modification, there is no cellular 
memory displayed. 
 
The response of H3K27me3 levels at hoxb promoters to valproate is contrary to that 
of the activating modifications (Figure 4.3c). No initial enrichment in response to 
valproate is displayed despite changes seen in activating modification levels. Thus, 
fold enrichments for this modification at these genes remained at one. 
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4.1.4 Does prolonged full cell cycle treatment with valproate result 
in altered transcription changes from the Hoxb cluster? 
RNA was extracted concomitant with chromatin extraction. Again, amplification from 
the cDNA of the genes studied was sporadic and hence no real gene expression 
changes were seen from representative genes of the Hoxb gene cluster throughout 
the period of the experiment. 
 
4.2 Are histone modification changes of epigenetic 
significance upon differentiation? 
Induction of gene expression requires many signals, of which, histone modifications 
are just one layer. The induced increase in activating histone modifications at Hoxb 
gene promoters in undifferentiated ES cells were not sufficient to induce gene 
expression from the Hoxb cluster. However, Hoxb genes were shown to be induced 
in ES cells upon differentiation, therefore the onset of differentiation must provide 
signals in addition to the activating histone modifications associated with 
transcriptional activity. Thus, could induced increases in active histone modifications 
in undifferentiated ES cells cause premature transcription from Hoxb loci in 
differentiating cells if these modifications overlapped with the signal to differentiate? 
CCE/R cells were therefore incubated for 8 hours in valproate (a timepoint where it 
has been shown that these genes are hyperacetylate) the cells induced to 
differentiate and then treated for a further 8 hours in valproate before its removal 
(Figure 4.4). In this manner, the cells are hyperacetylated whilst they receive the 
differentiation signal, though hyperacetylation does not remain throughout the 
experiment. Any epigenetic significance of hyperacetylation at the Hoxb will reveal  
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itself during differentiation by an early or possibly late induction of transcription from 
that locus.  
 
4.2.1 Do induced histone modification changes show epigenetic 
effects in differentiating cells? 
 
The timeline of events are displayed in Figure 4.4. The control population is the same 
as in Figure 3.4, but is displayed again here in order to provide a direct comparison 
between treated and untreated differentiating cells. For each gene studied, the 
remarkable observation is that the overall pattern of gene expression throughout 
differentiation is unchanged, though the absolute levels of gene activity are altered 
by valproate treatment (Figure 4.5). For genes where this is more pronounced, as for 
Hoxb2, Hoxb5 and Hoxb9, the change in absolute levels has resulted in a possible 
earlier induction of transcription from this gene (Figure 4.5b, e and i). There are 
similar effects at Hoxb1, Hoxb5, and Hoxb7 though they are less pronounced (Figure 
4.5 a,e,g). Hoxb3 on the other hand, shows a remarkably reduced level of 
transcription in the valproate treated population though the transcription timing is 
similar to that in control cells (Figure 4.5 c). Hoxb8 also displays a lower level of 
transcription from the treated cells (Figure 4.5h). Finally, Hoxb4 and b6 show 
transcription levels that are dependent on the day of extraction as to whether levels 
are higher or lower in treated cells (Figure 4.5 d,f). Thus, generally, there is no 
alteration in gene expression timing from the Hoxb cluster upon differentiation with 
retinoic acid after pre-treatment with valproate. 
121 
 
 
122 
5 Histone modifications through the cell cycle: a 
means of looking at epigenetic inheritance and 
predictive modifications 
For histone modifications to be truly epigenetic modifications instrumental in cell 
memory, they must be inherited through the cell cycle. Whilst no inheritance of 
externally induced histone modification changes could be seen at the Hoxb cluster, 
existing histone modification inheritance could result in the dictation of gene 
expression patterns required for differentiated cells to function within their niche. This 
inheritance includes their persistence or reimplementation during or after two 
potentially problematic stages of the cell cycle; mitosis and S phase (Figure 5.1). 
 
 At S phase, the DNA template is replicated, and the associated histones and their 
modifications too must be faithfully replicated and deposited at the relevant genome 
location. The mechanism by which this occurs is largely unknown, and is still hotly 
disputed. Some groups display evidence for a semi-conservative mechanism of 
nucleosome deposition, and others show that newly synthesized nucleosomes are 
deposited directly behind the replication fork (Probst et al, 2009). During mitosis, 
chromatin undergoes a dramatic compaction, furthermore, there is limited 
transcription from genes during this phase of the cell cycle. This is evidently 
problematic as regards inheritance of gene expression patterns, and, potentially 
histone modifications. The mechanisms that reintroduce transcription in G1 phase of 
the cell cycle must somehow know which genes to switch on and off. It is possible, 
and has been frequently suggested that this is the result of histone modification 
patterns maintained through this phase of the cell cycle. However, studies of histone 
modifications so far during this difficult phase of the cell cycle have been limited. 
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The methods used so far to study inheritance of histone modifications through the 
cell cycle have employed inhibitors to gain pure populations of metaphase cells. For 
example, one study treated with nocodazole for 16h in order to obtain a pure 
metaphase population, and another, treated with the same drug for 8 hours 
(Kouskouti & Talianidis, 2005; Valls et al, 2005). Both studies present evidence for 
inheritance of these marks through the cell cycle. Evidently, the addition of drugs 
might have additional effects upon the cells that could affect levels of histone 
modifications. Furthermore, both of these studies used transformed cell lines as their 
model. Transformed cells are known to have aberrantly regulated cell cycles, 
something that may be manifest in their gene regulation mechanisms and hence their 
inheritance patterns of histone modifications. Therefore, such studies could be 
improved by the use of primary cell lines. 
 
The study of histone marks through the cell cycle may allow the distinction of not only 
memory marks, but marks that are predictive for genes that are about to be switched 
on. In this study, in experiments described earlier, the presence of active 
modifications on Hox genes that are silent in embryonic stem cells indicates a 
possible role for these modifications in predicting transcription. If genes could be 
studied that show periodic expression through the cell cycle, then it would be 
possible to examine which of the marks at the genes are predictive, and which are 
heritable. Thus, for the purpose of this pilot study, genes that were chosen with which 
to develop the technique were cyclin B1, cyclin D1, cyclin E1 and cdc6 as genes with 
periodic cell cycle expression, and GAPDH as a control (Berger et al, 1999; 
Kiyokawa et al, 1992; Smits & Medema, 2001; Williams et al, 1997). Their periodic 
expression with respect to the cell cycle is shown in Figure 5.1b. A cell cycle inhibitor, 
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p57, was also chosen, as its expression is inducible and may give a further insight 
into the roles of permissive modifications. In addition, there is evidence that the Hox 
genes Hoxa5, Hoxa7 and Hoxa10 show an expression pattern with cell cycle 
periodicity. This was shown in a study that separated populations of synchronised 
HeLa cells by double thymidine block (Mishra et al, 2009). At these genes, in the 
same study, the levels of H3K4me3 and the association of MLL was also shown to 
cycle periodically with the cell cycle. However, the time-points were not taken 
frequently enough to show whether the H3K4me3 mark occurred before the gene 
was expressed, and therefore whether the marks were predictive of expression, or 
consequential. Also, the use of a transformed cell lines is not necessarily an 
appropriate model in which to study the fundamental control of gene expression. It is, 
however, highly possible that the expression of genes from the Hoxb cluster also 
cycles within the cell cycle in differentiated cells. Therefore studying the dynamics of 
histone modifications and the expression of Hoxb genes in such a system may help 
to understand the significance of the histone modifications at Hoxb genes in 
undifferentiated stem cells. 
 
Here, in this final chapter of results, a pilot study is described, aimed at delineating 
the relationship between heritable and predictive histone modifications through the 
cell cycle. The main aim was to develop a technique whereby the stages of the cell 
cycle could be resolved in live primary cells in a manner that would allow assay of 
histone modifications by chromatin immunoprecipitation. 
5.1.1 MEFs may be labelled with a live dye to produce a cell cycle 
profile 
Cells can be separated into the different stages of the cell cycle by fluorescent 
activated cell (FACs) sorting. Conventional labelling techniques to stain cells for DNA 
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content require either fixing or permeabilisation of the cell. Here, however, it was 
hoped to use a viable dye to label and sort the cells in order to preserve the true 
nature of the chromatin for immunoprecipitation. Both techniques come with their 
advantages and disadvantages. Fixing with ethanol, and permeabilisation with 
detergent will put the cells under significant stress, possibly causing a stress-
response after prolonged exposure that alters the histone modifications. However, 
the turnover of histone modifications is such that if cells could be fixed immediately, 
and physiologically representative chromatin could be extracted from these fixed 
cells then this method might produce a clean snapshot of the chromatin modifications 
at a defined point in the cell cycle. On the other hand, with live cells, it is known that 
intact chromatin can be extracted which will represent the physiological state of the 
cells, although the effect of turnover of the enzymes through any prolonged cell 
sorting is unknown. 
 
The dye chosen to label and sort the cells is a commercially available dye from 
Invitrogen; Vybrant DyeCycle green. This dye intercalates into the minor grove of the 
DNA, and so is able to permeabilise cells and label DNA without the need for fixing or 
addition of detergent. It is non-fluorescent until it binds DNA, at which point it has the 
same fluorescent properties as FITC, which enables its use in conventional FACs 
machines. Most importantly, this dye is a viable dye i.e. the cells may be labelled 
whilst live and cycling. The cells chosen to develop this technique are primary  
mouse embryonic fibroblasts (MEFs). 
In initial experiments MEFs and HL60s, for whom the cell cycle profile was known, 
were labelled using the dye according to the manufacturers instructions (Figure 5.2). 
Both HL60s and MEFs were labelled in such a way that a typical cell cycle profile 
was obtained by FACs analysis with a large peak indicating G1 and a smaller peak 
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indicating G2/M (Figure 5.2a). The FACs profiles shown are deliberately un-gated in 
order to show a complete picture of the effects of the dye. Typically, the fluorescence 
of the G2/M peak (600 in HL60s and 500 in MEFs) was twice that of the G1 peak 
(300 in HL60s and 250 in MEFs), indicating double the content of DNA in G2/M than 
in G1. The final noticeable feature is that there is a larger sub-G1 population in the 
MEFs than in the HL60s. This is most likely due to their primary nature resulting in 
more cell death.  
 
Using the Vybrant DyeCycle Dye, MEFs were sorted based upon DNA content into 
distinct G1, S and G2/M populations (Figure 5.2a). Cells from each population were 
then reanalysed to establish the purity of the population. It must be noted, however, 
that in order to create a stress-free environment for the cells, the cells were sorted 
into cell medium that did not contain the Vybrant DyeCycle dye and thus the dye may 
leach out of the cells after the sort causing the fluorescence profile to shift upon 
second analysis. However, in Figure 5.2a no shift in the fluorescence of the three 
populations is visible. Therefore, this is a viable technique with which to sort cells into 
the different phases of the cell cycle. 
 
5.2 A technique for immunoprecipitating small numbers of 
cells is applicable to FACs sorted cells 
5.2.1 Chromatin may be extracted from mixed populations of 
FACs sorted cells and Drosophila SL2 cells 
One of the main priorities in the development of the technique was to conserve the 
integrity of the cells’ chromatin. Therefore, we were reluctant to sort the cells any 
longer than necessary so as to prevent the induction of a stress response. 5-10,000 
cells per cell cycle fraction only, therefore, were obtainable by cell sorting in a time of  
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15 minutes. This is too low to undertake the conventional ChIP technique used 
throughout the rest of thesis as this requires about 107 cells. Although the small 
number of sorted cells could be increased by sorting for longer, this would prolong 
the stress the cells would undergo, and hence further increase the possibility that the 
histone modifications would be altered. Therefore, the carrier CHIP (CChIP) 
procedure was used to immunoprecipitate the chromatin (Figure 5.3, (O'Neill et al, 
2006). This is a technique developed to be able to immunoprecipitate native 
chromatin from low numbers of cells by “buffering” these low cell populations with 
Drosophila chromatin. It is reliant on the fact that mouse DNA may be distinguished 
from Drosophila DNA by using primers specific to mouse genes in PCR reactions 
during the final analysis. 
 
5.2.2 Primers may be designed that identify specifically mouse 
DNA from a mixed population of mouse and Drosophila DNA 
In order to detect mouse DNA in the bound and unbound fractions using the CChIP 
technique, mouse-specific primers must be used. Such primers must not cross-react 
with Drosophila DNA and so must be rigorously tested. Target genes used in the 
development of this technique were chosen for their cell cycle specific expression 
and so were frequently genes instrumental in the control of cell cycle progression and 
thus were highly conserved. As such, rigorous testing for cross-reaction was 
imperative. Initial testing was carried out using mouse and Drosophila DNA at a 
gradient of annealing temperatures from 56 to 64oC. In such a manner, the optimum 
annealing temperature was determined whereby there is no cross-reaction of the 
primers with Drosophila genomic DNA. The PCR products were then analysed on 
polyacrylamide to ensure a single gene product had been amplified. Two examples 
of primer optimisation are given in Figure 5.4. It is clear from the gel that there is no  
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problem with cross-reaction with Drosophila DNA at any of the temperatures using 
primers designed against cyclin D1 (Figure 5.4a). However, for p57, there is multiple 
cross reactions at all temperatures (Figure 5.4b), and to continue with CChIP 
analysis, these primers had to be redesigned. 
 
During the development of the FACs sort and CChIP technique, an acetyl mark, 
H4K8ac, and a histone H3 lysine 4 methylation mark were chosen for study as they 
were used in the previous study of the Hox genes. The sorted populations (around 5-
10,000 cells) were first pooled with 5 x 107 Drosophila SL2 cells. The chromatin was 
then extracted from cell nuclei, and digested to yield mono and oligo-nucleosomes, 
and then analysed on an agarose gel (Figure 5.5b). This mixed Drosophila and  
mouse chromatin was then immunoprecipitated with antibodies raised to the histone 
modifications chosen above. 
 
From Figure 5.5c, it is evident that there has been efficient precipitation of the SL2 
DNA using the antibodies raised to H4K8Ac and H3K4me2. However, in the pre-
immune control, there is no precipitated material and so there has been no non-
specific binding of the SL2 chromatin. 
 
The real test of the method was whether the specific primers were able to detect 
mouse DNA in mixed DNA populations obtained from the CChIP procedure. From 
Figure 5.5 d, it is evident that the radioactive PCR technique could be used to detect  
 mouse DNA from equivalent concentrations of the unbound and bound DNA 
fractions from the S phase population of cells precipitated with the anti-H3K4me2 
antibody. This is true at both 38 and 40 PCR cycles. This is significant since it is the  
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first time that the CChIP technology has been applied to FACs sorted cells, 
demonstrating the universal applicability of the technique.  
 
There were a number of occasions where mouse DNA could be detected in the 
bound fractions but not the unbound fractions, most likely due to an inhibitory effect 
of the Drosophila DNA (data not shown). Here, both unbound and bound DNA had to 
be serially diluted in order to determine the optimal concentration for PCR 
amplification. 
 
5.3 Analysis of housekeeping genes and cell cycle regulated 
genes 
5.3.1 Housekeeping genes show a varied pattern of histone 
modifications through the cell cycle 
As a control to genes whose expression alters through the cell cycle, a gene whose 
expression does not change through the cell cycle was also studied. This was 
important in order to check that any patterns of modifications seen were specific to 
these genes, and were not just an artefact of different efficiencies of precipitation at 
the different stages of the cell cycle (Fujii-Yamamoto et al, 2005). However, these 
effects are likely to be masked as the majority of the chromatin precipitated was 
asynchronous Drosophila chromatin. It could be envisioned that the condensed 
mitotic chromatin is difficult to digest at the micrococcal nuclease stage and hence 
might precipitate less efficiently which would go on to produce the artefactual result 
that all histone modifications are depleted at this stage in the cell cycle. If all genes 
including the housekeeping gene show similar results at one stage of the cell cycle 
then this result would have to be further investigated. 
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Gapdh is a housekeeping gene. From Figure 5.6, it is possible to see that during G1 
Gapdh is enriched for acetylation at lysine 8 of histone H4. It is then depleted for this 
modification during S phase and again, slightly enriched during metaphase. 
Previously reported expression data shows that Gapdh is, in fact present throughout 
the cell cycle in MEFs, so if acetylation is associated with active transcription, then 
why its status should change during the cell cycle is unclear (Fujii-Yamamoto et al, 
2005). It is possible that there is some previously unobserved cell cycle oscillation in 
Gapdh mRNA expression in MEFs which would require further investigation. From  
Figure 5.6b, it is very apparent that a second active mark H3K4me2 follows a similar 
pattern to H4K8Ac. H3K4me2 is also an active mark. Therefore, it could be that these 
marks are not directly involved in transcription at this Gapdh gene. 
 
5.3.2 Cyclin D displays a possible consequential mark of 
transcription 
The H4K8ac modification was examined at one location in the cyclin D1 promoter. 
The cyclin D1 gene is a cyclin expressed in early G1 (Kiyokawa et al, 1992). It is 
responsible for inducing cyclin E expression via its association with and activation of 
a kinase that phosphorylates and displaces a repressive E2F transcription factor 
complex from the cyclin E promoter. Given the timing of its transcription during the 
cell cycle, it might be expected that the active H4K8ac mark would be maximal during 
G1, if not predictively in metaphase. However, this is not the case. The results show 
that this active acetyl mark is almost depleted in G1 and is significantly enriched in S 
phase, with this enrichment tailing off during metaphase (Fig 5.7). Since this differs 
significantly from the pattern seen at the Gapdh promoter, from the same ChIP 
material, it is therefore, unlikely to be an artefact of precipitation at S phase. This  
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mark, therefore, might be a consequence of transcription, put in place as the 
polymerase passes, or be required for ongoing transcription. 
 
5.4 Further investigation using the cell cycle as a model 
The above study has shown that it is possible to use the CChIP technique upon cells 
separated into the different phases of the cell cycle using FACs analysis. This will 
help to resolve the roles of histone modifications in transcription. If applied to Hox 
gene analysis in embryonic stem cells, for example, this could provide fascinating 
insight into a study that showed that S phase must be crossed before Hoxb genes 
are switched on (Fisher & Mechali, 2003). There may, however, be one hurdle to 
studying ES cells using this technique. Multipotent adult stem cells are often 
characterised by what is known as the side population phenotype. This pheneotype 
is a reduced fluorescence when labelled with dyes such as Hoescht dye (Challen & 
Little, 2006). This results from the active efflux of the dye from the cell. Thus, in order 
to continue this study in ES cells, it is likely that a technique using fixed cells and a 
dye such as propidium iodide would have to be developed. However, the 
demonstration that CChIP may be applied to FACs sorted cells remains an exciting 
development in the investigation of the roles of histone modifications. 
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6 Discussion 
6.1 The putative roles of histone modifications 
Ever since the discovery that histone tails could be post-translationally modified, 
attempts have been made to correlate these modifications with a biological function. 
The modifications are placed by an array of enzymes at multiple locations upon 
histone tails. The conservation of these modifications, and their respective enzymes, 
through evolution suggests the marks are more than a mere “epi” phenomenon. One 
biological function that has been pinned on histone modifications is an active role in 
gene expression control (Allfrey et al, 1964). Initial evidence for this was 
demonstrated using radioactive acetate groups. The high turnover of these groups on 
histones was seen to correspond with high rates of RNA synthesis (Pogo et al, 
1968). However, forty years later there is still a lack of solid evidence for a causative 
role for histone modifications in gene transcription. Linked with this role in active 
transcription, another function in which histone modifications are believed to play a 
part is that of the propagation of cellular transcription patterns, a so called 
“epigenetic” memory. It is these relationships that have been investigated here and 
will be further discussed. 
6.2 The evidence for a causative link between histone 
modifications and transcription 
The evidence for histone modifications playing a role in transcription is currently 
embroiled in genome-wide mapping experiments. A significant initial study using the 
ChIP:chip technique was a genome-wide study in yeast which found that the histone 
modification H3K4me3 was associated with the promoters of active genes in yeast 
(Santos-Rosa et al, 2002). This type of study has now been extended by mapping 
large areas of eukaryotic genomes in a variety of cell types using ChIP:chip and 
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ChIP-seq, a related technique in which “high throughput” DNA sequencing is used 
instead of microarrays (Barski et al, 2007; Li et al, 2007; Mikkelsen et al, 2007; Roh 
et al, 2006). Such studies are able to correlate certain marks with actively 
transcribing or silent genes, however, this kind of evidence merely associates 
specific histone marks with gene transcription status. It does not show that marks 
dictate gene expression patterns. 
 
The potential for protein binding modules to recognise an altered binding surface on 
a nucleosome explains how an active role in transcription might be played by histone 
modifications. In this manner, histone modifications could serve in recruiting 
transcription factors or other proteins to chromatin. Evidence for such a mechanism 
may be found in the histone modification binding modules that do exist such as the 
bromodomains and chromodomains. However, the ability for these domains alone to 
be able to recruit proteins specifically to chromatin has been disputed (Ringrose & 
Paro, 2007). This is because interchanging the chromodomains of HP1 and 
polycomb is insufficient to target the heterologous proteins to targets enriched for the 
“targeting” modification in vivo (Platero et al, 1995; Ringrose & Paro, 2007). If the 
proteins were recruited to the DNA by their chromodomains alone, then swapping the 
domains would be enough to recruit them to the targets of the other protein. 
However, this is not the case, so other mechanisms must exist that recruit the 
proteins to the DNA resulting in gene repression. 
6.2.1 Causative “Predictive” histone modifications 
The finding that the normally active modification, acetylation may be present across 
the whole ß-globin locus at both the genes of the locus and the large non-transcribed 
region provided an “uncoupling” of histone modifications from the process of 
transcription itself (Hebbes et al, 1994). This led to the notion that histone 
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modifications are required for transcriptional “competence” of an entire locus with 
immediate control of transcription being mediated by additional factors. Such an idea 
is consistent with a “predictive” role for histone marks, that is, marks that are present 
in the absence of transcription that are later able to determine transcription from a 
locus.  
 
In an extension of a predictive, causal role for histone modifications in transcription, 
the “histone code hypothesis” was proposed (Strahl & Allis, 2000; Turner, 2002). This 
hypothesis proposes that defined combinations of histone marks determine 
transcription patterns. In such a manner, multiple marks cooperate by recruiting 
proteins with multiple histone-modification recognition sites, or recruit multiple 
proteins, building up the environment for correct gene transcription. Thus, 
combinations of marks should predict specific transcriptional outcomes and could be 
examined in inducible or transcriptionally “poised” systems. The Hox genes provide 
us with such a system. Their transcription may be induced in culture by the addition 
of retinoic acid (Simeone et al, 1990). This gene induction programme follows the 
same temporal pattern of expression as occurs in vivo. Thus, it gives the opportunity 
to study the causal or consequential role of histone modifications, and the predictive 
aspect of the histone code. That is, those modifications present in undifferentiated 
cells may be indicative of future transcription.  
 
6.3 Combinatorial predictive histone modifications at Hox 
genes 
The histone modifications at the promoters of the Hoxb gene cluster were here 
characterised in undifferentiated embryonic stem cells, i.e. in the absence of 
detectable transcription from these genes. One of the major predictions of the histone 
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code, one of the hypotheses under examination, is that histone modifications function 
in a combinatorial manner. Indeed, without combinations working together, the code 
is no longer a code. Here, three modifications were investigated; H3K4me3, H3K9ac 
and H3K27me3. H3K4me3 and H3K9ac have been previously found to be 
associated with active genes and H3K27me3 with repressed genes. The presence of 
any combination of these marks together at the promoters of Hoxb in ES cells may 
therefore indicate cooperation between these modifications in determining later 
patterns of transcription as these genes are not expressed in pluripotent cells. That 
is, they may be “predictive” of transcription at a later stage of development. 
 
At all the promoters of the Hoxb genes studied, the three modifications H3K4me3, 
H3K9ac and H3K27me3 were present. However, the pattern across the Hoxb cluster 
of the actively associated modifications, and the repressive associated modifications 
was very different. Both the actively associated modifications H3K4me3 and H3K9ac 
showed a large variation in their levels at the promoters of the different genes 
examined with their levels being highly correlated. Thus, there is a potential 
interaction between these two marks. There was, however, no general trend in these 
active modifications across the cluster. Both H3K9ac and H3K4me3 showed highest 
enrichment at the promoter of Hoxb9, and lowest enrichment at the promoter of 
Hoxb3. All genes were, nonetheless, consistently more enriched for H3K4me3 than 
they were H3K9ac. Care must be taken, however, when comparing absolute levels of 
different modifications due to the differing efficiencies of precipitation of different 
antibodies. Although this is controlled for by amplifying from the same amount of 
DNA in quantitative PCR reactions from the input and bound samples, this idea of 
different precipitation efficiency must be taken into account when comparing absolute 
levels of different modifications. 
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The polycomb-associated H3K27me3 mark and trithorax-associated H3K4me3 
showed more equivalent absolute levels than the two activating modifications across 
the promoters of the Hoxb genes. Again, possible effects due to different antibody 
precipitation must be kept in mind. However, there is a more important observation 
related to the pattern of this modification across the Hoxb promoters. That is, the 
H3K27me3 polycomb-associated mark shows a more uniform enrichment across the 
cluster at the positions examined than the H3K4me3 mark. It could therefore be 
envisaged that it forms a “blanket” across the cluster. These data are consistent with 
previous data seen at so-called “bivalent” genes (Azuara et al, 2006; Bernstein et al, 
2006). This “bivalent signature” describes the coordinate presence of both active and 
repressive marks originally described in pluripotent cells at the promoters of genes 
key for developmental regulation. At the Hox gene promoters, this was elucidated as 
being “large regions of H3 lysine 27 methylation harbouring smaller regions of H3 
lysine 4 methylation”. As discussed in the introduction to this thesis, the H3K27me3 
mark is deposited by and co-associated with the polycomb repressive complex 2 
(PRC2) and the H3K4me3 a mark deposited by the active transcription maintaining 
trithorax complex (Schuettengruber et al, 2007). The presence of these two marks at 
developmentally regulated gene promoters is believed to “poise” the genes ready for 
transcription whilst keeping them silent in the undifferentiated state. The data here 
generated using NChIP support the initial ChIP:chip characterisation in mouse 
embryonic stem cells showing the patterns of H3K4me3 at the Hox cluster to form 
peaks at the promoters, with H3K27me3 potentially covering the whole cluster.  
The presence of Hoxb gene transcripts was analysed in these undifferentiated 
CCE/R cells by cDNA analysis. This revealed, as expected, that there were no 
detectable Hoxb gene transcripts in these undifferentiated ES cells. The lack of 
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transcription from these genes suggests that marks normally associated with active 
transcription are here not sufficient to be causative of gene transcription. Therefore, 
any role they play in transcriptional activation must occur later in differentiation, when 
the genes are induced. It is important to note, however, that in this study, only full 
transcripts were assessed (the Hox genes are small and primers crossed the major 
exon of all Hox genes). In a separate study, the different forms of Pol lI were 
examined at bivalent genes, and showed the initiating form to be localised to these 
genes (Stock et al, 2007). Furthermore, it was shown that transcripts were produced, 
albeit at low levels. However, although RNA and cDNA was generated using similar 
methods as in this study, the Hoxb cluster was not examined. Therefore as shown 
here, the Hoxb genes may represent a subset of bivalent genes that are not 
expressed in ES cells, even at low levels. 
 
6.3.1 The role of “predictive” modifications in differentiation 
 
The possible predictive role of active marks at the Hoxb promoters was examined by 
differentiating these embryonic stem cells using retinoic acid and attempting to 
correlate levels of active marks at Hox genes with their induction of expression. For 
this, cells were first induced to differentiate by replating and withdrawal of LIF, and 
then pushed down the neuroectoderm lineage by the addition of retinoic acid 
(Rohwedel et al, 1999). This addition of retinoic acid has previously been shown to 
induce expression from the cluster in a co-linear fashion (Simeone et al, 1990). The 
genes do, indeed, show a co-linear timing of expression from the Hoxb cluster, co-
linear with their location on the chromosome in this system. For example, Hoxb1, the 
most 3’ gene is switched on first at day 2, and Hoxb13, the most 5’ gene, is switched 
on last at day 9. This pattern of induction does not, however, correlate with the levels 
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of active modifications at these genes. For example, Hoxb9 is the gene with the 
highest level of active modifications but is not the first gene to produce mRNA. 
Conversely, Hoxb3 that shows the lowest level of actively associated histone 
modifications is not the last to be induced upon differentiation. Temporal co-linearity 
is achieved irrespective of the levels of active histone modifications before 
differentiation. This is still consistent with a predictive role for these modifications in 
permitting future transcription from the locus upon differentiation, however, absolute 
levels, appear to be of no importance in a “predictive” role.  
 
These data are also consistent with another study in mouse ES cells studying the λ5-
VpreB1 locus. The VpreB1 and λ5 genes are expressed in pre-B and pro-B cells to 
form a surrogate antibody light chain at these highly specific stages of B cell 
development (Szutorisz et al, 2005). They are, therefore, not expressed in embryonic 
stem cells. At this early undifferentiated stage, however, NChIP data showed an 
intergenic cis-acting region is marked by histone H3 acetylation and H3 lysine 4 
methylation. These marks then spread towards the genes as the cells differentiate 
toward the B-cell lineage and are switched on. Importantly, if the ES cells were 
induced to differentiate down non-lymphoid lineages, then theses active marks 
disappear. Thus at this B cell-specific locus, active histone marks serve in setting up 
transcriptional competence in a predictive manner. The active marks elucidated at 
the Hoxb locus could be playing a similar role. 
 
6.4 The effects of externally induced hyperacetylation upon 
CCE/R cells 
In order to further elucidate the role that active histone modifications have at the Hox 
genes in transcription, embryonic stem cells were treated with the HDAC inhibitor 
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valproate. This inhibitor is know to cause global hyperacetylation in cultured cells, 
and its addition was intended to cause an increase in acetylation at the Hoxb locus. 
To further elucidate the role of these histone modifications at the Hoxb locus, any 
effects on transcription both in undifferentiated cells, and later on, in differentiation 
were also examined. However, the experiment revealed a valproate sensitivity that 
was surprisingly unique to the Hox genes and warrants further discussion. 
 
6.4.1 High turnover of acetate groups at Hox genes 
The addition of valproate to undifferentiated ES cells resulted in hyperacetylation at 
the promoters of the Hoxb cluster. However, its addition was unable to induce 
hyperacetylation at the promoters of any other genes examined, including the 
housekeeping gene Gapdh and the pluripotency markers, Nanog and Pou5f1. Such a 
refractory nature of gene promoter nucleosomes to valproate treatment has also 
been seen in HL60 cells (Vibhor Gupta, thesis 2008). Hox genes are, therefore, 
exceptional in their response to valproate. This sensitivity of Hox genes to valproate 
indicates that there is a high turnover of histone acetylation at these genes when 
compared with other genes. High turnover of histone acetylation has been used to 
define a class of genes that are highly responsive to mitogenic stimulation (Clayton et 
al, 2006; Hazzalin & Mahadevan, 2005). This was proposed to be a mechanism that 
“poised” these genes ready for transcription. Hox genes too are said to be “poised” 
and so could exhibit a similar high turnover of acetylation putting them in a similarly 
transcriptionally-ready state.  
 
6.4.2 The enzymology of high modification turnover at Hox genes 
The high turnover of histone acetylation seen at the promoters of the Hox genes, and 
their resultant sensitivity to valproate may be the result of the enzymes localised at 
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the promoters of these genes. An interesting early observation, indicating a possible 
role for histone deacteylation in polycomb silencing was that if both the Drosophila 
HDACI gene and polycomb genes were mutated in Drosophila, the two genetically 
interact, exaggerating the polycomb mutant phenotype (Chang et al, 2001). 
Subsequently The PRC2 complex component, Eed has been shown to interact with 
the class I HDAC, RPD3 and that the HDAC TSA is able to relieve transcriptional 
repression mediated by Eed. This suggests a role for histone deactylation in 
polycom-medited gene silencing (van der Vlag & Otte, 1999). Furthermore, the 
histone binding proteins RbAp46 and RbAp48 have been found in isolated PRC2 
complexes from HeLa nuclear extracts. As these complexes are repressive 
complexes, it is easy to infer that the presence of these histone binding proteins 
within the complex is in order to target a ‘repressive’ chromatin environment within 
the gene locus (Kuzmichev et al, 2002). Thus as PRC2 targets, this may provide an 
explanation for the sensitivity of the Hox genes to hyperacetylation by valproate as 
Hox genes. This is particularly so as the HDAC isolated from, and active in PRC2 
complexes is HDAC and valproate is a class I HADAC inhibitor, inhibiting HDACs I 
and II. This sensitivity due to the presence of polycomb complexes, would, however, 
have to be confirmed by proving localisation of polycomb and HDAC I at these 
genes. This could, however, explain the relative lack of sensitivity of Gapdh, Pou5f1 
and Nanog neither of which are polycomb group targets in ES cells.  
 
In addition to the HDACs, the HATs at the HoxB cluster could also be responsible for 
this hypersensitivity to valproate. The possible role of the histone acetyl transferase 
GCN5, in depositing the H3K9ac mark was also investigated. GCN5 knock-out mice 
and ES cells have been generated in a previous study (Lin et al, 2008). In these 
knock-out mice, Homeotic transformations are seen coordinate with the mis-
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localisation of expression of Hoxc8 and Hoxc9. This HAT was therefore chosen as a 
likely candidate for Hox gene acetylation. The role of this enzyme in histone Hoxc 
and Hoxb histone acetylation was tested using valproate and any changes in histone 
modifications H3K9ac, H3K4me3 and H3K27me3 assessed. If GCN5 is, indeed, 
responsible for histone acetylation at these genes, then no response to valproate 
would be visible.  
 
At the Hoxc9 gene, in the wild-type cells, hyperacetylation in response to valproate 
was seen, while, in the knock-out cells, the gene was not able to respond to 
valproate. Therefore, GCN5 must play a role in acetylation in response to valproate 
at this gene. A similar effect was seen on H3K4 methylation which exhibits elevated 
levels in response to valproate in the wild type but not the knock-out cells. An 
analogous phenomenon was seen at the Hoxc8 promoter, whereby there was 
hyperacetylation in the wild-type but not in the knock-out cells upon valproate 
treatment. However, there was no increase in the levels of H3K4me3 in either the 
wild type or the knock-out cells at these genes. Therefore at both Hoxc8 and Hoxc9, 
GCN5 plays a role in acetylation of the genes in response to valproate, though it is 
worth noting that H3K9 acetylation is not abolished in the knock-out cells. In stark 
contrast with the changes seen at the Hoxc8 and Hoxc9 genes, at all the Hoxb genes 
examined, the changes in histone acetylation were very similar in wild-type and 
knock-out cells, indicating that it is not GCN5 that specifically is able to acetylate 
histones at the Hoxb promoters. Rather, either it plays no role in acetylation at these 
genes, or there are other enzymes that are able to compensate for GCN5. Thus, the 
mechanisms for histone acetylation, and most probably gene activation are not 
conserved at Hox gene clusters. The GCN5 enzyme most probably operates in two 
different complexes in mammals (Nagy & Tora, 2007). Firstly, in a complex 
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analogous to the yeast transcriptional activator SAGA complex, and secondly in a 
complex known as ATAC. The possible localisation of these complexes at the Hoxc8 
and Hoxc9 genes would be an interesting further line of investigation. 
 
6.4.3 Reversible effects of Valproate on pluripotent gene 
expression 
Again, whilst treating with valproate, interesting, possibly linked, global phenomena 
occurred that also warrant further discussion. As mentioned above, the pou5f1 and 
Nanog gene promoters show no change in histone acetylation in response to 
valproate, However, they do show a change in H3K4me3 levels. This change is a 
decrease that is contrary to the global increase seen in this modification. The 
decrease in H3K4me3 levels at the promoters of Pou5f1 and Nanog are concomitant 
with a decrease in expression from these gene loci. In addition, a change in the 
cellular morphology upon treatment with valproate was observed, that hinted at 
differentiation of the cells. Since the changes in gene expression at Pou5f1 and 
Nanog are coordinate with changes in histone modifications, it is difficult to say 
whether the histone modification change is a requirement or a consequence of 
transcription. The decrease in expression from this locus is, however, not linked with 
a rise in H3K27me3. This is consistent with results from a previous study, suggesting 
Pou5f1 repression is under a mechanism of control independent from polycomb 
repression (Boyer et al, 2006).  
 
The repression of the pluripotent markers Nanog and Pou5f1 seen, and changes in 
morphology of these embryonic stem cells induced by valproate are consistent with 
previous studies using the histone deacetylase inhibitor TSA (Karantzal et al, 2008; 
McCool et al, 2007). One of these studies combined treating ES cells with 50nM TSA 
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for 12 hours and performing subsequent microarray analysis. Interestingly, in this 
study, similar changes in morphology of the cells were seen to those seen here upon 
addition of valproate (Karantzal et al, 2008). When the TSA treated cDNA 
populations were compared with cDNA generated from cells differentiated into 
embryoid bodies, genes were up or down regulated in the same direction under both 
conditions. In the second study, treatment with TSA was again shown to recapitulate 
the effects of differentiating by removal of LIF. Effects monitored include histone 
acetylation increases and induction of gene expression at Hoxb1 and Nestin (a 
neuroectoderm marker), and a reduction of expression of Nanog and Pou5f1. 
Importantly in this study, markers of all three germ lineages were induced by both LIF 
withdrawal and TSA treatment, indicating a loss of pluripotency but not a specific 
differentiation (McCool et al, 2007). Furthermore these changes were reversible upon 
removal of TSA. The authors propose this represents a reversible phenotypic change 
in the loss of pluripotency, that requires an additional signal for the ES cells to 
commit to differentiation. In the studies here, the reduction of Pou5f1 and Nanog 
expression are reversible upon wash out of the valproate (E. Boudadi, unpublished 
data) as are the changes in cellular morphology. Thus treatment of a HDAC inhibitor 
does not result in commitment to differentiation, merely a transient loss of 
pluripotency.  
 
There is, of course, a second possibility, that all that is seen upon treatment with 
valproate is not a “higher” loss of pluripotency, but specific effects at specific 
valproate sensitive genes. It could, therefore be a mere coincidence that the genes 
displaying valproate-related effects on gene expression are genes related to 
pluripotency. 
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6.5 The effects of increasing active histone modifications at 
the Hoxb cluster 
The addition of 1mM valproate for 2 and 8 hours in CCE/R cells was able to induce 
hyperacetylation at all of the Hoxb gene promoters examined as discussed above. 
Further to the valproate sensitivity of the acetylation marks at the Hoxb cluster, the 
H3K4me3 modification was also sensitive to valproate treatment. The H3K4me3 
mark increases concomitant with the increase in acetylation. Therefore, there is an 
increase in two active histone modifications at the Hoxb cluster upon valproate 
treatment. These changes in histone modifications seen in response to valproate are 
independent of transcription from the Hoxb loci as assessed by changes in mRNA 
levels of the Hoxb genes. That is, despite an increase in active histone modifications 
at the loci, no transcription was induced. Again, this was assessed by RNA 
production only, and it is possible that there is a higher level of recruitment of RNA 
polymerase to the promoter.  
 
6.5.1 Histone modification marks in determination of gene 
transcription programmes from the Hoxb locus 
At the Hoxb genes studied, it is likely that the induction of transcription requires the 
extra signals received from retinoic acid signalling pathways. In undifferentiated ES 
cells, at the silent but actively marked Hoxb cluster, the retinoic acid signal may take 
its effect by removing the repressive H3K27me3 mark. The effect of valproate on Hox 
gene expression was therefore further explored in the differentiation system in an 
attempt to link increased levels of actively associated histone modifications with 
induction of gene transcription. It was postulated that, if actively associated histone 
modifications play an active role in “poising” Hox genes for expression then increases 
in their levels in undifferentiated cells may result in early expression upon the final 
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“push” from retinoic acid signalling. In addition, in a study using the HDAC inhibitor 
TSA, TSA treatment for 6 days resulted in inhibition of differentiation of these cells. 
However, upon removal of TSA, still in the absence of LIF, embryoid bodies were 
formed much more rapidly than had they not been pre-treated with TSA (Lee et al, 
2004). Thus, HDAC treatment in the presence of the signal to differentiate may 
induce gene expression changes more rapidly upon subsequent differentiation, 
possibly due to hyperacetylation at these promoters. Cells were, therefore induced to 
differentiate in the presence of valproate.  
 
In this experiment, the undifferentiated cells were first incubated in valproate for 8 
hours, an incubation period shown in the previous experiment, to induce 
hyperacetylation at Hoxb gene promoters. Cells were then induced to differentiate by 
detachment and LIF withdrawal, and incubated in valproate for a further 8 hours. This 
was in order to achieve overlap between hyperacetylation, and the signal to 
differentiate (Figure 5.3). Retinoic acid was added two days after the initial signal to 
differentiate as previously. In this study no clear changes in gene expression timing 
from the Hoxb gene cluster upon treatment with valproate were observed. The cluster 
maintained its general feature of co-linear timing, with timing equivalent in untreated 
and treated cells. However, there were subtle differences between levels of gene 
transcripts at Hoxb2, Hoxb5 and Hoxb9 in treated and untreated cells. That is, these 
genes appeared to show earlier transcription in the treated cells. That this did not 
occur at the most 3’ gene, Hoxb1 disputes a mechanism of Hox gene activation 
whereby progressive chromatin opening induces sequential Hox gene transcription 
(Kmita & Duboule, 2003). However, it is difficult to tell whether these slight changes 
represent significant early induction, or just an increase in “leaky” expression that is 
seen at all genes before full induction. Such leaky expression may result from the 
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induction of the gene at different lineages of the embryoid body. Its increase may 
therefore result from valproate driving the cells down this different lineage. It may 
also be due to the low resolution of the differentiation system used. Overall, though, 
hyperacetylation and increased levels of H3K4me3 do not have a major effect upon 
the timing of Hoxb gene expression in differentiation when overlapped with the signal 
to differentiate.  
 
6.6 Predictive, permissive marks are overridden by a 
repressive mechanism 
The above data are consistent with evidence for predictive permissive histone 
modifications seen elsewhere in embryonic stem cells (Azuara et al, 2006; Bernstein 
et al, 2005). Such modifications are normally associated with active genes, though 
here are present in the absence of transcriptional activity. Even in their increase with 
the externally added agent, valproate, transcription cannot be induced in 
undifferentiated cells, or the timing altered in differentiating cells. However, in all of 
the scenarios examined, the H3K27me3 repressively modification was maintained, 
and it may be that this mark is intertwined in a dominant repressive mechanism over 
the activating modifications. That is, that the “blanket” of H3K27me3 seen over the 
Hoxb cluster is able to suppress any recruitment of transcriptionally activating 
proteins. This potential dominance of the H3K27me3 mark is confirmed in Eed 
knock-out ES cells (Boyer et al, 2006). Eed is a component of the PRC2 complex and 
works alongside Ezh2, the H3K27 methyl-transferase of the same complex. ES cells 
cannot be derived from blastocycts lacking the Ezh2 enzyme, however ES cells 
deficient in the Eed cofactor are viable and do show a loss of the H3K27me3 mark at 
PRC2 targets (Montgomery et al, 2005). Importantly for this study, Hoxb2, b4, b7 and 
Hoxb13 show significant de-repression in these cells when compared with wild-type 
155 
ES cells (Boyer et al, 2006). Therefore, the loss of H3K27me3 results in the 
expression, in undifferentiated ES cells of a subset of the Hox genes examined in this 
study, showing a possible repressive dominance of this mark that reduces the 
activating marks to “predictive” marks. ES cells deficient in Suz12 are also available 
and this repressive dominance of the PRC2 related mark could be further 
investigated within these cells (Suz12 is another cofactor for the EZH2 enzyme 
activity) (Pasini et al, 2007). Furthermore, in another study, differentiating ES cells by 
concomitant retinoic acid addition and removal of LIF showed the loss of H3K27me3 
at Hoxb1 the retinoic acid response element coordinated with its gene expression 
upon differentiation (Lee et al, 2007a). Whilst this does not show removal of 
H3K27me3 to be the limiting factor in induction of expression, the coincident timing of 
the two events is significant with regards to a possible dominant repressive role for 
the H3K27me3 mark.  
 
Contrary to data seen in this study with valproate, the HDAC inhibitor TSA was able 
to induce Hoxb1 expression after 5 hours of treatment in mouse ES cells, suggesting 
that active histone modifications may sometimes override repressive modifications at 
this gene (McCool et al, 2007). The most likely cause of this difference is the different 
in HDAC inhibitor used. As mentioned above at the beginning of chapter 3, valproate 
subjects the cells to some non-specific effects to which TSA is not prone. Most, 
notably, the disruption of Wnt signalling (a pathway involved in stem cell 
differntiation) might here be most relevant as an explanation as to why Hoxb1 may 
be induced by treatment with TSA and not valproate. The chelation of zinc and the 
sequestration of acetyl CoA may also provide some explanation, as might the need 
to use valproate at a much higher concentration than TSA. Such a higher 
concentration might exaggerate the non-specific effects of valproate with comparison 
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to TSA. It is possible also that their non HDAC deacteylase targets are slightly 
different, resulting the activation or repression of different signalling pathways. In 
addition, some differences between the two sets of experiments may be explained by 
the differences in ES cell line used. Whilst differences in gene expression patterns 
between mouse ES cell lines are subtle, they do exist, and so could result in slightly 
different responses to valproate (Sharova et al, 2007). In another study, treatment of 
undifferentiated ES cells with TSA for 14 hours upon removal of LIF, but without 
addition of retinoic acid resulted in the induction of expression of Hoxa1 (Lee et al, 
2007a). These conditions resulted in histone hyperacetylation but no removal of 
H3K27me3. In this same study, differentiation by removal of LIF and addition of 
retinoic acid results in the removal of this mark and histone hyperacetylation at 
Hoxa1. TSA treatment was also a requirement for Hoxa1 expression upon LIF 
removal in the absence of retinoic acid treatment as removal of LIF alone does not 
induce a rise in H4 acetylation levels. Therefore, here, at Hoxa1 histone acetylation 
caused by an external factor appears to be able to induce gene transcription that 
overrides any H3K27me3 present at the gene, so loss of H3K27me3 is not the final 
determining factor in transcription, though it does occur during “normal” 
differentiation. The experiments performed at the HoxA locus are most similar to the 
experiments performed here with valproate whereupon the genes were pre-treated 
and then induced to differentiate by the removal of LIF, overlapping with the 
valproate treatment for 8 hours. The most equivalent time point between this study 
and that at the Hoxa cluster is that after 8 hours of LIF removal. However, here, 
valproate is not able to induce expression of the Hoxb genes, despite inducing 
histone hyperacetylation. Indeed, Hoxb gene expression continues in a co-linear 
fashion much as in control cells. Since the main discrepancies between the two 
studies are the Hox genes examined and the HDAC inhibitor used, these must be the 
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main reason for any differences observed. Therefore, it is most likely that the Hox 
genes have differing control mechanisms, as seen in the different use of GCN5 at 
Hoxb and Hoxc, and utilise different tailored mechanisms for control of gene 
expression. The use of a different histone deacetylase inhibitor could, too be of 
significance. The two inhibitors may have subtly different specificities and this could 
even be applicable to non-histone targets such as transcription factors(Thorne et al, 
2009). 
 
There is further evidence that suggests that H3K27me3 is not a “master” regulator as 
indicated by the data in this study at Hoxb. Such evidence may be found in Suz12 
knock-out ES cells (Pasini et al, 2007). Suz12 is a component of the PRC2 complex 
that is required for the H3K27me3 methylase activity of the complex These cells 
show a significant loss of the H3K27me3 mark and an increased expression of some 
but not all of the PRC2 targets that have lost this mark. Therefore, H3K27me3 is not 
always a “dominant repressive” mechanism and alternatives must be explored to 
explain the presence of active marks at the transcriptionally inactive Hoxb cluster in 
embryonic stem cells. 
6.6.1 Alternative repressive control at the Hoxb cluster 
The increase in acetylation at the Hoxb genes in response to valproate in 
undifferentiated ES cells here is consistent with data shown in embryonic stem cells 
at Hoxb1 and Hoxb9 using the histone deacetylase inhibitor TSA. In this study, TSA 
was able to induce hyperacetylation at these genes independent of a change in 
transcription (Chambeyron & Bickmore, 2004). Also, in this study, significant levels of 
activating modifications were seen at Hoxb1 and Hoxb9 before their transcription as 
in the experiments described in this thesis. However, an alternative explanation was 
proposed for the repression of transcription at this cluster not related to repressive 
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histone modifications, namely changes in the higher order genome 
architecture(Chambeyron & Bickmore, 2004). Upon activation, a large 
decondensation of the locus was seen, something that is not recreated by treatment 
with TSA. Regions of the cluster were also seen to loop away from their chromosome 
territory upon activation. Thus, for the cluster to become transcriptionally competent, 
it must overcome chromatin condensation. Note, however, chromatin 
decondensation could still result in the loss of H3K27me3 from the Hoxb genes, 
possibly in a complex interplay, that should not be thought of as hierarchical but 
cooperative. A cooperative mechanism could coordinate the multiple transcription 
factors that must be involved in this complex interplay. For example, retinoic acid 
signalling is known to be involved in the activation of the Hox genes, and therefore 
this too must play a role in activation of gene expression. 
 
A discussion on gene silencing would be incomplete without the inclusion of DNA 
methylation. There is evidence that DNA methylation plays a role in Hox gene 
silencing. The polycomb component EZH2 may associate with the DNA methyl 
transferase for more permanent silencing of polycomb targets, such as the Hox 
genes (Vire et al, 2006). In addition, Hox genes were identified as CpG island 
containing tissue-specifically methylated genes, indicating a role for DNA methylation 
in their tissue-specific expression (Illingworth et al, 2008). Hox genes were also found 
to be derepressed in MEFs lacking Lsh a component involved in DNA methylation, 
though this study did not include a survey of the Hoxb cluster (Xi et al, 2007). Thus, 
although the evidence points towards DNA methylation being important in control of 
Hox genes, it also suggests that its role comes at a later stage in development than 
in the study here. Thus, it is unlikely that DNA methylation is the mechanism by 
which the activating modifications seen in undifferentiated cells are overridden. 
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6.6.2 Cross-talk implements the predictive code 
The histone code hypothesis predicts that it is combinations of modifications that 
determine transcriptional outcomes. These combinations may serve to bring in 
multiple or individual proteins that may recognise more than one histone mark. They 
may also result in the ejection of proteins from chromatin. For such a hypothesis to 
be true, there must be mechanisms in place in cells for the deposition of such 
combinatorial marks. These may be manifest in cross-talk between histone 
modifications through their respective enzymes. For example, cross-talk may arise 
from different activities acting as complexes such as the MLL and MOF enzymes, 
histone methyl transferases and histone acetyl transferases that have been found in 
a complex together (Dou et al, 2005). Thus, the localisation of this complex to 
chromatin results in the deposition of these marks at similar locations on genes. 
Combinatorial modifications may also arise from one modification resulting in the 
recruitment of a second histone-modifying enzyme. For example, in yeast, the Yng1 
PHD finger is able to bind to the H3K4me3 modification and recruit histone acetyl 
transferase activity to these loci. Here, there is evidence for cross-talk between 
H3K4me3 and histone acetylation as has already been described in HL60 cells 
(Nightingale et al, 2007). In this study in ES cells at the Hoxb cluster, the evidence for 
such a cross-talk is found firstly in the correlation between the patterns of H3K9ac 
and H3K4me3 modifications at the Hoxb cluster, and secondly in their similar 
responses to valproate. The correlation of the two marks means that the pattern of 
modifications across the promoters of the Hoxb genes is similar for the two active 
modifications (Figure 3.1). Indeed, if plotted against each other, a highly significant 
correlation can be calculated in both CCE/R cells and wild type 3G4 cells (Figure 
6.1a and b). This cross talk also means that a significant increase in response to 
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valproate is observed at the promoters of Hoxb genes for both these modifications in 
CCE/R cells. Interestingly, in GCN5 knock-out 3G4 cells, there is no such significant 
correlation between the two marks (Figure 6.1c). However, there is one outlier, 
Hoxb5 that is skewing the regression analysis, resulting in an insignificant 
correlation. Removal of this outlier results in an r2 of 0.8. Thus, it cannot be 
concluded that GCN5 has a pivotal role to play in the cross talk of these marks. In 
these 3G4 cells, however, in neither wild type nor knock-out there is not an increase 
in H3K4me3 upon valproate treatment. This does indicates a difference in histone 
cross talk in these cells most likely due to the different ES cell lines used.  
 
A self perpetuating mechanism has been proposed that may explain the link between 
the histone modifications H3K4me3 and H3K9ac (Figure 6.2) (Vermilyea et al, in 
press). The balanced action of histone acetyl transferases, and histone deactylases 
result in a dynamic level of histone acetylation at the H3 tail (Figure 6.2a). Acetylated 
peptides are shown to be better substrates for the lysine-specific methyl transferases 
(Figure 6.2b) (Nightingale et al, 2007). Therefore, any tail with high levels of histone 
acetylation, is likely to have high levels of H3K4methylation as shown here at the Hox 
genes. H3K4 methylation is then able to recruit the SAGA/Slk histone acetyl 
transferase via the H3K4me3-binding Chd1 thereby maintaining acetylation levels at 
these loci (Pray-Grant et al, 2005)(Figure 6.2c). Therefore, the levels of the two 
modifications would be maintained in close concert in a sort of “feed forward” loop. 
This would be still be true if the cells are treated with an HDAC inhibitor, and may 
explain why the levels of H3K4me3 increase upon treatment with the HDAC inhibitor  
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(Figure 6.2 b, d). Therefore, this model may explain cross talk between H3K9ac and 
H3K4me3 at the Hoxb cluster. Further study into histone cross-talk may provide 
further interactions that are involved in the placement of a “code”. Here, at the Hoxb 
cluster this code serves in a predictive fashion as there is no transcription from the 
Hoxb genes despite the presence of active modifications.  
 
6.7 Memory of histone modification changes 
There is a final reason for choosing the Hox gene cluster as a model system in which 
to study histone modifications. Histone modifications are often defined as epigenetic 
modifications. The epigenetic information is the information necessary to interpret the 
underlying DNA sequence and such information is believed to be inherited as part of 
a cell “memory”. That is, for a cell to retain its identity, it must retain its gene 
expression programme from one generation to the next via these epigenetic 
mechanisms. Due to their association with active or inactive patterns of gene 
expression, it has been postulated that histone modifications are inherited through 
the cell cycle as part of this epigenetic programme and are responsible for 
maintaining gene expression programmes through an active role in transcription.  
 
The role of histone modifications in “epigenetic” maintenance of gene expression 
programmes is, however, widely disputed (Ptashne, 2007). For histone modifications 
to be truly epigenetic, they would need to be inherited through the cell cycle. This 
includes two critical phases where epigenetic modifications could be wiped clean. 
Firstly, in mitosis there is no gene expression and so expression patterns must be 
reintroduced in G1, and secondly in S-phase epigenetic mechanisms must be re-
introduced to newly synthesised strands of DNA. The mechanistic explanation of how 
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histone modifications might be propagated through S-phase is still very much an 
ongoing work (Probst et al, 2009). For example, a recent study attempting to identify 
the mechanisms that transmit H3K27methylation through the cell cycle showed 
EZH2, the enzyme that deposits this mark, at the site of DNA replication, but was 
unable to coordinate this with the cell cycle inheritance of H3K27me3, EZH2 
association and gene repression (Hansen et al, 2008).  
 
6.7.1 The inheritance of histone modifications through mitosis 
The inheritance of histone modifications through mitosis is potentially highly 
significant as they could then be responsible for re-introducing gene expression 
programmes in G1. Memory of this transcription is not maintained by transcription 
factors since most sequence-specific transcription factors are removed from the DNA 
during mitosis (Martinez-Balbas et al, 1995). Histone acetyl modifying enzymes, too 
are removed from the DNA during mitosis leaving histone modification patterns static 
(Kruhlak et al, 2001). There have been few studies that display inheritance of histone 
modification changes through mitosis. An initial indication that histone modifications 
could be remembered through mitosis was observed in the yeast S. pombe. Yeast 
were grown for several cell cycles in TSA, a treatment that was able to induce 
hyperacetylation at normally silent genes inserted into centric heterochromatin. Both 
the acetylation, and the active state of these genes was maintained through several 
cell cycles. However this concomitant inheritance of both functions (i.e. both marks 
and transcriptional activity) makes it difficult to resolve if it is the acetylation that is 
maintaining transcription, or vice versa. More recently, inappropriate transcriptional 
states were shown to be inherited in nuclear transfer studies in Xenopus. The first 
nuclear transfer took a muscle lineage nucleus and placed it in a recipient enucleated 
egg, the second round of transfer took non-muscle cells from the resulting blastula 
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and transferred this nucleus to a recipient enucleated egg. In this second embryo the 
muscle gene MyoD was expressed in non-muscle lineages even after these two 
successive nuclear transfer experiments. Therefore, even after two periods of 12 cell 
cycles of transcriptional silence after nuclear transfer, memory of MyoD expression 
remained (Ng & Gurdon, 2008). This inappropriate expression was reliant upon the 
histone H3.3 and its associated H3K4me3 modification, providing evidence for a role 
of chromatin in epigenetic memory. Finally, in an attempt to analyse memory though 
the cell cycle studies looking at active genes at defined points in the cell cycle have 
shown that histone modifications do remain in mitosis on genes that were active 
throughout G2 phase (Kouskouti & Talianidis, 2005; Valls et al, 2005).  
 
The classical example for stable maintenance of gene expression programmes can 
be found in the polycomb and trithorax proteins. In the developing embryo, Hox gene 
expression programmes must be maintained into adulthood. The trithorax and 
polycomb group proteins are known to be largely responsible for maintenance at 
these genes, where this association has been proposed to be propagated by the 
maintenance of their associated histone modifications, H3K4me3 and H3K27me3. 
This is because the proteins themselves are displaced from chromatin during mitosis 
(Buchenau et al, 1998). Therefore the Hox genes were chosen in this study as a 
good model in which to study potential inheritance in externally-induced histone 
modifications. Indeed, a role for histone modifications in epigenetics is not possible if 
a change in their levels cannot be maintained. 
 
Recent experiments in the early embryo have demonstrated that memory 
mechanisms for externally-induced histone modifications in the early embryo at Hoxb 
genes may exist (verMilyea et al in press). When embryos were cultured in the 
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presence of valproate from the 8-cell to the morula stage, the valproate washed out, 
and the embryos further cultured to blastocyst, higher levels of both histone 
acetylation and H3K4 trimethylation were observed in the treated versus the 
untreated blastocysts. Thus, changes in histone modifications earlier induced by 
valproate were remembered later in differentiation. Interestingly, the initial increase in 
“activating” histone modifications, and the maintenance of these modifications 
occurred in the absence of any transcription from the locus. Therefore, the memory 
mechanism was transcriptionally independent. 
 
Given the results in the early embryo, it was decided to extend the valproate 
treatment studies here to analyse memory mechanisms present over the Hox 
clusters in undifferentiated CCE/R cells. Undifferentiated CCE/R cells were treated 
with valproate for 8 hours, the valproate washed-out, and any memory of valproate-
induced histone modification changes analysed 48 hours later. It is known that such 
a wash-out results in rapid removal of any global histone hyperacetylation, however, 
the effect upon individual genes in this system is not known. An 8 hour treatment and 
wash-out did not result in any visible memory of histone modifications changes at the 
Hoxb genes. Both an initial 8 hour treatment and a 16 hour treatment resulted in 
hyper H3K9 acetylation and increases in H3K4 tri-methylation as seen previously, 
but these were consistently not maintained over the 48 hour period. Moreover, again 
the increases in ‘active” modifications were transcription independent, both at their 
initial increase, and upon their wash-out 48 hours later. That is, at all timepoints 
examined, there was no detectable transcription from these genes. Thus there is a 
major difference in ES cells and early embryos, in that changes in histone 
modifications are not maintained in ES cells at Hoxb genes, but are maintained in 
early embryos. This is despite the similar treatment times (16hrs in ES cells and 
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18hrs in early embryos). However, the two studies do show commonality in their 
transcription-independence of histone modifications. That is, an increase in active 
histone modifications in both studies failed to result in an increase in transcription. 
 
The discrepancies in histone modifications seen in the early embryo and ES cells are 
surprising given the mechanism discussed above that nicely models cross talk at the 
Hoxb locus (Figure 6.2). Given the likelihood that these enzymes operate in both the 
early embryo and in ES cells, it is surprising that no memory of histone modification 
changes was seen in ES cells. This could possibly be the result of different enzyme 
complexes being utilised at these different stages of development, therefore resulting 
in the cross-talk seen in ES cells not persisting into memory in this system. 
 
The differences in memory of histone modification changes seen between memory in 
ES cells and in early embryos could, undoubtedly, result from the difference in 
developmental stage the embryonic stem cells represent compared with the early 
stages examined in early embryos. ES cells are derived from the epiblast of the inner 
cell mass of the mouse blastocyst. Thus, they represent a stage post that treated 
with valproate in the studies on the early embryo. Therefore, could it be that memory 
mechanisms are only displayed in response to valproate at this early stage? 
Possibly, this represents an early stage in which epigenetic mechanisms are put in 
place, and therefore any external alterations would be remembered along with the 
embryos normal epigenetic programme. Therefore, a later treatment with valproate at 
the blastocycst stage might recapitulate the findings found in this study, i.e. that 
external alterations in histone modifications are not remembered at the Hoxb cluster. 
Alternatively, the validity of ES cells as an in vitro model for epiblast cells has also 
been called into question (Silva & Smith, 2008). Therefore, the possible 
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discrepancies may be simply that ES cells are not a valid model for in vivo studies. 
However, the ability to differentiate ES cells into many different lineages contradicts 
this (Murry & Keller, 2008). That is, ES cells are able to respond to epigenetic 
alterations from external signals to differentiate. Thus, the discrepancies seen 
between the two studies are likely to arise due to the differences in developmental 
stage examined, with the situation in ES cells representing a true picture of the 
epigenetic mechanisms within epiblast cells of the blastocyst. 
 
Thus the active histone modifications at the Hoxb cluster show a high turnover, but 
are not directly linked with transcription. This could be an effect of a dominant 
repressive H3K27me3 mark. Furthermore the modifications H3K9ac and H3K4me3 
are highly correlated but this close relationship does not self perpetuate to leave a 
memory of externally-induced increases in histone modifications. Therefore 
transcription independent cross-talk is seen but the dynamic nature of the 
modifications at the cluster in ES cells means that the equilibrium soon finds its 
natural balance after external peturbation.  
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